{
  "resourceType": "Bundle",
  "id": "all-predictions",
  "type": "collection",
  "timestamp": "2026-02-26T08:17:36.257672",
  "total": 1457,
  "link": [
    {
      "relation": "self",
      "url": "https://twtxgnn.yao.care/fhir/Bundle/all-predictions.json"
    }
  ],
  "entry": [
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/tenofovir_alafenamide",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "tenofovir_alafenamide",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "tenofovir_alafenamide",
              "display": "Tenofovir alafenamide"
            }
          ],
          "text": "Tenofovir alafenamide"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "Descovy適用於與其他抗反轉錄病毒藥物併用，藉以治療人類免疫不全病毒第一型(HIV-1)的成人與..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tenofovir_alafenamide-feline-acquired-immunodeficiency-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tenofovir_alafenamide-feline-acquired-immunodeficiency-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tenofovir_alafenamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "feline acquired immunodeficiency syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tenofovir_alafenamide-simian-immunodeficiency-virus-infection",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tenofovir_alafenamide-simian-immunodeficiency-virus-infection",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tenofovir_alafenamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "simian immunodeficiency virus infection"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tenofovir_alafenamide-neurodevelopmental-disorder-with-ataxic-ga",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tenofovir_alafenamide-neurodevelopmental-disorder-with-ataxic-ga",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tenofovir_alafenamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/trabectedin",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "trabectedin",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "trabectedin",
              "display": "Trabectedin"
            }
          ],
          "text": "Trabectedin"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "適用於治療患有無法切除或轉移性脂肪肉瘤(liposarcoma)或平滑肌肉瘤(leiomyosarc..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/trabectedin-female-breast-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "trabectedin-female-breast-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/trabectedin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "female breast carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9973000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/cytarabine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "cytarabine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "cytarabine",
              "display": "Cytarabine"
            }
          ],
          "text": "Cytarabine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "1. 於新確診為FLT3突變陽性的急性骨髓性白血病(AML)成人病人之標準前導(daunorubic..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cytarabine-small-cell-lung-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cytarabine-small-cell-lung-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cytarabine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "small cell lung carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9978
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cytarabine-primary-pulmonary-lymphoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cytarabine-primary-pulmonary-lymphoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cytarabine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "primary pulmonary lymphoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9978
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cytarabine-well-differentiated-fetal-adenocarcinoma-of-the-lung",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cytarabine-well-differentiated-fetal-adenocarcinoma-of-the-lung",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cytarabine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "well-differentiated fetal adenocarcinoma of the lung"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cytarabine-pulmonary-blastoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cytarabine-pulmonary-blastoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cytarabine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pulmonary blastoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cytarabine-upper-aerodigestive-tract-neoplasm",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cytarabine-upper-aerodigestive-tract-neoplasm",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cytarabine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "upper aerodigestive tract neoplasm"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9948999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cytarabine-ganglioneuroblastoma-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cytarabine-ganglioneuroblastoma-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cytarabine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "ganglioneuroblastoma (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9936
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cytarabine-vertebral-anomalies-and-variable-endocrine-and-t-cell",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cytarabine-vertebral-anomalies-and-variable-endocrine-and-t-cell",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cytarabine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "vertebral anomalies and variable endocrine and T-cell dysfunction"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9932
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cytarabine-retroperitoneal-neoplasm",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cytarabine-retroperitoneal-neoplasm",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cytarabine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "retroperitoneal neoplasm"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9923000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cytarabine-neuroblastoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cytarabine-neuroblastoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cytarabine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "neuroblastoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9919
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/docetaxel",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "docetaxel",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "docetaxel",
              "display": "Docetaxel"
            }
          ],
          "text": "Docetaxel"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "(一)使用於下列HER2 過度表現或HER2 基因amplification 之早期乳癌、轉移性乳癌..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/docetaxel-female-breast-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "docetaxel-female-breast-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/docetaxel"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "female breast carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/docetaxel-ewing-sarcoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "docetaxel-ewing-sarcoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/docetaxel"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Ewing sarcoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/docetaxel-well-differentiated-fetal-adenocarcinoma-of-the-lung",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "docetaxel-well-differentiated-fetal-adenocarcinoma-of-the-lung",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/docetaxel"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "well-differentiated fetal adenocarcinoma of the lung"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/docetaxel-small-cell-lung-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "docetaxel-small-cell-lung-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/docetaxel"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "small cell lung carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9983
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/docetaxel-primary-pulmonary-lymphoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "docetaxel-primary-pulmonary-lymphoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/docetaxel"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "primary pulmonary lymphoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9983
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/docetaxel-botryoid-type-embryonal-rhabdomyosarcoma-of-the-vagina",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "docetaxel-botryoid-type-embryonal-rhabdomyosarcoma-of-the-vagina",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/docetaxel"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "botryoid-type embryonal rhabdomyosarcoma of the vagina"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/docetaxel-pulmonary-blastoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "docetaxel-pulmonary-blastoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/docetaxel"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pulmonary blastoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/docetaxel-rhabdomyosarcoma-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "docetaxel-rhabdomyosarcoma-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/docetaxel"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "rhabdomyosarcoma (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9979
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/docetaxel-embryonal-extrahepatic-bile-duct-rhabdomyosarcoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "docetaxel-embryonal-extrahepatic-bile-duct-rhabdomyosarcoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/docetaxel"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "embryonal extrahepatic bile duct rhabdomyosarcoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/docetaxel-parameningeal-embryonal-rhabdomyosarcoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "docetaxel-parameningeal-embryonal-rhabdomyosarcoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/docetaxel"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "parameningeal embryonal rhabdomyosarcoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/pimozide",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "pimozide",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "pimozide",
              "display": "Pimozide"
            }
          ],
          "text": "Pimozide"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "精神病、精神異常"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pimozide-trichotillomania",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pimozide-trichotillomania",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pimozide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "trichotillomania"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pimozide-manic-bipolar-affective-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pimozide-manic-bipolar-affective-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pimozide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "manic bipolar affective disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pimozide-insomnia-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pimozide-insomnia-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pimozide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "insomnia (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pimozide-major-affective-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pimozide-major-affective-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pimozide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "major affective disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pimozide-attention-deficit-hyperactivity-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pimozide-attention-deficit-hyperactivity-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pimozide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "attention deficit-hyperactivity disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pimozide-faciodigitogenital-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pimozide-faciodigitogenital-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pimozide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "faciodigitogenital syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pimozide-malan-overgrowth-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pimozide-malan-overgrowth-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pimozide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Malan overgrowth syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pimozide-attention-deficit-hyperactivity-disorder-inattentive-ty",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pimozide-attention-deficit-hyperactivity-disorder-inattentive-ty",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pimozide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "attention deficit hyperactivity disorder, inattentive type"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9972
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pimozide-agoraphobia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pimozide-agoraphobia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pimozide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "agoraphobia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9971
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pimozide-benign-paroxysmal-torticollis-of-infancy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pimozide-benign-paroxysmal-torticollis-of-infancy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pimozide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "benign paroxysmal torticollis of infancy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9965
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/trastuzumab_deruxtecan",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "trastuzumab_deruxtecan",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "trastuzumab_deruxtecan",
              "display": "Trastuzumab deruxtecan"
            }
          ],
          "text": "Trastuzumab deruxtecan"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "一、\t轉移性乳癌(BC)\n1.\tHER2陽性：單獨使用於具有無法切除或轉移性HER2陽性乳癌(IHC..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/trastuzumab_deruxtecan-drug-induced-osteoporosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "trastuzumab_deruxtecan-drug-induced-osteoporosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/trastuzumab_deruxtecan"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "drug-induced osteoporosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9931
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/tyrosine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "tyrosine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "tyrosine",
              "display": "Tyrosine"
            }
          ],
          "text": "Tyrosine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "本品是一種酪胺酸激酶抑制劑(tyrosine kinase inhibitors, TKI)，適用於..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tyrosine-cauda-equina-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tyrosine-cauda-equina-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tyrosine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cauda equina syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tyrosine-obsolete-neurogenic-bladder-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tyrosine-obsolete-neurogenic-bladder-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tyrosine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "obsolete neurogenic bladder (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tyrosine-angle-closure-glaucoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tyrosine-angle-closure-glaucoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tyrosine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "angle-closure glaucoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tyrosine-hyperthyroidism",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tyrosine-hyperthyroidism",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tyrosine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hyperthyroidism"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9951000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tyrosine-postural-orthostatic-tachycardia-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tyrosine-postural-orthostatic-tachycardia-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tyrosine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "postural orthostatic tachycardia syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9945999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tyrosine-hyperthyroxinemia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tyrosine-hyperthyroxinemia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tyrosine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hyperthyroxinemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9945999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tyrosine-resistance-to-thyroid-hormone-due-to-a-mutation-in-thyr",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tyrosine-resistance-to-thyroid-hormone-due-to-a-mutation-in-thyr",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tyrosine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9940000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tyrosine-aqueous-misdirection",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tyrosine-aqueous-misdirection",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tyrosine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "aqueous misdirection"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9934999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tyrosine-traumatic-glaucoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tyrosine-traumatic-glaucoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tyrosine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "traumatic glaucoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9934999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tyrosine-neovascular-glaucoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tyrosine-neovascular-glaucoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tyrosine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "neovascular glaucoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9932
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/cerliponase_alfa",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "cerliponase_alfa",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "cerliponase_alfa",
              "display": "Cerliponase alfa"
            }
          ],
          "text": "Cerliponase alfa"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "治療患有神經元蠟樣脂褐質儲積症2型(CLN2)疾病(也稱為三肽基肽酶1[TPP1]缺乏症)病人。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cerliponase_alfa-scheie-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cerliponase_alfa-scheie-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cerliponase_alfa"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Scheie syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cerliponase_alfa-hurler-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cerliponase_alfa-hurler-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cerliponase_alfa"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Hurler syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cerliponase_alfa-lysosomal-storage-disease-with-skeletal-involve",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cerliponase_alfa-lysosomal-storage-disease-with-skeletal-involve",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cerliponase_alfa"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "lysosomal storage disease with skeletal involvement"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cerliponase_alfa-cholesteryl-ester-storage-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cerliponase_alfa-cholesteryl-ester-storage-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cerliponase_alfa"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cholesteryl ester storage disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cerliponase_alfa-gaucher-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cerliponase_alfa-gaucher-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cerliponase_alfa"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Gaucher disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cerliponase_alfa-familial-encephalopathy-with-neuroserpin-inclus",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cerliponase_alfa-familial-encephalopathy-with-neuroserpin-inclus",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cerliponase_alfa"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "familial encephalopathy with neuroserpin inclusion bodies"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cerliponase_alfa-wolman-disease-with-hypolipoproteinemia-and-aca",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cerliponase_alfa-wolman-disease-with-hypolipoproteinemia-and-aca",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cerliponase_alfa"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Wolman disease with hypolipoproteinemia and acanthocytosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cerliponase_alfa-myoclonic-epilepsy-juvenile-susceptibility-to",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cerliponase_alfa-myoclonic-epilepsy-juvenile-susceptibility-to",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cerliponase_alfa"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "myoclonic epilepsy, juvenile, susceptibility to"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cerliponase_alfa-proximal-myopathy-with-extrapyramidal-signs",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cerliponase_alfa-proximal-myopathy-with-extrapyramidal-signs",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cerliponase_alfa"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "proximal myopathy with extrapyramidal signs"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cerliponase_alfa-autosomal-ichthyosis-syndrome-with-fatal-diseas",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cerliponase_alfa-autosomal-ichthyosis-syndrome-with-fatal-diseas",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cerliponase_alfa"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "autosomal ichthyosis syndrome with fatal disease course"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/tranexamic_acid",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "tranexamic_acid",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "tranexamic_acid",
              "display": "Tranexamic acid"
            }
          ],
          "text": "Tranexamic acid"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "止血劑"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tranexamic_acid-amenorrhea-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tranexamic_acid-amenorrhea-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tranexamic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "amenorrhea (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9919
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/titanium_dioxide",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "titanium_dioxide",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "titanium_dioxide",
              "display": "Titanium dioxide"
            }
          ],
          "text": "Titanium dioxide"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "感冒諸症狀（流鼻水、鼻塞、打噴嚏、咽喉痛、咳嗽、畏寒、發燒、頭痛、關節痛、肌肉痛等）之緩解。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/titanium_dioxide-drug-induced-osteoporosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "titanium_dioxide-drug-induced-osteoporosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/titanium_dioxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "drug-induced osteoporosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/titanium_dioxide-diabetic-retinopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "titanium_dioxide-diabetic-retinopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/titanium_dioxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "diabetic retinopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/titanium_dioxide-diabetic-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "titanium_dioxide-diabetic-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/titanium_dioxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "diabetic cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/titanium_dioxide-severe-nonproliferative-diabetic-retinopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "titanium_dioxide-severe-nonproliferative-diabetic-retinopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/titanium_dioxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "severe nonproliferative diabetic retinopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/titanium_dioxide-craniostenosis-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "titanium_dioxide-craniostenosis-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/titanium_dioxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "craniostenosis cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/titanium_dioxide-mature-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "titanium_dioxide-mature-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/titanium_dioxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "mature cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/titanium_dioxide-tetanic-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "titanium_dioxide-tetanic-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/titanium_dioxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "tetanic cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/titanium_dioxide-diabetes-mellitus-type-2-associated-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "titanium_dioxide-diabetes-mellitus-type-2-associated-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/titanium_dioxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "diabetes mellitus type 2 associated cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/titanium_dioxide-immature-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "titanium_dioxide-immature-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/titanium_dioxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "immature cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/titanium_dioxide-cortical-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "titanium_dioxide-cortical-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/titanium_dioxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cortical cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/acitretin",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "acitretin",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "acitretin",
              "display": "Acitretin"
            }
          ],
          "text": "Acitretin"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "嚴重性牛皮癬、皮膚角化症。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/acitretin-acne-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "acitretin-acne-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/acitretin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acne (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/acitretin-pediatric-systemic-lupus-erythematosus",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "acitretin-pediatric-systemic-lupus-erythematosus",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/acitretin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pediatric systemic lupus erythematosus"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9934999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/acitretin-fetal-erythroblastosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "acitretin-fetal-erythroblastosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/acitretin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "fetal erythroblastosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9928
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/acitretin-familial-cutaneous-telangiectasia-and-oropharyngeal-pr",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "acitretin-familial-cutaneous-telangiectasia-and-oropharyngeal-pr",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/acitretin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/carisoprodol",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "carisoprodol",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "carisoprodol",
              "display": "Carisoprodol"
            }
          ],
          "text": "Carisoprodol"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "肌肉之異常緊張疾患"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/carisoprodol-insomnia-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "carisoprodol-insomnia-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/carisoprodol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "insomnia (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9902
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/tinidazole",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "tinidazole",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "tinidazole",
              "display": "Tinidazole"
            }
          ],
          "text": "Tinidazole"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "男、女兩性生殖泌尿系的陰道滴蟲症、赤痢變形蟲症、及賈第鞭毛蟲痢疾症"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tinidazole-postmenopausal-atrophic-vaginitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tinidazole-postmenopausal-atrophic-vaginitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tinidazole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "postmenopausal atrophic vaginitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tinidazole-ulceration-of-vulva",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tinidazole-ulceration-of-vulva",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tinidazole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "ulceration of vulva"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tinidazole-vulvar-neoplasm",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tinidazole-vulvar-neoplasm",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tinidazole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "vulvar neoplasm"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9986
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tinidazole-breast-fibrocystic-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tinidazole-breast-fibrocystic-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tinidazole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "breast fibrocystic disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9975
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tinidazole-aids",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tinidazole-aids",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tinidazole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "AIDS"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9969
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tinidazole-blunt-duct-adenosis-of-breast",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tinidazole-blunt-duct-adenosis-of-breast",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tinidazole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "blunt duct adenosis of breast"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9968
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tinidazole-apocrine-adenosis-of-breast",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tinidazole-apocrine-adenosis-of-breast",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tinidazole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "apocrine adenosis of breast"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9968
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tinidazole-aids-related-complex",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tinidazole-aids-related-complex",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tinidazole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "AIDS related complex"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9939
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tinidazole-congenital-human-immunodeficiency-virus",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tinidazole-congenital-human-immunodeficiency-virus",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tinidazole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congenital human immunodeficiency virus"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9939
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tinidazole-benign-mammary-dysplasia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tinidazole-benign-mammary-dysplasia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tinidazole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "benign mammary dysplasia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/travoprost",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "travoprost",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "travoprost",
              "display": "travoprost"
            }
          ],
          "text": "travoprost"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/travoprost-visceral-calciphylaxis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "travoprost-visceral-calciphylaxis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/travoprost"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "visceral calciphylaxis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/travoprost-venous-thoracic-outlet-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "travoprost-venous-thoracic-outlet-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/travoprost"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "venous thoracic outlet syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/travoprost-arterial-thoracic-outlet-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "travoprost-arterial-thoracic-outlet-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/travoprost"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "arterial thoracic outlet syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/flunitrazepam",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "flunitrazepam",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "flunitrazepam",
              "display": "Flunitrazepam"
            }
          ],
          "text": "Flunitrazepam"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "失眠"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/flunitrazepam-insomnia-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "flunitrazepam-insomnia-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/flunitrazepam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "insomnia (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/flunitrazepam-migraine-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "flunitrazepam-migraine-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/flunitrazepam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "migraine disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9971
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/flunitrazepam-migraine-with-brainstem-aura",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "flunitrazepam-migraine-with-brainstem-aura",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/flunitrazepam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "migraine with brainstem aura"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9963
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/flunitrazepam-anxiety",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "flunitrazepam-anxiety",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/flunitrazepam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "anxiety"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9963
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/flunitrazepam-anxiety-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "flunitrazepam-anxiety-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/flunitrazepam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "anxiety disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9958
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/flunitrazepam-alcohol-withdrawal-delirium",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "flunitrazepam-alcohol-withdrawal-delirium",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/flunitrazepam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "alcohol withdrawal delirium"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/flunitrazepam-migraine-with-or-without-aura-susceptibility-to",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "flunitrazepam-migraine-with-or-without-aura-susceptibility-to",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/flunitrazepam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "migraine with or without aura, susceptibility to"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9948999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/flunitrazepam-agoraphobia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "flunitrazepam-agoraphobia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/flunitrazepam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "agoraphobia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9939
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/flunitrazepam-benign-paroxysmal-torticollis-of-infancy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "flunitrazepam-benign-paroxysmal-torticollis-of-infancy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/flunitrazepam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "benign paroxysmal torticollis of infancy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9936
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/flunitrazepam-atrophoderma-vermiculata",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "flunitrazepam-atrophoderma-vermiculata",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/flunitrazepam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "atrophoderma vermiculata"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/remdesivir",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "remdesivir",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "remdesivir",
              "display": "Remdesivir"
            }
          ],
          "text": "Remdesivir"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "適應症變更：\r\n１、類風濕性關節炎：合併methotrexate 或其他傳統型疾病緩解型抗風濕藥物(..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/remdesivir-multiple-endocrine-neoplasia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "remdesivir-multiple-endocrine-neoplasia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/remdesivir"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "multiple endocrine neoplasia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/remdesivir-hiv-infectious-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "remdesivir-hiv-infectious-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/remdesivir"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "HIV infectious disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9932
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/remdesivir-feline-acquired-immunodeficiency-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "remdesivir-feline-acquired-immunodeficiency-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/remdesivir"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "feline acquired immunodeficiency syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9906999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/remdesivir-simian-immunodeficiency-virus-infection",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "remdesivir-simian-immunodeficiency-virus-infection",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/remdesivir"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "simian immunodeficiency virus infection"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9906999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/remdesivir-neurodevelopmental-disorder-with-ataxic-gait-absent-s",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "remdesivir-neurodevelopmental-disorder-with-ataxic-gait-absent-s",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/remdesivir"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9903
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/remdesivir-homozygous-familial-hypercholesterolemia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "remdesivir-homozygous-familial-hypercholesterolemia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/remdesivir"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "homozygous familial hypercholesterolemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9903
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/denosumab",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "denosumab",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "denosumab",
              "display": "Denosumab"
            }
          ],
          "text": "Denosumab"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "1.\t多發性骨髓瘤及實質腫瘤骨轉移:適用於實體腫瘤已有骨轉移及多發性骨髓瘤之成人病人，預防發生骨骼相..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/denosumab-severe-nonproliferative-diabetic-retinopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "denosumab-severe-nonproliferative-diabetic-retinopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/denosumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "severe nonproliferative diabetic retinopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9963
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/denosumab-diabetic-retinopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "denosumab-diabetic-retinopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/denosumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "diabetic retinopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9923000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/regorafenib",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "regorafenib",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "regorafenib",
              "display": "Regorafenib"
            }
          ],
          "text": "Regorafenib"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "大腸直腸癌：\r\nRegorafenib適用於治療先前曾接受下列療法的轉移性大腸直腸癌(mCRC)患者..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/regorafenib-liposarcoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "regorafenib-liposarcoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/regorafenib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "liposarcoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/regorafenib-ovarian-myxoid-liposarcoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "regorafenib-ovarian-myxoid-liposarcoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/regorafenib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "ovarian myxoid liposarcoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9968
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/regorafenib-clear-cell-renal-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "regorafenib-clear-cell-renal-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/regorafenib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "clear cell renal carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9947
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/regorafenib-unclassified-renal-cell-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "regorafenib-unclassified-renal-cell-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/regorafenib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "unclassified renal cell carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9924
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/regorafenib-renal-cell-carcinoma-associated-with-xp11-2-transloc",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "regorafenib-renal-cell-carcinoma-associated-with-xp11-2-transloc",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/regorafenib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9924
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/regorafenib-renal-cell-carcinoma-associated-with-neuroblastoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "regorafenib-renal-cell-carcinoma-associated-with-neuroblastoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/regorafenib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "renal cell carcinoma associated with neuroblastoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9924
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/regorafenib-childhood-kidney-cell-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "regorafenib-childhood-kidney-cell-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/regorafenib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "childhood kidney cell carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9906999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/regorafenib-vulva-sarcoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "regorafenib-vulva-sarcoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/regorafenib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "vulva sarcoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9906
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/nitrofurantoin",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "nitrofurantoin",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "nitrofurantoin",
              "display": "Nitrofurantoin"
            }
          ],
          "text": "Nitrofurantoin"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "抗菌劑"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nitrofurantoin-rheumatoid-arthritis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nitrofurantoin-rheumatoid-arthritis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nitrofurantoin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "rheumatoid arthritis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nitrofurantoin-autosomal-dominant-familial-hematuria-retinal-art",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nitrofurantoin-autosomal-dominant-familial-hematuria-retinal-art",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nitrofurantoin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9981
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nitrofurantoin-brain-small-vessel-disease-1-with-or-without-ocul",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nitrofurantoin-brain-small-vessel-disease-1-with-or-without-ocul",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nitrofurantoin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brain small vessel disease 1 with or without ocular anomalies"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9981
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nitrofurantoin-diabetic-nephropathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nitrofurantoin-diabetic-nephropathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nitrofurantoin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "diabetic nephropathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nitrofurantoin-brachydactyly-syndactyly-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nitrofurantoin-brachydactyly-syndactyly-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nitrofurantoin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brachydactyly-syndactyly syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9975
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nitrofurantoin-colobomatous-microphthalmia-rhizomelic-dysplasia-",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nitrofurantoin-colobomatous-microphthalmia-rhizomelic-dysplasia-",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nitrofurantoin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "colobomatous microphthalmia-rhizomelic dysplasia syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9971
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nitrofurantoin-sclerosing-cholangitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nitrofurantoin-sclerosing-cholangitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nitrofurantoin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "sclerosing cholangitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9959
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nitrofurantoin-methemoglobinemia-alpha-type",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nitrofurantoin-methemoglobinemia-alpha-type",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nitrofurantoin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "methemoglobinemia, alpha type"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9942
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nitrofurantoin-gout",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nitrofurantoin-gout",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nitrofurantoin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gout"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9942
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nitrofurantoin-methemoglobinemia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nitrofurantoin-methemoglobinemia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nitrofurantoin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "methemoglobinemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9937999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/cephalexin",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "cephalexin",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "cephalexin",
              "display": "Cephalexin"
            }
          ],
          "text": "Cephalexin"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "抗生素。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/famotidine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "famotidine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "famotidine",
              "display": "Famotidine"
            }
          ],
          "text": "Famotidine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "住院病人伴隨有病理性胃酸分泌過高之症狀，頑固性（難治的）十二指腸潰瘍，或不能口服之病人消化性潰瘍之短..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/famotidine-duodenogastric-reflux",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "famotidine-duodenogastric-reflux",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/famotidine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "duodenogastric reflux"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/famotidine-duodenal-obstruction",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "famotidine-duodenal-obstruction",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/famotidine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "duodenal obstruction"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/famotidine-active-peptic-ulcer-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "famotidine-active-peptic-ulcer-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/famotidine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "active peptic ulcer disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/famotidine-peptic-ulcer-perforation",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "famotidine-peptic-ulcer-perforation",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/famotidine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "peptic ulcer perforation"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/famotidine-gastrojejunal-ulcer",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "famotidine-gastrojejunal-ulcer",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/famotidine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gastrojejunal ulcer"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/famotidine-abnormality-of-glucagon-secretion",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "famotidine-abnormality-of-glucagon-secretion",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/famotidine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "abnormality of glucagon secretion"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/famotidine-gastroduodenitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "famotidine-gastroduodenitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/famotidine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gastroduodenitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/famotidine-peptic-ulcer-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "famotidine-peptic-ulcer-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/famotidine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "peptic ulcer disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9972
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/famotidine-multiple-endocrine-neoplasia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "famotidine-multiple-endocrine-neoplasia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/famotidine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "multiple endocrine neoplasia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9969
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/famotidine-acne-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "famotidine-acne-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/famotidine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acne (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/irbesartan",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "irbesartan",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "irbesartan",
              "display": "Irbesartan"
            }
          ],
          "text": "Irbesartan"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "降血壓劑"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/irbesartan-malignant-hypertensive-renal-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "irbesartan-malignant-hypertensive-renal-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/irbesartan"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "malignant hypertensive renal disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9931
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/irbesartan-malignant-renovascular-hypertension",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "irbesartan-malignant-renovascular-hypertension",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/irbesartan"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "malignant renovascular hypertension"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9931
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/irbesartan-pulmonary-hypertension-with-unclear-multifactorial-me",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "irbesartan-pulmonary-hypertension-with-unclear-multifactorial-me",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/irbesartan"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pulmonary hypertension with unclear multifactorial mechanism"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9925
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/irbesartan-pulmonary-hypertension-owing-to-lung-disease-and-or-h",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "irbesartan-pulmonary-hypertension-owing-to-lung-disease-and-or-h",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/irbesartan"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pulmonary hypertension owing to lung disease and/or hypoxia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9925
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/thiamine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "thiamine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "thiamine",
              "display": "Thiamine"
            }
          ],
          "text": "Thiamine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "腳氣、神經炎、視神經炎"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/thiamine-hyperthyroidism",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "thiamine-hyperthyroidism",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/thiamine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hyperthyroidism"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9944
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/thiamine-resistance-to-thyroid-hormone-due-to-a-mutation-in-thyr",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "thiamine-resistance-to-thyroid-hormone-due-to-a-mutation-in-thyr",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/thiamine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9943000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/thiamine-primary-hereditary-glaucoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "thiamine-primary-hereditary-glaucoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/thiamine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "primary hereditary glaucoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9940000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/thiamine-open-angle-glaucoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "thiamine-open-angle-glaucoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/thiamine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "open-angle glaucoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9936
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/paclitaxel",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "paclitaxel",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "paclitaxel",
              "display": "Paclitaxel"
            }
          ],
          "text": "Paclitaxel"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "Herceptin應使用於下列HER2過度表現或HER2基因amplification之早期乳癌、轉..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/paclitaxel-female-breast-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "paclitaxel-female-breast-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/paclitaxel"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "female breast carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/paclitaxel-estrogen-receptor-negative-breast-cancer",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "paclitaxel-estrogen-receptor-negative-breast-cancer",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/paclitaxel"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "estrogen-receptor negative breast cancer"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/paclitaxel-hormone-resistant-breast-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "paclitaxel-hormone-resistant-breast-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/paclitaxel"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hormone-resistant breast carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/paclitaxel-estrogen-receptor-positive-breast-cancer",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "paclitaxel-estrogen-receptor-positive-breast-cancer",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/paclitaxel"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "estrogen-receptor positive breast cancer"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/paclitaxel-ehrlich-tumor-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "paclitaxel-ehrlich-tumor-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/paclitaxel"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Ehrlich tumor carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/paclitaxel-bilateral-breast-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "paclitaxel-bilateral-breast-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/paclitaxel"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "bilateral breast carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/paclitaxel-breast-carcinoma-by-gene-expression-profile",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "paclitaxel-breast-carcinoma-by-gene-expression-profile",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/paclitaxel"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "breast carcinoma by gene expression profile"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/paclitaxel-nipple-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "paclitaxel-nipple-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/paclitaxel"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "nipple carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/paclitaxel-parameningeal-embryonal-rhabdomyosarcoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "paclitaxel-parameningeal-embryonal-rhabdomyosarcoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/paclitaxel"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "parameningeal embryonal rhabdomyosarcoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9973000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/paclitaxel-botryoid-type-embryonal-rhabdomyosarcoma-of-the-vagin",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "paclitaxel-botryoid-type-embryonal-rhabdomyosarcoma-of-the-vagin",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/paclitaxel"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "botryoid-type embryonal rhabdomyosarcoma of the vagina"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9973000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/polyethylene_glycol",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "polyethylene_glycol",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "polyethylene_glycol",
              "display": "Polyethylene glycol"
            }
          ],
          "text": "Polyethylene glycol"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "治療慢性腎病(CKD, chronic kidney disease)所引起的症狀性貧血。Mirce..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/polyethylene_glycol-congenital-ichthyosiform-erythroderma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "polyethylene_glycol-congenital-ichthyosiform-erythroderma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/polyethylene_glycol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congenital ichthyosiform erythroderma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9903
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/cladribine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "cladribine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "cladribine",
              "display": "Cladribine"
            }
          ],
          "text": "Cladribine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "復發型多發性硬化症(臨床上有發作，且前二年有二次復發者)"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cladribine-parameningeal-embryonal-rhabdomyosarcoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cladribine-parameningeal-embryonal-rhabdomyosarcoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cladribine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "parameningeal embryonal rhabdomyosarcoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cladribine-botryoid-type-embryonal-rhabdomyosarcoma-of-the-vagin",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cladribine-botryoid-type-embryonal-rhabdomyosarcoma-of-the-vagin",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cladribine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "botryoid-type embryonal rhabdomyosarcoma of the vagina"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cladribine-embryonal-extrahepatic-bile-duct-rhabdomyosarcoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cladribine-embryonal-extrahepatic-bile-duct-rhabdomyosarcoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cladribine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "embryonal extrahepatic bile duct rhabdomyosarcoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cladribine-prostate-embryonal-rhabdomyosarcoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cladribine-prostate-embryonal-rhabdomyosarcoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cladribine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "prostate embryonal rhabdomyosarcoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9975
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cladribine-extrahepatic-bile-duct-rhabdomyosarcoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cladribine-extrahepatic-bile-duct-rhabdomyosarcoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cladribine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "extrahepatic bile duct rhabdomyosarcoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9975
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cladribine-rhabdomyosarcoma-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cladribine-rhabdomyosarcoma-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cladribine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "rhabdomyosarcoma (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9974
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cladribine-liver-sarcoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cladribine-liver-sarcoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cladribine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "liver sarcoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/buprenorphine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "buprenorphine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "buprenorphine",
              "display": "Buprenorphine"
            }
          ],
          "text": "Buprenorphine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "需要長期全天性使用類鴉片鎮痛劑之中度至重度癌症疼痛，以及對非類鴉片鎮痛劑無效之重度疼痛。說明：僅限使..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/buprenorphine-acute-intermittent-porphyria",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "buprenorphine-acute-intermittent-porphyria",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/buprenorphine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acute intermittent porphyria"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9941
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/buprenorphine-lingual-facial-buccal-dyskinesia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "buprenorphine-lingual-facial-buccal-dyskinesia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/buprenorphine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "lingual-facial-buccal dyskinesia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9932
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/buprenorphine-chronic-tic-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "buprenorphine-chronic-tic-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/buprenorphine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "chronic tic disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9913
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/buprenorphine-continuous-spikes-and-waves-during-sleep",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "buprenorphine-continuous-spikes-and-waves-during-sleep",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/buprenorphine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "continuous spikes and waves during sleep"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9904999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/buprenorphine-benign-shuddering-attacks",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "buprenorphine-benign-shuddering-attacks",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/buprenorphine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "benign shuddering attacks"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9903
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/buprenorphine-extrapyramidal-and-movement-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "buprenorphine-extrapyramidal-and-movement-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/buprenorphine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "extrapyramidal and movement disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9903
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/naftifine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "naftifine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "naftifine",
              "display": "Naftifine"
            }
          ],
          "text": "Naftifine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "1.髮癬菌種，小芽胞癬菌種、毛絮狀表皮黴癬菌在皮膚及其附多組織所引起之感染。2.表皮念珠菌病。3.甲..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/naftifine-cutaneous-candidiasis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "naftifine-cutaneous-candidiasis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/naftifine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cutaneous candidiasis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/naftifine-majocchi-granuloma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "naftifine-majocchi-granuloma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/naftifine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Majocchi granuloma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9969
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/naftifine-ectothrix-infectious-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "naftifine-ectothrix-infectious-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/naftifine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "ectothrix infectious disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9969
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/naftifine-pityriasis-versicolor",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "naftifine-pityriasis-versicolor",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/naftifine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pityriasis versicolor"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9968
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/naftifine-endothrix-infectious-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "naftifine-endothrix-infectious-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/naftifine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "endothrix infectious disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9965
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/naftifine-dermatophytosis-of-scalp-or-beard",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "naftifine-dermatophytosis-of-scalp-or-beard",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/naftifine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "dermatophytosis of scalp or beard"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9965
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/naftifine-superficial-mycosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "naftifine-superficial-mycosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/naftifine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "superficial mycosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9963
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/naftifine-tinea-profunda",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "naftifine-tinea-profunda",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/naftifine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "tinea profunda"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9956999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/nepafenac",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "nepafenac",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "nepafenac",
              "display": "Nepafenac"
            }
          ],
          "text": "Nepafenac"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "用於成人患者預防及治療白內障手術相關的術後疼痛及發炎"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nepafenac-eye-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nepafenac-eye-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nepafenac"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "eye disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nepafenac-optic-papillitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nepafenac-optic-papillitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nepafenac"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "optic papillitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nepafenac-hypotrichosis-simplex-of-the-scalp",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nepafenac-hypotrichosis-simplex-of-the-scalp",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nepafenac"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hypotrichosis simplex of the scalp"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nepafenac-seborrheic-keratosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nepafenac-seborrheic-keratosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nepafenac"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "seborrheic keratosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9983
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nepafenac-von-hippel-anomaly",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nepafenac-von-hippel-anomaly",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nepafenac"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "von Hippel anomaly"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9982
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nepafenac-congenital-hypotrichosis-milia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nepafenac-congenital-hypotrichosis-milia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nepafenac"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congenital hypotrichosis milia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9982
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nepafenac-mcpherson-robertson-cammarano-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nepafenac-mcpherson-robertson-cammarano-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nepafenac"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "mcpherson robertson cammarano syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9982
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nepafenac-lagophthalmos",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nepafenac-lagophthalmos",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nepafenac"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "lagophthalmos"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9981
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nepafenac-vulvar-inverted-follicular-keratosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nepafenac-vulvar-inverted-follicular-keratosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nepafenac"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "vulvar inverted follicular keratosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9981
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nepafenac-vitreous-detachment",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nepafenac-vitreous-detachment",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nepafenac"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "vitreous detachment"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9981
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/trihexyphenidyl",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "trihexyphenidyl",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "trihexyphenidyl",
              "display": "Trihexyphenidyl"
            }
          ],
          "text": "Trihexyphenidyl"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "帕金森氏症"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/trihexyphenidyl-attention-deficit-hyperactivity-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "trihexyphenidyl-attention-deficit-hyperactivity-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/trihexyphenidyl"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "attention deficit-hyperactivity disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/trihexyphenidyl-faciodigitogenital-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "trihexyphenidyl-faciodigitogenital-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/trihexyphenidyl"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "faciodigitogenital syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9986
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/trihexyphenidyl-attention-deficit-hyperactivity-disorder-inatten",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "trihexyphenidyl-attention-deficit-hyperactivity-disorder-inatten",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/trihexyphenidyl"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "attention deficit hyperactivity disorder, inattentive type"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9975
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/trihexyphenidyl-rasmussen-subacute-encephalitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "trihexyphenidyl-rasmussen-subacute-encephalitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/trihexyphenidyl"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Rasmussen subacute encephalitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9965999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/trihexyphenidyl-pla2g6-associated-neurodegeneration",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "trihexyphenidyl-pla2g6-associated-neurodegeneration",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/trihexyphenidyl"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "PLA2G6-associated neurodegeneration"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9958
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/trihexyphenidyl-congenital-disorder-of-glycosylation-with-defect",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "trihexyphenidyl-congenital-disorder-of-glycosylation-with-defect",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/trihexyphenidyl"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congenital disorder of glycosylation with defective fucosylation"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9956
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/trihexyphenidyl-polymicrogyria-perisylvian-with-cerebellar-hypop",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "trihexyphenidyl-polymicrogyria-perisylvian-with-cerebellar-hypop",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/trihexyphenidyl"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9956
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/trihexyphenidyl-retinal-dystrophy-with-or-without-extraocular-an",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "trihexyphenidyl-retinal-dystrophy-with-or-without-extraocular-an",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/trihexyphenidyl"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "retinal dystrophy with or without extraocular anomalies"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/trihexyphenidyl-myelitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "trihexyphenidyl-myelitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/trihexyphenidyl"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "myelitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/trihexyphenidyl-charcot-marie-tooth-disease-demyelinating-type-1",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "trihexyphenidyl-charcot-marie-tooth-disease-demyelinating-type-1",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/trihexyphenidyl"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Charcot-Marie-Tooth disease, demyelinating, type 1G"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/tioconazole",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "tioconazole",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "tioconazole",
              "display": "Tioconazole"
            }
          ],
          "text": "Tioconazole"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "感受性黴菌引起之局部感染症"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tioconazole-vulvovaginitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tioconazole-vulvovaginitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tioconazole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "vulvovaginitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9923000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tioconazole-vulvitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tioconazole-vulvitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tioconazole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "vulvitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tioconazole-postmenopausal-atrophic-vaginitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tioconazole-postmenopausal-atrophic-vaginitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tioconazole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "postmenopausal atrophic vaginitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9919
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/aluminum_hydroxide",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "aluminum_hydroxide",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "aluminum_hydroxide",
              "display": "Aluminum hydroxide"
            }
          ],
          "text": "Aluminum hydroxide"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "制酸劑"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_hydroxide-active-peptic-ulcer-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_hydroxide-active-peptic-ulcer-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_hydroxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "active peptic ulcer disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9964
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_hydroxide-gastroduodenitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_hydroxide-gastroduodenitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_hydroxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gastroduodenitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9959
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_hydroxide-gastrojejunal-ulcer",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_hydroxide-gastrojejunal-ulcer",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_hydroxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gastrojejunal ulcer"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_hydroxide-peptic-ulcer-perforation",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_hydroxide-peptic-ulcer-perforation",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_hydroxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "peptic ulcer perforation"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/propantheline",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "propantheline",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "propantheline",
              "display": "Propantheline"
            }
          ],
          "text": "Propantheline"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "胃、十二指腸潰瘍、胃炎、子宮痙攣"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/propantheline-gastroduodenitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "propantheline-gastroduodenitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/propantheline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gastroduodenitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/propantheline-irritable-bowel-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "propantheline-irritable-bowel-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/propantheline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "irritable bowel syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9915999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/belimumab",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "belimumab",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "belimumab",
              "display": "Belimumab"
            }
          ],
          "text": "Belimumab"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "1.與標準治療併用，適用於在標準治療下仍存有高疾病活性(如：同時符合anti-dsDNA陽性、低補體..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/belimumab-primary-release-disorder-of-platelets",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "belimumab-primary-release-disorder-of-platelets",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/belimumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "primary release disorder of platelets"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/belimumab-pseudo-von-willebrand-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "belimumab-pseudo-von-willebrand-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/belimumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pseudo-von Willebrand disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/belimumab-glanzmann-thrombasthenia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "belimumab-glanzmann-thrombasthenia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/belimumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Glanzmann thrombasthenia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/belimumab-fetal-and-neonatal-alloimmune-thrombocytopenia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "belimumab-fetal-and-neonatal-alloimmune-thrombocytopenia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/belimumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "fetal and neonatal alloimmune thrombocytopenia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9959
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/belimumab-severe-nonproliferative-diabetic-retinopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "belimumab-severe-nonproliferative-diabetic-retinopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/belimumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "severe nonproliferative diabetic retinopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9904999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/belimumab-autosomal-dominant-macrothrombocytopenia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "belimumab-autosomal-dominant-macrothrombocytopenia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/belimumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "autosomal dominant macrothrombocytopenia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9904000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/ethynodiol_diacetate",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "ethynodiol_diacetate",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "ethynodiol_diacetate",
              "display": "Ethynodiol diacetate"
            }
          ],
          "text": "Ethynodiol diacetate"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "抑制排卵。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ethynodiol_diacetate-acne-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ethynodiol_diacetate-acne-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ethynodiol_diacetate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acne (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9956999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ethynodiol_diacetate-female-infertility",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ethynodiol_diacetate-female-infertility",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ethynodiol_diacetate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "female infertility"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9931
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ethynodiol_diacetate-46-xy-disorder-of-sex-development-due-to-te",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ethynodiol_diacetate-46-xy-disorder-of-sex-development-due-to-te",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ethynodiol_diacetate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "46,XY disorder of sex development due to testicular steroidogenesis defect"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9919
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ethynodiol_diacetate-longitudinal-vaginal-septum",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ethynodiol_diacetate-longitudinal-vaginal-septum",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ethynodiol_diacetate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "longitudinal vaginal septum"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9909
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ethynodiol_diacetate-transverse-vaginal-septum",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ethynodiol_diacetate-transverse-vaginal-septum",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ethynodiol_diacetate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "transverse vaginal septum"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9909
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ethynodiol_diacetate-eye-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ethynodiol_diacetate-eye-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ethynodiol_diacetate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "eye disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9901000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/oteracil",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "oteracil",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "oteracil",
              "display": "Oteracil"
            }
          ],
          "text": "Oteracil"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "1.\t胃癌：\n(１)\t胃癌術後輔助性化療，用於罹患TNM Stage II (排除TI)、IIIA或..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/oteracil-colonic-neoplasm",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "oteracil-colonic-neoplasm",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/oteracil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "colonic neoplasm"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/oteracil-cecum-villous-adenoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "oteracil-cecum-villous-adenoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/oteracil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cecum villous adenoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/oteracil-cecum-neuroendocrine-tumor-g1",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "oteracil-cecum-neuroendocrine-tumor-g1",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/oteracil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cecum neuroendocrine tumor G1"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/oteracil-lipoma-of-colon",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "oteracil-lipoma-of-colon",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/oteracil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "lipoma of colon"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/oteracil-cecal-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "oteracil-cecal-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/oteracil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cecal disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/oteracil-rectosigmoid-junction-neoplasm",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "oteracil-rectosigmoid-junction-neoplasm",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/oteracil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "rectosigmoid junction neoplasm"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/oteracil-benign-neoplasm-of-cecum",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "oteracil-benign-neoplasm-of-cecum",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/oteracil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "benign neoplasm of cecum"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/oteracil-colonic-lymphangioma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "oteracil-colonic-lymphangioma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/oteracil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "colonic lymphangioma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/oteracil-colon-leiomyoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "oteracil-colon-leiomyoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/oteracil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "colon leiomyoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/oteracil-cavernous-hemangioma-of-colon",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "oteracil-cavernous-hemangioma-of-colon",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/oteracil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cavernous hemangioma of colon"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/vitamin_e",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "vitamin_e",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "vitamin_e",
              "display": "Vitamin E"
            }
          ],
          "text": "Vitamin E"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "末梢血行障害、習慣性早流產及其他維他命Ｅ缺乏症"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vitamin_e-inborn-disorder-of-bilirubin-metabolism",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vitamin_e-inborn-disorder-of-bilirubin-metabolism",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vitamin_e"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "inborn disorder of bilirubin metabolism"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vitamin_e-bilirubin-metabolism-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vitamin_e-bilirubin-metabolism-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vitamin_e"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "bilirubin metabolism disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vitamin_e-hereditary-north-american-indian-childhood-cirrhosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vitamin_e-hereditary-north-american-indian-childhood-cirrhosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vitamin_e"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hereditary North American Indian childhood cirrhosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vitamin_e-drug-induced-liver-injury",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vitamin_e-drug-induced-liver-injury",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vitamin_e"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "drug-induced liver injury"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vitamin_e-microvillus-inclusion-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vitamin_e-microvillus-inclusion-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vitamin_e"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "microvillus inclusion disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vitamin_e-hyperbiliverdinemia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vitamin_e-hyperbiliverdinemia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vitamin_e"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hyperbiliverdinemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vitamin_e-navajo-neurohepatopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vitamin_e-navajo-neurohepatopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vitamin_e"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Navajo neurohepatopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vitamin_e-nevus-of-ito",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vitamin_e-nevus-of-ito",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vitamin_e"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "nevus of Ito"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vitamin_e-adult-onset-multiple-mitochondrial-dna-deletion-syndro",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vitamin_e-adult-onset-multiple-mitochondrial-dna-deletion-syndro",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vitamin_e"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vitamin_e-mitochondrial-dna-depletion-syndrome-hepatocerebral-fo",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vitamin_e-mitochondrial-dna-depletion-syndrome-hepatocerebral-fo",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vitamin_e"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "mitochondrial DNA depletion syndrome, hepatocerebral form"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/amcinonide",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "amcinonide",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "amcinonide",
              "display": "Amcinonide"
            }
          ],
          "text": "Amcinonide"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "急慢性皮膚病如異位性皮膚炎、接觸性或濕疹性皮膚病、牛皮癬及神經性皮膚炎"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/amcinonide-vulvar-inverted-follicular-keratosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "amcinonide-vulvar-inverted-follicular-keratosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/amcinonide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "vulvar inverted follicular keratosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9982
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/amcinonide-annular-atrophic-lichen-planus",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "amcinonide-annular-atrophic-lichen-planus",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/amcinonide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "annular atrophic lichen planus"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9973000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/amcinonide-lichen-planus-pigmentosus",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "amcinonide-lichen-planus-pigmentosus",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/amcinonide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "lichen planus pigmentosus"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9973000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/amcinonide-hypertrophic-lichen-planus",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "amcinonide-hypertrophic-lichen-planus",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/amcinonide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hypertrophic lichen planus"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9973000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/amcinonide-lichen-planus-pemphigoides",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "amcinonide-lichen-planus-pemphigoides",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/amcinonide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "lichen planus pemphigoides"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9964
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/amcinonide-primary-cutaneous-b-cell-lymphoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "amcinonide-primary-cutaneous-b-cell-lymphoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/amcinonide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "primary cutaneous B-cell lymphoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9942
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/amcinonide-dermatitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "amcinonide-dermatitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/amcinonide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "dermatitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.993
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/amcinonide-2-hydroxyethyl-methacrylate-sensitization",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "amcinonide-2-hydroxyethyl-methacrylate-sensitization",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/amcinonide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "2-hydroxyethyl methacrylate sensitization"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.99
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/benzylpenicillin",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "benzylpenicillin",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "benzylpenicillin",
              "display": "Benzylpenicillin"
            }
          ],
          "text": "Benzylpenicillin"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "革蘭氏陰、陽性細菌引起之感染症"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/benzylpenicillin-pericoronitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "benzylpenicillin-pericoronitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/benzylpenicillin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pericoronitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9936
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/benzylpenicillin-gingival-recession",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "benzylpenicillin-gingival-recession",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/benzylpenicillin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gingival recession"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9931
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/benzylpenicillin-canker-sore",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "benzylpenicillin-canker-sore",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/benzylpenicillin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "canker sore"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9926999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/benzylpenicillin-ulcerative-stomatitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "benzylpenicillin-ulcerative-stomatitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/benzylpenicillin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "ulcerative stomatitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9926
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/benzylpenicillin-denture-stomatitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "benzylpenicillin-denture-stomatitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/benzylpenicillin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "denture stomatitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9926
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/benzylpenicillin-chemotherapy-induced-oral-mucositis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "benzylpenicillin-chemotherapy-induced-oral-mucositis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/benzylpenicillin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "chemotherapy-induced oral mucositis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9926
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/benzylpenicillin-leukoplakia-of-gingiva",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "benzylpenicillin-leukoplakia-of-gingiva",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/benzylpenicillin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "leukoplakia of gingiva"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9906
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/timepidium",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "timepidium",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "timepidium",
              "display": "Timepidium"
            }
          ],
          "text": "Timepidium"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "下列諸症狀所引起之痙攣的緩解：胃炎、胃、十二指腸潰瘍、腸炎膽囊、膽道疾患、尿路結石、胰臟炎所起之疼痛..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/timepidium-insomnia-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "timepidium-insomnia-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/timepidium"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "insomnia (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9945
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/voriconazole",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "voriconazole",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "voriconazole",
              "display": "Voriconazole"
            }
          ],
          "text": "Voriconazole"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "抗黴菌用藥"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/isosorbide_dinitrate",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "isosorbide_dinitrate",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "isosorbide_dinitrate",
              "display": "Isosorbide dinitrate"
            }
          ],
          "text": "Isosorbide dinitrate"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "預防狹心症之發作。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/isosorbide_dinitrate-alopecia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "isosorbide_dinitrate-alopecia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/isosorbide_dinitrate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "alopecia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/isosorbide_dinitrate-congenital-hypotrichosis-milia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "isosorbide_dinitrate-congenital-hypotrichosis-milia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/isosorbide_dinitrate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congenital hypotrichosis milia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/isosorbide_dinitrate-hypotrichosis-simplex-of-the-scalp",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "isosorbide_dinitrate-hypotrichosis-simplex-of-the-scalp",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/isosorbide_dinitrate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hypotrichosis simplex of the scalp"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/isosorbide_dinitrate-pulmonary-hypertension",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "isosorbide_dinitrate-pulmonary-hypertension",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/isosorbide_dinitrate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pulmonary hypertension"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/isosorbide_dinitrate-diffuse-alopecia-areata",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "isosorbide_dinitrate-diffuse-alopecia-areata",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/isosorbide_dinitrate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "diffuse alopecia areata"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/isosorbide_dinitrate-vascular-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "isosorbide_dinitrate-vascular-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/isosorbide_dinitrate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "vascular disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/isosorbide_dinitrate-hypertrichosis-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "isosorbide_dinitrate-hypertrichosis-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/isosorbide_dinitrate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hypertrichosis (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/isosorbide_dinitrate-kyphoscoliotic-heart-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "isosorbide_dinitrate-kyphoscoliotic-heart-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/isosorbide_dinitrate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "kyphoscoliotic heart disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/isosorbide_dinitrate-visceral-calciphylaxis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "isosorbide_dinitrate-visceral-calciphylaxis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/isosorbide_dinitrate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "visceral calciphylaxis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/isosorbide_dinitrate-arterial-thoracic-outlet-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "isosorbide_dinitrate-arterial-thoracic-outlet-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/isosorbide_dinitrate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "arterial thoracic outlet syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/dronedarone",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "dronedarone",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "dronedarone",
              "display": "Dronedarone"
            }
          ],
          "text": "Dronedarone"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "血管擴張劑。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dronedarone-stroke-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dronedarone-stroke-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dronedarone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "stroke disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dronedarone-obsolete-susceptibility-to-ischemic-stroke",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dronedarone-obsolete-susceptibility-to-ischemic-stroke",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dronedarone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "obsolete susceptibility to ischemic stroke"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dronedarone-abri-amyloidosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dronedarone-abri-amyloidosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dronedarone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "ABri amyloidosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dronedarone-cerebrovascular-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dronedarone-cerebrovascular-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dronedarone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cerebrovascular disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9971
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dronedarone-brain-stem-infarction",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dronedarone-brain-stem-infarction",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dronedarone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brain stem infarction"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9971
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dronedarone-sick-sinus-syndrome-2-autosomal-dominant",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dronedarone-sick-sinus-syndrome-2-autosomal-dominant",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dronedarone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "sick sinus syndrome 2, autosomal dominant"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9963
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dronedarone-duodenal-obstruction",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dronedarone-duodenal-obstruction",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dronedarone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "duodenal obstruction"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9956
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dronedarone-cerebral-artery-occlusion",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dronedarone-cerebral-artery-occlusion",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dronedarone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cerebral artery occlusion"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9944
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dronedarone-sarcoglycanopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dronedarone-sarcoglycanopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dronedarone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "sarcoglycanopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9943000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dronedarone-wildervanck-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dronedarone-wildervanck-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dronedarone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Wildervanck syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9937
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/temozolomide",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "temozolomide",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "temozolomide",
              "display": "Temozolomide"
            }
          ],
          "text": "Temozolomide"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "轉移性大腸直腸癌(mCRC)\r\n與含有5-fluorouracil為基礎的化學療法合併使用，可以作為..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/temozolomide-adult-astrocytic-tumour",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "temozolomide-adult-astrocytic-tumour",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/temozolomide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "adult astrocytic tumour"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9936
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/temozolomide-cauda-equina-neoplasm",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "temozolomide-cauda-equina-neoplasm",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/temozolomide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cauda equina neoplasm"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.993
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/diosmin",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "diosmin",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "diosmin",
              "display": "Diosmin"
            }
          ],
          "text": "Diosmin"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "靜脈曲張與痔瘡用藥。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/diosmin-amenorrhea-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "diosmin-amenorrhea-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/diosmin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "amenorrhea (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9942
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/trifluoperazine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "trifluoperazine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "trifluoperazine",
              "display": "Trifluoperazine"
            }
          ],
          "text": "Trifluoperazine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "意識運動機能亢進引起之急、慢性精神病"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/trifluoperazine-manic-bipolar-affective-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "trifluoperazine-manic-bipolar-affective-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/trifluoperazine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "manic bipolar affective disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9951000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/caspofungin",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "caspofungin",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "caspofungin",
              "display": "Caspofungin"
            }
          ],
          "text": "Caspofungin"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "抗真菌藥物。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/caspofungin-gastrin-secretion-abnormality",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "caspofungin-gastrin-secretion-abnormality",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/caspofungin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gastrin secretion abnormality"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9944
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/cisatracurium",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "cisatracurium",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "cisatracurium",
              "display": "Cisatracurium"
            }
          ],
          "text": "Cisatracurium"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "本品為一高選擇性及競爭性的非去極化神經肌肉阻斷劑。可作為全身麻醉之輔助劑或加護病房使用，用以鬆弛骨骼..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cisatracurium-cauda-equina-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cisatracurium-cauda-equina-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cisatracurium"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cauda equina syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cisatracurium-preeclampsia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cisatracurium-preeclampsia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cisatracurium"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "preeclampsia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cisatracurium-obsolete-neurogenic-bladder-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cisatracurium-obsolete-neurogenic-bladder-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cisatracurium"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "obsolete neurogenic bladder (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cisatracurium-migraine-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cisatracurium-migraine-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cisatracurium"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "migraine disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cisatracurium-thrombotic-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cisatracurium-thrombotic-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cisatracurium"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "thrombotic disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cisatracurium-irritable-bowel-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cisatracurium-irritable-bowel-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cisatracurium"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "irritable bowel syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cisatracurium-migraine-with-brainstem-aura",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cisatracurium-migraine-with-brainstem-aura",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cisatracurium"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "migraine with brainstem aura"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cisatracurium-mild-pre-eclampsia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cisatracurium-mild-pre-eclampsia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cisatracurium"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "mild pre-eclampsia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cisatracurium-severe-pre-eclampsia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cisatracurium-severe-pre-eclampsia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cisatracurium"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "severe pre-eclampsia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cisatracurium-neurocirculatory-asthenia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cisatracurium-neurocirculatory-asthenia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cisatracurium"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "neurocirculatory asthenia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/prednisolone",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "prednisolone",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "prednisolone",
              "display": "Prednisolone"
            }
          ],
          "text": "Prednisolone"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "腎上腺皮質外科手術時休克之預防、藥物過敏、顆粒性白血球缺乏症、風濕性關節炎、急性風濕症、單發性關節炎..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisolone-alopecia-areata",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisolone-alopecia-areata",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisolone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "alopecia areata"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisolone-alopecia-mucinosa",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisolone-alopecia-mucinosa",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisolone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "alopecia mucinosa"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisolone-telogen-effluvium",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisolone-telogen-effluvium",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisolone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "telogen effluvium"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisolone-quinquaud-s-folliculitis-decalvans",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisolone-quinquaud-s-folliculitis-decalvans",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisolone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Quinquaud's folliculitis decalvans"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisolone-alopecia-antibody-deficiency",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisolone-alopecia-antibody-deficiency",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisolone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "alopecia antibody deficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisolone-hereditary-hypotrichosis-with-recurrent-skin-vesicl",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisolone-hereditary-hypotrichosis-with-recurrent-skin-vesicl",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisolone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hereditary hypotrichosis with recurrent skin vesicles"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisolone-alopecia-intellectual-disability-hypergonadotropic-",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisolone-alopecia-intellectual-disability-hypergonadotropic-",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisolone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisolone-atrichia-with-papular-lesions",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisolone-atrichia-with-papular-lesions",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisolone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "atrichia with papular lesions"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisolone-prolapse-of-lacrimal-gland",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisolone-prolapse-of-lacrimal-gland",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisolone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "prolapse of lacrimal gland"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisolone-idiopathic-steroid-sensitive-nephrotic-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisolone-idiopathic-steroid-sensitive-nephrotic-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisolone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "idiopathic steroid-sensitive nephrotic syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9986
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/leflunomide",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "leflunomide",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "leflunomide",
              "display": "Leflunomide"
            }
          ],
          "text": "Leflunomide"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "治療成人類風濕性關節炎，並可能減緩類風濕性病程對關節所造成之結構性損害(即屬於DMARD DISEA..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/leflunomide-brachydactyly-syndactyly-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "leflunomide-brachydactyly-syndactyly-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/leflunomide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brachydactyly-syndactyly syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/leflunomide-colobomatous-microphthalmia-rhizomelic-dysplasia-syn",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "leflunomide-colobomatous-microphthalmia-rhizomelic-dysplasia-syn",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/leflunomide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "colobomatous microphthalmia-rhizomelic dysplasia syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/sodium_carbonate",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "sodium_carbonate",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "sodium_carbonate",
              "display": "Sodium carbonate"
            }
          ],
          "text": "Sodium carbonate"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "ＣＥＦＴＡＺＩＤＩＭＥ　是殺菌性頭孢子菌抗生素、對多種乙內醯胺有抵抗力、並對廣範圍的革蘭氏陽性及陰性..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sodium_carbonate-cauda-equina-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sodium_carbonate-cauda-equina-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sodium_carbonate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cauda equina syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sodium_carbonate-anaphylaxis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sodium_carbonate-anaphylaxis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sodium_carbonate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "anaphylaxis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9972
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sodium_carbonate-food-dependent-exercise-induced-anaphylaxis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sodium_carbonate-food-dependent-exercise-induced-anaphylaxis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sodium_carbonate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "food-dependent exercise-induced anaphylaxis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9963
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sodium_carbonate-obsolete-neurogenic-bladder-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sodium_carbonate-obsolete-neurogenic-bladder-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sodium_carbonate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "obsolete neurogenic bladder (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9962000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sodium_carbonate-dry-eye-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sodium_carbonate-dry-eye-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sodium_carbonate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "dry eye syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9958
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sodium_carbonate-ventricular-tachycardia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sodium_carbonate-ventricular-tachycardia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sodium_carbonate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "ventricular tachycardia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9918
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/pitolisant",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "pitolisant",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "pitolisant",
              "display": "Pitolisant"
            }
          ],
          "text": "Pitolisant"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "１、治療6歲以上猝睡症(伴隨或未伴隨猝倒現象)的病人。\r\n２、改善患有阻塞性睡眠呼吸中止 (OSA)..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pitolisant-insomnia-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pitolisant-insomnia-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pitolisant"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "insomnia (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9971
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pitolisant-attention-deficit-hyperactivity-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pitolisant-attention-deficit-hyperactivity-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pitolisant"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "attention deficit-hyperactivity disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9936
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pitolisant-faciodigitogenital-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pitolisant-faciodigitogenital-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pitolisant"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "faciodigitogenital syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9929000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/pentoxifylline",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "pentoxifylline",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "pentoxifylline",
              "display": "Pentoxifylline"
            }
          ],
          "text": "Pentoxifylline"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "末稍血管循環障礙。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/vonoprazan",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "vonoprazan",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "vonoprazan",
              "display": "Vonoprazan"
            }
          ],
          "text": "Vonoprazan"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "1.\t糜爛性食道炎(EE)的治療及維持治療。\r\n2.\t治療胃潰瘍。\r\n3.\t治療十二指腸潰瘍。\r\n4..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vonoprazan-active-peptic-ulcer-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vonoprazan-active-peptic-ulcer-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vonoprazan"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "active peptic ulcer disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vonoprazan-peptic-ulcer-perforation",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vonoprazan-peptic-ulcer-perforation",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vonoprazan"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "peptic ulcer perforation"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vonoprazan-gastrojejunal-ulcer",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vonoprazan-gastrojejunal-ulcer",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vonoprazan"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gastrojejunal ulcer"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vonoprazan-hiatus-hernia-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vonoprazan-hiatus-hernia-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vonoprazan"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hiatus hernia (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vonoprazan-achlorhydria",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vonoprazan-achlorhydria",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vonoprazan"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "achlorhydria"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9986
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vonoprazan-pylorospasm",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vonoprazan-pylorospasm",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vonoprazan"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pylorospasm"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vonoprazan-dieulafoy-lesion",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vonoprazan-dieulafoy-lesion",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vonoprazan"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Dieulafoy lesion"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vonoprazan-gastric-dilatation",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vonoprazan-gastric-dilatation",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vonoprazan"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gastric dilatation"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vonoprazan-cascade-stomach",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vonoprazan-cascade-stomach",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vonoprazan"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cascade stomach"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vonoprazan-hemorrhagic-duodenitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vonoprazan-hemorrhagic-duodenitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vonoprazan"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hemorrhagic duodenitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9974
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/magnesium_sulfate",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "magnesium_sulfate",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "magnesium_sulfate",
              "display": "Magnesium sulfate"
            }
          ],
          "text": "Magnesium sulfate"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "發育不良、營養補給、虛弱體質、熱性消耗性疾患之補助治療、妊娠婦之營養補給"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/magnesium_sulfate-preeclampsia-eclampsia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "magnesium_sulfate-preeclampsia-eclampsia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/magnesium_sulfate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "preeclampsia/eclampsia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/magnesium_sulfate-toxemia-of-pregnancy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "magnesium_sulfate-toxemia-of-pregnancy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/magnesium_sulfate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "toxemia of pregnancy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/magnesium_sulfate-thrombotic-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "magnesium_sulfate-thrombotic-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/magnesium_sulfate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "thrombotic disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/magnesium_sulfate-pharyngitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "magnesium_sulfate-pharyngitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/magnesium_sulfate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pharyngitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9961
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/magnesium_sulfate-nasal-cavity-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "magnesium_sulfate-nasal-cavity-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/magnesium_sulfate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "nasal cavity disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9959
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/magnesium_sulfate-psychotic-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "magnesium_sulfate-psychotic-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/magnesium_sulfate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "psychotic disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/magnesium_sulfate-acute-laryngopharyngitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "magnesium_sulfate-acute-laryngopharyngitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/magnesium_sulfate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acute laryngopharyngitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9947
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/magnesium_sulfate-headache-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "magnesium_sulfate-headache-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/magnesium_sulfate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "headache disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9936
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/magnesium_sulfate-trigeminal-autonomic-cephalalgia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "magnesium_sulfate-trigeminal-autonomic-cephalalgia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/magnesium_sulfate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "trigeminal autonomic cephalalgia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9918
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/magnesium_sulfate-treatment-refractory-schizophrenia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "magnesium_sulfate-treatment-refractory-schizophrenia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/magnesium_sulfate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "treatment-refractory schizophrenia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9911
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/gefitinib",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "gefitinib",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "gefitinib",
              "display": "Gefitinib"
            }
          ],
          "text": "Gefitinib"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "Gefitinib適用於先前已接受過化學治療後，但仍局部惡化或轉移之肺腺癌病患之第二線用藥。Gefi..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/gefitinib-fibromatosis-gingival",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "gefitinib-fibromatosis-gingival",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/gefitinib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "fibromatosis, gingival"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/gefitinib-fibroma-of-lung",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "gefitinib-fibroma-of-lung",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/gefitinib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "fibroma of lung"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9986
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/gefitinib-inclusion-body-myopathy-with-early-onset-paget-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "gefitinib-inclusion-body-myopathy-with-early-onset-paget-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/gefitinib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9986
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/gefitinib-hamartoma-of-lung",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "gefitinib-hamartoma-of-lung",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/gefitinib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hamartoma of lung"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9986
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/gefitinib-lung-hilum-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "gefitinib-lung-hilum-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/gefitinib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "lung hilum carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9986
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/gefitinib-lung-benign-neoplasm",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "gefitinib-lung-benign-neoplasm",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/gefitinib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "lung benign neoplasm"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/gefitinib-leukomelanoderma-infantilism-intellectual-disability-h",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "gefitinib-leukomelanoderma-infantilism-intellectual-disability-h",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/gefitinib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Leukomelanoderma-infantilism-intellectual disability-hypodontia-hypotrichosis syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/gefitinib-lung-germ-cell-tumor",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "gefitinib-lung-germ-cell-tumor",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/gefitinib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "lung germ cell tumor"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/gefitinib-pulmonary-sulcus-neoplasm",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "gefitinib-pulmonary-sulcus-neoplasm",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/gefitinib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pulmonary sulcus neoplasm"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/gefitinib-junctional-epidermolysis-bullosa",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "gefitinib-junctional-epidermolysis-bullosa",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/gefitinib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "junctional epidermolysis bullosa"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/ribavirin",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "ribavirin",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "ribavirin",
              "display": "Ribavirin"
            }
          ],
          "text": "Ribavirin"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "治療慢性B型肝炎：對於沒有肝硬化的病人以及有代償功能的肝硬化病人，珮格西施適合用來治療HBeAg陽性..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ribavirin-chronic-hepatitis-b-virus-infection",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ribavirin-chronic-hepatitis-b-virus-infection",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ribavirin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "chronic hepatitis B virus infection"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9986
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ribavirin-hepatopulmonary-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ribavirin-hepatopulmonary-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ribavirin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hepatopulmonary syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9956999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ribavirin-early-onset-familial-noncirrhotic-portal-hypertension",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ribavirin-early-onset-familial-noncirrhotic-portal-hypertension",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ribavirin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "early-onset familial noncirrhotic portal hypertension"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9956999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ribavirin-idiopathic-copper-associated-cirrhosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ribavirin-idiopathic-copper-associated-cirrhosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ribavirin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "idiopathic copper-associated cirrhosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9956999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ribavirin-hepatoportal-sclerosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ribavirin-hepatoportal-sclerosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ribavirin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hepatoportal sclerosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9956999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ribavirin-primitive-portal-vein-thrombosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ribavirin-primitive-portal-vein-thrombosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ribavirin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "primitive portal vein thrombosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9956999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ribavirin-hepatic-porphyria",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ribavirin-hepatic-porphyria",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ribavirin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hepatic porphyria"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ribavirin-igg4-related-pachymeningitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ribavirin-igg4-related-pachymeningitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ribavirin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "IgG4-related pachymeningitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9944
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ribavirin-igg4-related-mesenteritis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ribavirin-igg4-related-mesenteritis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ribavirin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "IgG4-related mesenteritis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9931
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ribavirin-igg4-related-aortitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ribavirin-igg4-related-aortitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ribavirin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "IgG4-related aortitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9931
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/tazarotene",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "tazarotene",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "tazarotene",
              "display": "Tazarotene"
            }
          ],
          "text": "Tazarotene"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "乾癬。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tazarotene-seborrheic-dermatitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tazarotene-seborrheic-dermatitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tazarotene"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "seborrheic dermatitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9979
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tazarotene-seborrheic-keratosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tazarotene-seborrheic-keratosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tazarotene"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "seborrheic keratosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9951000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tazarotene-vulvar-inverted-follicular-keratosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tazarotene-vulvar-inverted-follicular-keratosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tazarotene"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "vulvar inverted follicular keratosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9937999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/vinorelbine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "vinorelbine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "vinorelbine",
              "display": "Vinorelbine"
            }
          ],
          "text": "Vinorelbine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "1.非小細胞肺癌。2.轉移性乳癌。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vinorelbine-ewing-sarcoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vinorelbine-ewing-sarcoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vinorelbine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Ewing sarcoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vinorelbine-fibromatosis-gingival",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vinorelbine-fibromatosis-gingival",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vinorelbine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "fibromatosis, gingival"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vinorelbine-fibroma-of-lung",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vinorelbine-fibroma-of-lung",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vinorelbine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "fibroma of lung"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vinorelbine-lung-germ-cell-tumor",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vinorelbine-lung-germ-cell-tumor",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vinorelbine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "lung germ cell tumor"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vinorelbine-pulmonary-sulcus-neoplasm",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vinorelbine-pulmonary-sulcus-neoplasm",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vinorelbine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pulmonary sulcus neoplasm"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vinorelbine-hamartoma-of-lung",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vinorelbine-hamartoma-of-lung",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vinorelbine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hamartoma of lung"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vinorelbine-small-cell-lung-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vinorelbine-small-cell-lung-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vinorelbine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "small cell lung carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vinorelbine-lung-benign-neoplasm",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vinorelbine-lung-benign-neoplasm",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vinorelbine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "lung benign neoplasm"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vinorelbine-lung-hilum-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vinorelbine-lung-hilum-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vinorelbine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "lung hilum carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vinorelbine-pulmonary-blastoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vinorelbine-pulmonary-blastoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vinorelbine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pulmonary blastoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/scopolamine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "scopolamine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "scopolamine",
              "display": "Scopolamine"
            }
          ],
          "text": "Scopolamine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "胃腸痙攣及其運動亢進、膽管痙攣及其運動障害、尿路痙攣"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/scopolamine-cauda-equina-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "scopolamine-cauda-equina-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/scopolamine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cauda equina syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/scopolamine-obsolete-neurogenic-bladder-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "scopolamine-obsolete-neurogenic-bladder-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/scopolamine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "obsolete neurogenic bladder (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/scopolamine-papillary-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "scopolamine-papillary-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/scopolamine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "papillary conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/scopolamine-atopic-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "scopolamine-atopic-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/scopolamine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "atopic conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/scopolamine-rosacea-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "scopolamine-rosacea-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/scopolamine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "rosacea conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9940000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/scopolamine-vernal-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "scopolamine-vernal-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/scopolamine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "vernal conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9908
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/fosfomycin",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "fosfomycin",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "fosfomycin",
              "display": "Fosfomycin"
            }
          ],
          "text": "Fosfomycin"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "成年女性及青少女之急性非複雜性膀胱炎、成年男性接受經直腸前列腺切片檢查之預防性抗生素。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fosfomycin-gonococcal-urethritis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fosfomycin-gonococcal-urethritis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fosfomycin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gonococcal urethritis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fosfomycin-ureaplasma-urethritis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fosfomycin-ureaplasma-urethritis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fosfomycin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Ureaplasma urethritis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fosfomycin-uterine-inflammatory-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fosfomycin-uterine-inflammatory-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fosfomycin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "uterine inflammatory disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fosfomycin-xanthogranulomatous-pyelonephritis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fosfomycin-xanthogranulomatous-pyelonephritis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fosfomycin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "xanthogranulomatous pyelonephritis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fosfomycin-epiglottitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fosfomycin-epiglottitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fosfomycin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "epiglottitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fosfomycin-urogenital-tuberculosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fosfomycin-urogenital-tuberculosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fosfomycin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "urogenital tuberculosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fosfomycin-laryngitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fosfomycin-laryngitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fosfomycin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "laryngitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9968
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fosfomycin-polyclonal-hyperviscosity-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fosfomycin-polyclonal-hyperviscosity-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fosfomycin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "polyclonal hyperviscosity syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9947
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fosfomycin-hyperamylasemia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fosfomycin-hyperamylasemia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fosfomycin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hyperamylasemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9947
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fosfomycin-pyelitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fosfomycin-pyelitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fosfomycin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pyelitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9937
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/felodipine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "felodipine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "felodipine",
              "display": "Felodipine"
            }
          ],
          "text": "Felodipine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "高血壓、心絞痛。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/felodipine-pulmonary-hypertension-owing-to-lung-disease-and-or-h",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "felodipine-pulmonary-hypertension-owing-to-lung-disease-and-or-h",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/felodipine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pulmonary hypertension owing to lung disease and/or hypoxia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/felodipine-pulmonary-hypertension-with-unclear-multifactorial-me",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "felodipine-pulmonary-hypertension-with-unclear-multifactorial-me",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/felodipine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pulmonary hypertension with unclear multifactorial mechanism"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/felodipine-malignant-renovascular-hypertension",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "felodipine-malignant-renovascular-hypertension",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/felodipine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "malignant renovascular hypertension"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/felodipine-malignant-hypertensive-renal-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "felodipine-malignant-hypertensive-renal-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/felodipine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "malignant hypertensive renal disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/felodipine-braddock-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "felodipine-braddock-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/felodipine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Braddock syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/felodipine-chronic-pulmonary-heart-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "felodipine-chronic-pulmonary-heart-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/felodipine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "chronic pulmonary heart disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9919
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/felodipine-prinzmetal-angina",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "felodipine-prinzmetal-angina",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/felodipine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Prinzmetal angina"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9906999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/acebutolol",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "acebutolol",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "acebutolol",
              "display": "Acebutolol"
            }
          ],
          "text": "Acebutolol"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "ＢＥＴＡ交感神經遮斷劑"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/acebutolol-malignant-hypertensive-renal-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "acebutolol-malignant-hypertensive-renal-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/acebutolol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "malignant hypertensive renal disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/acebutolol-malignant-renovascular-hypertension",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "acebutolol-malignant-renovascular-hypertension",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/acebutolol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "malignant renovascular hypertension"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/loteprednol_etabonate",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "loteprednol_etabonate",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "loteprednol_etabonate",
              "display": "Loteprednol etabonate"
            }
          ],
          "text": "Loteprednol etabonate"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "眼瞼結膜及眼球結膜、角膜及眼球前部構造等對類固醇有反應之發炎，如過敏性結膜炎，酒渣鼻角膜炎，表淺性點..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/loteprednol_etabonate-conjunctival-folliculosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "loteprednol_etabonate-conjunctival-folliculosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/loteprednol_etabonate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "conjunctival folliculosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9969
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/loteprednol_etabonate-chronic-follicular-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "loteprednol_etabonate-chronic-follicular-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/loteprednol_etabonate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "chronic follicular conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9969
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/loteprednol_etabonate-serous-conjunctivitis-except-viral",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "loteprednol_etabonate-serous-conjunctivitis-except-viral",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/loteprednol_etabonate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "serous conjunctivitis except viral"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9969
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/loteprednol_etabonate-parasitic-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "loteprednol_etabonate-parasitic-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/loteprednol_etabonate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "parasitic conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9969
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/loteprednol_etabonate-pseudomembranous-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "loteprednol_etabonate-pseudomembranous-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/loteprednol_etabonate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pseudomembranous conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9965999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/loteprednol_etabonate-angelucci-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "loteprednol_etabonate-angelucci-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/loteprednol_etabonate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Angelucci syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9965999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/loteprednol_etabonate-acute-hemorrhagic-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "loteprednol_etabonate-acute-hemorrhagic-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/loteprednol_etabonate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acute hemorrhagic conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9962000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/loteprednol_etabonate-rosacea-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "loteprednol_etabonate-rosacea-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/loteprednol_etabonate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "rosacea conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9934000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/loteprednol_etabonate-acute-contagious-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "loteprednol_etabonate-acute-contagious-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/loteprednol_etabonate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acute contagious conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9926
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/loteprednol_etabonate-otitis-externa",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "loteprednol_etabonate-otitis-externa",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/loteprednol_etabonate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "otitis externa"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9913
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/metoprolol",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "metoprolol",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "metoprolol",
              "display": "Metoprolol"
            }
          ],
          "text": "Metoprolol"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "高血壓、狹心症。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/metoprolol-malignant-hypertensive-renal-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "metoprolol-malignant-hypertensive-renal-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/metoprolol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "malignant hypertensive renal disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/metoprolol-malignant-renovascular-hypertension",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "metoprolol-malignant-renovascular-hypertension",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/metoprolol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "malignant renovascular hypertension"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/metoprolol-pulmonary-hypertension-owing-to-lung-disease-and-or-h",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "metoprolol-pulmonary-hypertension-owing-to-lung-disease-and-or-h",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/metoprolol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pulmonary hypertension owing to lung disease and/or hypoxia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/metoprolol-pulmonary-hypertension-with-unclear-multifactorial-me",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "metoprolol-pulmonary-hypertension-with-unclear-multifactorial-me",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/metoprolol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pulmonary hypertension with unclear multifactorial mechanism"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/metoprolol-braddock-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "metoprolol-braddock-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/metoprolol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Braddock syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/metoprolol-posteroinferior-myocardial-infarction",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "metoprolol-posteroinferior-myocardial-infarction",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/metoprolol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "posteroinferior myocardial infarction"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/metoprolol-posterolateral-myocardial-infarction",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "metoprolol-posterolateral-myocardial-infarction",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/metoprolol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "posterolateral myocardial infarction"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/metoprolol-septal-myocardial-infarction",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "metoprolol-septal-myocardial-infarction",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/metoprolol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "septal myocardial infarction"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/metoprolol-chronic-pulmonary-heart-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "metoprolol-chronic-pulmonary-heart-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/metoprolol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "chronic pulmonary heart disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9940000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/metoprolol-trichotillomania",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "metoprolol-trichotillomania",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/metoprolol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "trichotillomania"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9904999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/ritonavir",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "ritonavir",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "ritonavir",
              "display": "Ritonavir"
            }
          ],
          "text": "Ritonavir"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "本品與100毫克ritonavir及其他反轉錄病毒藥物併用，適用於曾經接受三種主要類別的抗病毒藥物治..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ritonavir-simian-immunodeficiency-virus-infection",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ritonavir-simian-immunodeficiency-virus-infection",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ritonavir"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "simian immunodeficiency virus infection"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ritonavir-feline-acquired-immunodeficiency-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ritonavir-feline-acquired-immunodeficiency-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ritonavir"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "feline acquired immunodeficiency syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ritonavir-neurodevelopmental-disorder-with-ataxic-gait-absent-sp",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ritonavir-neurodevelopmental-disorder-with-ataxic-gait-absent-sp",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ritonavir"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/insulin_lispro",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "insulin_lispro",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "insulin_lispro",
              "display": "Insulin lispro"
            }
          ],
          "text": "Insulin lispro"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "糖尿病。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/insulin_lispro-autoimmune-oophoritis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "insulin_lispro-autoimmune-oophoritis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/insulin_lispro"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "autoimmune oophoritis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9978
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/insulin_lispro-thiamine-responsive-dysfunction-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "insulin_lispro-thiamine-responsive-dysfunction-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/insulin_lispro"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "thiamine-responsive dysfunction syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9937
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/insulin_lispro-focal-stiff-limb-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "insulin_lispro-focal-stiff-limb-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/insulin_lispro"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "focal stiff limb syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9936
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/insulin_lispro-classic-stiff-person-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "insulin_lispro-classic-stiff-person-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/insulin_lispro"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "classic stiff person syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9936
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/insulin_lispro-opsismodysplasia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "insulin_lispro-opsismodysplasia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/insulin_lispro"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "opsismodysplasia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9934000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/insulin_lispro-drug-induced-localized-lipodystrophy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "insulin_lispro-drug-induced-localized-lipodystrophy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/insulin_lispro"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "drug-induced localized lipodystrophy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9909
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/insulin_lispro-pancreatic-agenesis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "insulin_lispro-pancreatic-agenesis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/insulin_lispro"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pancreatic agenesis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9909
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/insulin_lispro-centrifugal-lipodystrophy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "insulin_lispro-centrifugal-lipodystrophy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/insulin_lispro"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "centrifugal lipodystrophy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9904000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/insulin_lispro-pressure-induced-localized-lipoatrophy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "insulin_lispro-pressure-induced-localized-lipoatrophy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/insulin_lispro"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pressure-induced localized lipoatrophy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9903
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/hydroxyprogesterone_caproate",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "hydroxyprogesterone_caproate",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "hydroxyprogesterone_caproate",
              "display": "Hydroxyprogesterone caproate"
            }
          ],
          "text": "Hydroxyprogesterone caproate"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "起因於囊腺體增生過盛之機能性出血"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroxyprogesterone_caproate-endometriosis-of-uterus",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroxyprogesterone_caproate-endometriosis-of-uterus",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroxyprogesterone_caproate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "endometriosis of uterus"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroxyprogesterone_caproate-renal-hypoplasia-bilateral",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroxyprogesterone_caproate-renal-hypoplasia-bilateral",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroxyprogesterone_caproate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "renal hypoplasia, bilateral"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroxyprogesterone_caproate-endometriosis-in-cutaneous-scar",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroxyprogesterone_caproate-endometriosis-in-cutaneous-scar",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroxyprogesterone_caproate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "endometriosis in cutaneous scar"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroxyprogesterone_caproate-endometriosis-of-rectovaginal-septu",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroxyprogesterone_caproate-endometriosis-of-rectovaginal-septu",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroxyprogesterone_caproate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "endometriosis of rectovaginal septum and vagina"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroxyprogesterone_caproate-renal-hypoplasia-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroxyprogesterone_caproate-renal-hypoplasia-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroxyprogesterone_caproate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "renal hypoplasia (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroxyprogesterone_caproate-uterine-corpus-cancer",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroxyprogesterone_caproate-uterine-corpus-cancer",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroxyprogesterone_caproate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "uterine corpus cancer"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroxyprogesterone_caproate-cervix-endometriosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroxyprogesterone_caproate-cervix-endometriosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroxyprogesterone_caproate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cervix endometriosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroxyprogesterone_caproate-endometrial-cancer",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroxyprogesterone_caproate-endometrial-cancer",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroxyprogesterone_caproate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "endometrial cancer"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroxyprogesterone_caproate-breast-fibrocystic-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroxyprogesterone_caproate-breast-fibrocystic-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroxyprogesterone_caproate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "breast fibrocystic disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroxyprogesterone_caproate-infantile-cerebral-and-cerebellar-a",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroxyprogesterone_caproate-infantile-cerebral-and-cerebellar-a",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroxyprogesterone_caproate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/alprostadil",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "alprostadil",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "alprostadil",
              "display": "Alprostadil"
            }
          ],
          "text": "Alprostadil"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "週邊動脈阻塞疾病症狀改善。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alprostadil-aortic-malformation",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alprostadil-aortic-malformation",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alprostadil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "aortic malformation"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alprostadil-congenital-tricuspid-stenosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alprostadil-congenital-tricuspid-stenosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alprostadil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congenital tricuspid stenosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alprostadil-congenital-valvular-dysplasia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alprostadil-congenital-valvular-dysplasia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alprostadil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congenital valvular dysplasia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alprostadil-tricuspid-valve-agenesis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alprostadil-tricuspid-valve-agenesis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alprostadil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "tricuspid valve agenesis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alprostadil-straddling-or-overriding-tricuspid-valve",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alprostadil-straddling-or-overriding-tricuspid-valve",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alprostadil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "straddling or overriding tricuspid valve"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alprostadil-tricuspid-valve-prolapse-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alprostadil-tricuspid-valve-prolapse-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alprostadil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "tricuspid valve prolapse (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alprostadil-anomaly-of-the-tricuspid-subvalvular-apparatus",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alprostadil-anomaly-of-the-tricuspid-subvalvular-apparatus",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alprostadil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "anomaly of the tricuspid subvalvular apparatus"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alprostadil-double-outlet-right-ventricle-with-atrioventricular-",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alprostadil-double-outlet-right-ventricle-with-atrioventricular-",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alprostadil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "double outlet right ventricle with atrioventricular septal defect, pulmonary stenosis, heterotaxy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alprostadil-heart-septal-defect",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alprostadil-heart-septal-defect",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alprostadil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "heart septal defect"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9939
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alprostadil-endemic-goiter",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alprostadil-endemic-goiter",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alprostadil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "endemic goiter"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9934000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/sodium_citrate",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "sodium_citrate",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "sodium_citrate",
              "display": "Sodium citrate"
            }
          ],
          "text": "Sodium citrate"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "止咳劑"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sodium_citrate-papillary-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sodium_citrate-papillary-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sodium_citrate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "papillary conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sodium_citrate-nasal-cavity-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sodium_citrate-nasal-cavity-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sodium_citrate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "nasal cavity disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sodium_citrate-acute-laryngopharyngitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sodium_citrate-acute-laryngopharyngitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sodium_citrate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acute laryngopharyngitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sodium_citrate-stomach-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sodium_citrate-stomach-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sodium_citrate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "stomach disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sodium_citrate-postgastrectomy-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sodium_citrate-postgastrectomy-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sodium_citrate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "postgastrectomy syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9979
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sodium_citrate-gastroduodenitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sodium_citrate-gastroduodenitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sodium_citrate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gastroduodenitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9962000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sodium_citrate-familial-visceral-myopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sodium_citrate-familial-visceral-myopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sodium_citrate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "familial visceral myopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9942
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sodium_citrate-rosacea-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sodium_citrate-rosacea-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sodium_citrate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "rosacea conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9926999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sodium_citrate-allergic-urticaria",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sodium_citrate-allergic-urticaria",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sodium_citrate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "allergic urticaria"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9918
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/dipyridamole",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "dipyridamole",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "dipyridamole",
              "display": "Dipyridamole"
            }
          ],
          "text": "Dipyridamole"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "對於慢性狹心症治療可能有效"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dipyridamole-prinzmetal-angina",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dipyridamole-prinzmetal-angina",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dipyridamole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Prinzmetal angina"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dipyridamole-stroke-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dipyridamole-stroke-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dipyridamole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "stroke disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dipyridamole-thrombotic-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dipyridamole-thrombotic-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dipyridamole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "thrombotic disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dipyridamole-sick-sinus-syndrome-2-autosomal-dominant",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dipyridamole-sick-sinus-syndrome-2-autosomal-dominant",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dipyridamole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "sick sinus syndrome 2, autosomal dominant"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dipyridamole-transient-ischemic-attack-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dipyridamole-transient-ischemic-attack-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dipyridamole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "transient ischemic attack (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dipyridamole-sarcoglycanopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dipyridamole-sarcoglycanopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dipyridamole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "sarcoglycanopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9982
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dipyridamole-wildervanck-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dipyridamole-wildervanck-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dipyridamole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Wildervanck syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9978
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dipyridamole-macrocephaly-dysmorphic-facies-and-psychomotor-reta",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dipyridamole-macrocephaly-dysmorphic-facies-and-psychomotor-reta",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dipyridamole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "macrocephaly, dysmorphic facies, and psychomotor retardation"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dipyridamole-cavernous-sinus-thrombosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dipyridamole-cavernous-sinus-thrombosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dipyridamole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cavernous sinus thrombosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9972
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dipyridamole-lateral-sinus-thrombosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dipyridamole-lateral-sinus-thrombosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dipyridamole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "lateral sinus thrombosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9972
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/terbutaline",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "terbutaline",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "terbutaline",
              "display": "Terbutaline"
            }
          ],
          "text": "Terbutaline"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "支氣管氣喘、支氣管炎、氣喘性支氣管炎、支氣管擴張症，及肺氣腫。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/terbutaline-obstructive-lung-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "terbutaline-obstructive-lung-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/terbutaline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "obstructive lung disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/terbutaline-respiratory-malformation",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "terbutaline-respiratory-malformation",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/terbutaline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "respiratory malformation"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9952
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/terbutaline-rienhoff-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "terbutaline-rienhoff-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/terbutaline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Rienhoff syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9937999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/aluminum_oxide",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "aluminum_oxide",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "aluminum_oxide",
              "display": "Aluminum oxide"
            }
          ],
          "text": "Aluminum oxide"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "制酸劑及賦形劑"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_oxide-rheumatoid-arthritis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_oxide-rheumatoid-arthritis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_oxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "rheumatoid arthritis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_oxide-brachydactyly-syndactyly-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_oxide-brachydactyly-syndactyly-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_oxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brachydactyly-syndactyly syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_oxide-colobomatous-microphthalmia-rhizomelic-dysplasia-",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_oxide-colobomatous-microphthalmia-rhizomelic-dysplasia-",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_oxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "colobomatous microphthalmia-rhizomelic dysplasia syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_oxide-heparin-cofactor-2-deficiency",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_oxide-heparin-cofactor-2-deficiency",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_oxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "heparin cofactor 2 deficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_oxide-hemoglobinopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_oxide-hemoglobinopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_oxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hemoglobinopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_oxide-factor-5-excess-with-spontaneous-thrombosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_oxide-factor-5-excess-with-spontaneous-thrombosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_oxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "factor 5 excess with spontaneous thrombosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_oxide-antithrombin-deficiency-type-2",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_oxide-antithrombin-deficiency-type-2",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_oxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "antithrombin deficiency type 2"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_oxide-thrombotic-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_oxide-thrombotic-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_oxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "thrombotic disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_oxide-beta-thalassemia-with-other-manifestations",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_oxide-beta-thalassemia-with-other-manifestations",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_oxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "beta-thalassemia with other manifestations"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_oxide-hemolytic-anemia-due-to-glucophosphate-isomerase-",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_oxide-hemolytic-anemia-due-to-glucophosphate-isomerase-",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_oxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hemolytic anemia due to glucophosphate isomerase deficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/minoxidil",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "minoxidil",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "minoxidil",
              "display": "minoxidil"
            }
          ],
          "text": "minoxidil"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/minoxidil-hypotrichosis-simplex-of-the-scalp",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "minoxidil-hypotrichosis-simplex-of-the-scalp",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/minoxidil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hypotrichosis simplex of the scalp"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/minoxidil-congenital-hypotrichosis-milia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "minoxidil-congenital-hypotrichosis-milia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/minoxidil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congenital hypotrichosis milia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/minoxidil-diffuse-alopecia-areata",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "minoxidil-diffuse-alopecia-areata",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/minoxidil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "diffuse alopecia areata"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/pentosan_polysulfate",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "pentosan_polysulfate",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "pentosan_polysulfate",
              "display": "Pentosan polysulfate"
            }
          ],
          "text": "Pentosan polysulfate"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "因間質性膀胱炎引起的膀胱疼痛或不適的解除。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pentosan_polysulfate-primary-release-disorder-of-platelets",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pentosan_polysulfate-primary-release-disorder-of-platelets",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pentosan_polysulfate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "primary release disorder of platelets"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9971
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pentosan_polysulfate-glanzmann-thrombasthenia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pentosan_polysulfate-glanzmann-thrombasthenia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pentosan_polysulfate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Glanzmann thrombasthenia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9965
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pentosan_polysulfate-pseudo-von-willebrand-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pentosan_polysulfate-pseudo-von-willebrand-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pentosan_polysulfate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pseudo-von Willebrand disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9962000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/tetryzoline",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "tetryzoline",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "tetryzoline",
              "display": "Tetryzoline"
            }
          ],
          "text": "Tetryzoline"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "過敏性結膜炎，眼瞼緣炎，角膜炎。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tetryzoline-nasal-cavity-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tetryzoline-nasal-cavity-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tetryzoline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "nasal cavity disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tetryzoline-acute-laryngopharyngitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tetryzoline-acute-laryngopharyngitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tetryzoline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acute laryngopharyngitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/iodixanol",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "iodixanol",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "iodixanol",
              "display": "Iodixanol"
            }
          ],
          "text": "Iodixanol"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "X光對比劑:用於心臟血管、腦血管、周邊動脈造影、腹腔動脈造影、泌尿道攝影、靜脈造影、電腦斷層影像加強..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/iodixanol-osteoarthritis-susceptibility",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "iodixanol-osteoarthritis-susceptibility",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/iodixanol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "osteoarthritis susceptibility"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9915999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/iodixanol-osteoarthritis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "iodixanol-osteoarthritis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/iodixanol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "osteoarthritis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9906999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/iodixanol-rheumatoid-arthritis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "iodixanol-rheumatoid-arthritis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/iodixanol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "rheumatoid arthritis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.99
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/vigabatrin",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "vigabatrin",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "vigabatrin",
              "display": "Vigabatrin"
            }
          ],
          "text": "Vigabatrin"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "抗癲？之輔助療法。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/chloral_hydrate",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "chloral_hydrate",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "chloral_hydrate",
              "display": "Chloral hydrate"
            }
          ],
          "text": "Chloral hydrate"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "止癢"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/durvalumab",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "durvalumab",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "durvalumab",
              "display": "Durvalumab"
            }
          ],
          "text": "Durvalumab"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "與durvalumab併用，適用於治療未曾接受全身性療法之晚期或無法切除之肝細胞癌成人病人。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/durvalumab-prostatic-urethra-urothelial-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "durvalumab-prostatic-urethra-urothelial-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/durvalumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "prostatic urethra urothelial carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/durvalumab-kidney-pelvis-sarcomatoid-transitional-cell-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "durvalumab-kidney-pelvis-sarcomatoid-transitional-cell-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/durvalumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "kidney pelvis sarcomatoid transitional cell carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/durvalumab-infiltrating-bladder-urothelial-carcinoma-sarcomatoid",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "durvalumab-infiltrating-bladder-urothelial-carcinoma-sarcomatoid",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/durvalumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "infiltrating bladder urothelial carcinoma sarcomatoid variant"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/durvalumab-renal-pelvis-papillary-urothelial-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "durvalumab-renal-pelvis-papillary-urothelial-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/durvalumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "renal pelvis papillary urothelial carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/durvalumab-uterine-ligament-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "durvalumab-uterine-ligament-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/durvalumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "uterine ligament adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/durvalumab-endocervical-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "durvalumab-endocervical-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/durvalumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "endocervical carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/durvalumab-adenoid-cystic-carcinoma-of-the-cervix-uteri",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "durvalumab-adenoid-cystic-carcinoma-of-the-cervix-uteri",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/durvalumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "adenoid cystic carcinoma of the cervix uteri"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/durvalumab-uterine-ligament-serous-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "durvalumab-uterine-ligament-serous-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/durvalumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "uterine ligament serous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/durvalumab-signet-ring-cell-variant-cervical-mucinous-adenocarci",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "durvalumab-signet-ring-cell-variant-cervical-mucinous-adenocarci",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/durvalumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "signet ring cell variant cervical mucinous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/durvalumab-intestinal-variant-cervical-mucinous-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "durvalumab-intestinal-variant-cervical-mucinous-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/durvalumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "intestinal variant cervical mucinous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/moclobemide",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "moclobemide",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "moclobemide",
              "display": "Moclobemide"
            }
          ],
          "text": "Moclobemide"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "憂鬱症。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/moclobemide-agoraphobia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "moclobemide-agoraphobia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/moclobemide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "agoraphobia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9943000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/moclobemide-benign-paroxysmal-torticollis-of-infancy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "moclobemide-benign-paroxysmal-torticollis-of-infancy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/moclobemide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "benign paroxysmal torticollis of infancy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.993
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/probenecid",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "probenecid",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "probenecid",
              "display": "Probenecid"
            }
          ],
          "text": "Probenecid"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "痛風、痛風性關節炎"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/probenecid-hypouricemia-renal",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "probenecid-hypouricemia-renal",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/probenecid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hypouricemia, renal"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9973000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/probenecid-lesch-nyhan-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "probenecid-lesch-nyhan-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/probenecid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Lesch-Nyhan syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9939
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/probenecid-hypoxanthine-guanine-phosphoribosyltransferase-partia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "probenecid-hypoxanthine-guanine-phosphoribosyltransferase-partia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/probenecid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hypoxanthine guanine phosphoribosyltransferase partial deficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9937
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/atezolizumab",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "atezolizumab",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "atezolizumab",
              "display": "Atezolizumab"
            }
          ],
          "text": "Atezolizumab"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "適應症：1、非小細胞肺癌：(1)單獨使用，適用於第II至IIIA期(UICC/AJCC分期系統第7版..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/atezolizumab-prostatic-urethra-urothelial-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "atezolizumab-prostatic-urethra-urothelial-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/atezolizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "prostatic urethra urothelial carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/atezolizumab-kidney-pelvis-sarcomatoid-transitional-cell-carcino",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "atezolizumab-kidney-pelvis-sarcomatoid-transitional-cell-carcino",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/atezolizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "kidney pelvis sarcomatoid transitional cell carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/atezolizumab-infiltrating-bladder-urothelial-carcinoma-sarcomato",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "atezolizumab-infiltrating-bladder-urothelial-carcinoma-sarcomato",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/atezolizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "infiltrating bladder urothelial carcinoma sarcomatoid variant"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/atezolizumab-renal-pelvis-papillary-urothelial-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "atezolizumab-renal-pelvis-papillary-urothelial-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/atezolizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "renal pelvis papillary urothelial carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/atezolizumab-uterine-ligament-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "atezolizumab-uterine-ligament-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/atezolizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "uterine ligament adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/atezolizumab-endocervical-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "atezolizumab-endocervical-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/atezolizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "endocervical carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/atezolizumab-adenoid-cystic-carcinoma-of-the-cervix-uteri",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "atezolizumab-adenoid-cystic-carcinoma-of-the-cervix-uteri",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/atezolizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "adenoid cystic carcinoma of the cervix uteri"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/atezolizumab-uterine-ligament-serous-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "atezolizumab-uterine-ligament-serous-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/atezolizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "uterine ligament serous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/atezolizumab-signet-ring-cell-variant-cervical-mucinous-adenocar",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "atezolizumab-signet-ring-cell-variant-cervical-mucinous-adenocar",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/atezolizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "signet ring cell variant cervical mucinous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/atezolizumab-intestinal-variant-cervical-mucinous-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "atezolizumab-intestinal-variant-cervical-mucinous-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/atezolizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "intestinal variant cervical mucinous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/naproxen",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "naproxen",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "naproxen",
              "display": "Naproxen"
            }
          ],
          "text": "Naproxen"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "骨關節炎、類風濕性關節炎、幼年型關節炎、關節粘連性脊椎炎、腱炎、滑囊炎和急性痛風、原發性經痛、解除輕..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/naproxen-brachydactyly-syndactyly-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "naproxen-brachydactyly-syndactyly-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/naproxen"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brachydactyly-syndactyly syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9934999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/naproxen-colobomatous-microphthalmia-rhizomelic-dysplasia-syndro",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "naproxen-colobomatous-microphthalmia-rhizomelic-dysplasia-syndro",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/naproxen"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "colobomatous microphthalmia-rhizomelic dysplasia syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9922
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/naproxen-acromesomelic-dysplasia-hunter-thompson-type",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "naproxen-acromesomelic-dysplasia-hunter-thompson-type",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/naproxen"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acromesomelic dysplasia, Hunter-Thompson type"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9917
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/naproxen-brachyolmia-amelogenesis-imperfecta-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "naproxen-brachyolmia-amelogenesis-imperfecta-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/naproxen"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brachyolmia-amelogenesis imperfecta syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9906
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/brivaracetam",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "brivaracetam",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "brivaracetam",
              "display": "Brivaracetam"
            }
          ],
          "text": "Brivaracetam"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "抗癲癇藥"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/brivaracetam-visual-epilepsy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "brivaracetam-visual-epilepsy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/brivaracetam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "visual epilepsy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9951000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/brivaracetam-status-epilepticus",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "brivaracetam-status-epilepticus",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/brivaracetam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "status epilepticus"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9940000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/brivaracetam-eating-seizures",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "brivaracetam-eating-seizures",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/brivaracetam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "eating seizures"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9919
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/brivaracetam-orgasm-induced-seizures",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "brivaracetam-orgasm-induced-seizures",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/brivaracetam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "orgasm-induced seizures"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9919
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/brivaracetam-thinking-seizures",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "brivaracetam-thinking-seizures",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/brivaracetam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "thinking seizures"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9919
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/brivaracetam-startle-epilepsy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "brivaracetam-startle-epilepsy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/brivaracetam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "startle epilepsy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9919
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/brivaracetam-micturation-induced-seizures",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "brivaracetam-micturation-induced-seizures",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/brivaracetam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "micturation-induced seizures"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9919
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/brivaracetam-audiogenic-seizures",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "brivaracetam-audiogenic-seizures",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/brivaracetam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "audiogenic seizures"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9919
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/brivaracetam-beta-ketothiolase-deficiency",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "brivaracetam-beta-ketothiolase-deficiency",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/brivaracetam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "beta-ketothiolase deficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9914000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/brivaracetam-adolescent-adult-onset-autosomal-dominant-epilepsy-",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "brivaracetam-adolescent-adult-onset-autosomal-dominant-epilepsy-",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/brivaracetam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "adolescent/adult onset autosomal dominant epilepsy with auditory features"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/butenafine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "butenafine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "butenafine",
              "display": "Butenafine"
            }
          ],
          "text": "Butenafine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "指(趾)間黴菌病(香港腳)、圓癬(體癬)股癬等皮膚真菌屬黴菌引起之皮膚感染症。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/butenafine-cutaneous-candidiasis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "butenafine-cutaneous-candidiasis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/butenafine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cutaneous candidiasis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9933
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/butenafine-superficial-mycosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "butenafine-superficial-mycosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/butenafine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "superficial mycosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9902
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/butenafine-endothrix-infectious-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "butenafine-endothrix-infectious-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/butenafine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "endothrix infectious disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9902
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/butenafine-ectothrix-infectious-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "butenafine-ectothrix-infectious-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/butenafine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "ectothrix infectious disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9902
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/butenafine-majocchi-granuloma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "butenafine-majocchi-granuloma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/butenafine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Majocchi granuloma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9902
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/riluzole",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "riluzole",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "riluzole",
              "display": "Riluzole"
            }
          ],
          "text": "Riluzole"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "肌萎縮脊髓側索硬化症（ＡＭＯＴＲＯＰＨＩＣ　ＬＡＴＥＲＡＬ　ＳＣＬＥＲＯＳＩＳ，ＡＬＳ）。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/riluzole-bilateral-parasagittal-parieto-occipital-polymicrogyria",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "riluzole-bilateral-parasagittal-parieto-occipital-polymicrogyria",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/riluzole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "bilateral parasagittal parieto-occipital polymicrogyria"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/riluzole-axial-spondylometaphyseal-dysplasia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "riluzole-axial-spondylometaphyseal-dysplasia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/riluzole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "axial spondylometaphyseal dysplasia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/riluzole-lower-motor-neuron-syndrome-with-late-adult-onset",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "riluzole-lower-motor-neuron-syndrome-with-late-adult-onset",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/riluzole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "lower motor neuron syndrome with late-adult onset"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/riluzole-trichomegaly-retina-pigmentary-degeneration-dwarfism-sy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "riluzole-trichomegaly-retina-pigmentary-degeneration-dwarfism-sy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/riluzole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "trichomegaly-retina pigmentary degeneration-dwarfism syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/riluzole-lethal-arthrogryposis-anterior-horn-cell-disease-syndro",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "riluzole-lethal-arthrogryposis-anterior-horn-cell-disease-syndro",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/riluzole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "lethal arthrogryposis-anterior horn cell disease syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/riluzole-monomelic-amyotrophy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "riluzole-monomelic-amyotrophy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/riluzole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "monomelic amyotrophy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/riluzole-mills-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "riluzole-mills-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/riluzole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Mills syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/riluzole-amyotrophic-lateral-sclerosis-susceptibility-to",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "riluzole-amyotrophic-lateral-sclerosis-susceptibility-to",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/riluzole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "amyotrophic lateral sclerosis, susceptibility to"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/riluzole-autosomal-dominant-mitochondrial-myopathy-with-exercise",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "riluzole-autosomal-dominant-mitochondrial-myopathy-with-exercise",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/riluzole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "autosomal dominant mitochondrial myopathy with exercise intolerance"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/riluzole-amyotrohpic-lateral-sclerosis-type-22",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "riluzole-amyotrohpic-lateral-sclerosis-type-22",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/riluzole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "amyotrohpic lateral sclerosis type 22"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/milrinone",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "milrinone",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "milrinone",
              "display": "Milrinone"
            }
          ],
          "text": "Milrinone"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "充血性心衰竭的短期療法"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/milrinone-alopecia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "milrinone-alopecia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/milrinone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "alopecia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/milrinone-hypotrichosis-simplex-of-the-scalp",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "milrinone-hypotrichosis-simplex-of-the-scalp",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/milrinone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hypotrichosis simplex of the scalp"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/milrinone-congenital-hypotrichosis-milia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "milrinone-congenital-hypotrichosis-milia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/milrinone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congenital hypotrichosis milia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/milrinone-diffuse-alopecia-areata",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "milrinone-diffuse-alopecia-areata",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/milrinone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "diffuse alopecia areata"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/milrinone-headache-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "milrinone-headache-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/milrinone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "headache disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9945999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/milrinone-congestive-heart-failure",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "milrinone-congestive-heart-failure",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/milrinone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congestive heart failure"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9945
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/milrinone-migraine-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "milrinone-migraine-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/milrinone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "migraine disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9945
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/milrinone-migraine-with-brainstem-aura",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "milrinone-migraine-with-brainstem-aura",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/milrinone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "migraine with brainstem aura"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9937999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/milrinone-trigeminal-autonomic-cephalalgia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "milrinone-trigeminal-autonomic-cephalalgia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/milrinone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "trigeminal autonomic cephalalgia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9925
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/milrinone-acute-pulmonary-heart-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "milrinone-acute-pulmonary-heart-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/milrinone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acute pulmonary heart disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9919
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/berberine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "berberine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "berberine",
              "display": "Berberine"
            }
          ],
          "text": "Berberine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "腹瀉、急慢性腸炎、腸內異常醱酵、細菌性痢疾"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/berberine-severe-pre-eclampsia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "berberine-severe-pre-eclampsia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/berberine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "severe pre-eclampsia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9983
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/berberine-mild-pre-eclampsia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "berberine-mild-pre-eclampsia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/berberine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "mild pre-eclampsia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9983
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/berberine-monocytic-leukemia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "berberine-monocytic-leukemia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/berberine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "monocytic leukemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9974
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/berberine-multiple-endocrine-neoplasia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "berberine-multiple-endocrine-neoplasia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/berberine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "multiple endocrine neoplasia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9972
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/berberine-preeclampsia-eclampsia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "berberine-preeclampsia-eclampsia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/berberine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "preeclampsia/eclampsia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9971
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/berberine-spermatocytic-seminoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "berberine-spermatocytic-seminoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/berberine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "spermatocytic seminoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9967
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/berberine-placental-hemangioma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "berberine-placental-hemangioma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/berberine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "placental hemangioma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9963
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/berberine-tubular-variant-testicular-seminoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "berberine-tubular-variant-testicular-seminoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/berberine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "tubular variant testicular seminoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.996
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/berberine-gestational-trophoblastic-neoplasm",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "berberine-gestational-trophoblastic-neoplasm",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/berberine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gestational trophoblastic neoplasm"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9956
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/berberine-toxemia-of-pregnancy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "berberine-toxemia-of-pregnancy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/berberine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "toxemia of pregnancy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/hydroquinone",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "hydroquinone",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "hydroquinone",
              "display": "Hydroquinone"
            }
          ],
          "text": "Hydroquinone"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "雀斑、黑斑"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroquinone-seborrheic-keratosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroquinone-seborrheic-keratosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroquinone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "seborrheic keratosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9973000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroquinone-vulvar-inverted-follicular-keratosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroquinone-vulvar-inverted-follicular-keratosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroquinone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "vulvar inverted follicular keratosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9964
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroquinone-exanthem-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroquinone-exanthem-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroquinone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "exanthem (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9942
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroquinone-lichen-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroquinone-lichen-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroquinone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "lichen disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9906999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/inositol",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "inositol",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "inositol",
              "display": "Inositol"
            }
          ],
          "text": "Inositol"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "末梢血管擴張劑"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/inositol-hepatoportal-sclerosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "inositol-hepatoportal-sclerosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/inositol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hepatoportal sclerosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/inositol-idiopathic-copper-associated-cirrhosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "inositol-idiopathic-copper-associated-cirrhosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/inositol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "idiopathic copper-associated cirrhosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/inositol-early-onset-familial-noncirrhotic-portal-hypertension",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "inositol-early-onset-familial-noncirrhotic-portal-hypertension",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/inositol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "early-onset familial noncirrhotic portal hypertension"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/inositol-hepatopulmonary-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "inositol-hepatopulmonary-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/inositol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hepatopulmonary syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/inositol-primitive-portal-vein-thrombosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "inositol-primitive-portal-vein-thrombosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/inositol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "primitive portal vein thrombosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/inositol-hepatic-porphyria",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "inositol-hepatic-porphyria",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/inositol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hepatic porphyria"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/inositol-congestive-heart-failure",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "inositol-congestive-heart-failure",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/inositol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congestive heart failure"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9944
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/inositol-hyperlipoproteinemia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "inositol-hyperlipoproteinemia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/inositol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hyperlipoproteinemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9940000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/inositol-acute-pulmonary-heart-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "inositol-acute-pulmonary-heart-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/inositol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acute pulmonary heart disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9934000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/inositol-glycogen-storage-disease-due-to-hepatic-glycogen-syntha",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "inositol-glycogen-storage-disease-due-to-hepatic-glycogen-syntha",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/inositol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "glycogen storage disease due to hepatic glycogen synthase deficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9926
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/ferrous_gluconate",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "ferrous_gluconate",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "ferrous_gluconate",
              "display": "Ferrous gluconate"
            }
          ],
          "text": "Ferrous gluconate"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "貧血症"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ferrous_gluconate-plummer-vinson-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ferrous_gluconate-plummer-vinson-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ferrous_gluconate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Plummer-Vinson syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ferrous_gluconate-vitamin-b12-and-folate-independent-constitutio",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ferrous_gluconate-vitamin-b12-and-folate-independent-constitutio",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ferrous_gluconate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "vitamin B12- and folate-independent constitutional megaloblastic anemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ferrous_gluconate-non-syndromic-esophageal-malformation",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ferrous_gluconate-non-syndromic-esophageal-malformation",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ferrous_gluconate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "non-syndromic esophageal malformation"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9967
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ferrous_gluconate-biotin-metabolic-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ferrous_gluconate-biotin-metabolic-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ferrous_gluconate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "biotin metabolic disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9942
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ferrous_gluconate-vitamin-deficiency-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ferrous_gluconate-vitamin-deficiency-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ferrous_gluconate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "vitamin deficiency disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9917
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/amorolfine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "amorolfine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "amorolfine",
              "display": "Amorolfine"
            }
          ],
          "text": "Amorolfine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "由皮真菌、酵母菌及黴菌引起之遠端及外側之輕度甲癬。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/amorolfine-drug-induced-osteoporosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "amorolfine-drug-induced-osteoporosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/amorolfine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "drug-induced osteoporosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/amorolfine-disease-of-retroperitoneum",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "amorolfine-disease-of-retroperitoneum",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/amorolfine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "disease of retroperitoneum"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/amorolfine-disease-of-uterine-broad-ligament",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "amorolfine-disease-of-uterine-broad-ligament",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/amorolfine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "disease of uterine broad ligament"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/amorolfine-lumbar-spinal-stenosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "amorolfine-lumbar-spinal-stenosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/amorolfine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "lumbar spinal stenosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/amorolfine-abdominal-cystic-lymphangioma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "amorolfine-abdominal-cystic-lymphangioma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/amorolfine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "abdominal cystic lymphangioma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/amorolfine-abdominal-ectopic-pregnancy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "amorolfine-abdominal-ectopic-pregnancy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/amorolfine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "abdominal ectopic pregnancy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/amorolfine-celiac-trunk-compression-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "amorolfine-celiac-trunk-compression-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/amorolfine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "celiac trunk compression syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/amorolfine-lymph-node-palisaded-myofibroblastoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "amorolfine-lymph-node-palisaded-myofibroblastoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/amorolfine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "lymph node palisaded myofibroblastoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/amorolfine-sacrum-chordoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "amorolfine-sacrum-chordoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/amorolfine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "sacrum chordoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/amorolfine-urethral-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "amorolfine-urethral-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/amorolfine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "urethral disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/ipilimumab",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "ipilimumab",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "ipilimumab",
              "display": "Ipilimumab"
            }
          ],
          "text": "Ipilimumab"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "1、無法切除或轉移性黑色素瘤：單一療法或併用ipilimumab適用於治療無法切除或轉移性黑色素瘤病..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ipilimumab-choroideremia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ipilimumab-choroideremia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ipilimumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "choroideremia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9906
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ipilimumab-non-cutaneous-melanoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ipilimumab-non-cutaneous-melanoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ipilimumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "non-cutaneous melanoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9902
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/pravastatin",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "pravastatin",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "pravastatin",
              "display": "Pravastatin"
            }
          ],
          "text": "Pravastatin"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "血脂調節劑"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pravastatin-homozygous-familial-hypercholesterolemia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pravastatin-homozygous-familial-hypercholesterolemia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pravastatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "homozygous familial hypercholesterolemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pravastatin-hiv-infectious-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pravastatin-hiv-infectious-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pravastatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "HIV infectious disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9974
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pravastatin-neurodevelopmental-disorder-with-ataxic-gait-absent-",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pravastatin-neurodevelopmental-disorder-with-ataxic-gait-absent-",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pravastatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9962000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pravastatin-feline-acquired-immunodeficiency-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pravastatin-feline-acquired-immunodeficiency-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pravastatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "feline acquired immunodeficiency syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pravastatin-simian-immunodeficiency-virus-infection",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pravastatin-simian-immunodeficiency-virus-infection",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pravastatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "simian immunodeficiency virus infection"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pravastatin-familial-hypercholesterolemia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pravastatin-familial-hypercholesterolemia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pravastatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "familial hypercholesterolemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9934000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pravastatin-hypoalphalipoproteinemia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pravastatin-hypoalphalipoproteinemia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pravastatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hypoalphalipoproteinemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9921
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pravastatin-hypercholesterolemia-due-to-cholesterol-7alpha-hydro",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pravastatin-hypercholesterolemia-due-to-cholesterol-7alpha-hydro",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pravastatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9906999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pravastatin-cholesterol-ester-transfer-protein-deficiency",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pravastatin-cholesterol-ester-transfer-protein-deficiency",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pravastatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cholesterol-ester transfer protein deficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9904000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/dupilumab",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "dupilumab",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "dupilumab",
              "display": "Dupilumab"
            }
          ],
          "text": "Dupilumab"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "1. 異位性皮膚炎：可用於治療患有中度至重度異位性皮膚炎且對局部處方治療控制不佳或不適合使用該療法的..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dupilumab-bronchitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dupilumab-bronchitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dupilumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "bronchitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dupilumab-dermatitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dupilumab-dermatitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dupilumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "dermatitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9971
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dupilumab-acne-keloid",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dupilumab-acne-keloid",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dupilumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acne keloid"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9961
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dupilumab-exanthem-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dupilumab-exanthem-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dupilumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "exanthem (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9956999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dupilumab-neonatal-dermatomyositis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dupilumab-neonatal-dermatomyositis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dupilumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "neonatal dermatomyositis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9956
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dupilumab-acrodermatitis-chronica-atrophicans",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dupilumab-acrodermatitis-chronica-atrophicans",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dupilumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acrodermatitis chronica atrophicans"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dupilumab-amyopathic-dermatomyositis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dupilumab-amyopathic-dermatomyositis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dupilumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "amyopathic dermatomyositis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9953
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dupilumab-secondary-interstitial-lung-disease-specific-to-childh",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dupilumab-secondary-interstitial-lung-disease-specific-to-childh",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dupilumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "secondary interstitial lung disease specific to childhood associated with a connective tissue disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9952
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dupilumab-hydroa-vacciniforme-familial",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dupilumab-hydroa-vacciniforme-familial",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dupilumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hydroa vacciniforme, familial"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dupilumab-severe-nonproliferative-diabetic-retinopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dupilumab-severe-nonproliferative-diabetic-retinopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dupilumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "severe nonproliferative diabetic retinopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/povidone",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "povidone",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "povidone",
              "display": "Povidone"
            }
          ],
          "text": "Povidone"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "手術前後醫護人員消毒及手術前病患之消毒。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/povidone-congenital-ichthyosiform-erythroderma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "povidone-congenital-ichthyosiform-erythroderma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/povidone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congenital ichthyosiform erythroderma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9911
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/pitavastatin",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "pitavastatin",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "pitavastatin",
              "display": "Pitavastatin"
            }
          ],
          "text": "Pitavastatin"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "原發性高膽固醇血症及混合型血脂異常與10歲以上兒童家族性高膽固醇血症。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pitavastatin-homozygous-familial-hypercholesterolemia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pitavastatin-homozygous-familial-hypercholesterolemia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pitavastatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "homozygous familial hypercholesterolemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pitavastatin-hyperlipoproteinemia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pitavastatin-hyperlipoproteinemia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pitavastatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hyperlipoproteinemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pitavastatin-familial-hypercholesterolemia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pitavastatin-familial-hypercholesterolemia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pitavastatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "familial hypercholesterolemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pitavastatin-cholesterol-ester-transfer-protein-deficiency",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pitavastatin-cholesterol-ester-transfer-protein-deficiency",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pitavastatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cholesterol-ester transfer protein deficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pitavastatin-hypercholesterolemia-autosomal-dominant",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pitavastatin-hypercholesterolemia-autosomal-dominant",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pitavastatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hypercholesterolemia, autosomal dominant"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pitavastatin-hypercholesterolemia-due-to-cholesterol-7alpha-hydr",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pitavastatin-hypercholesterolemia-due-to-cholesterol-7alpha-hydr",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pitavastatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pitavastatin-hiv-infectious-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pitavastatin-hiv-infectious-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pitavastatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "HIV infectious disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pitavastatin-neurodevelopmental-disorder-with-ataxic-gait-absent",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pitavastatin-neurodevelopmental-disorder-with-ataxic-gait-absent",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pitavastatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pitavastatin-hyperlipidemia-due-to-hepatic-triglyceride-lipase-d",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pitavastatin-hyperlipidemia-due-to-hepatic-triglyceride-lipase-d",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pitavastatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hyperlipidemia due to hepatic triglyceride lipase deficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pitavastatin-simian-immunodeficiency-virus-infection",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pitavastatin-simian-immunodeficiency-virus-infection",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pitavastatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "simian immunodeficiency virus infection"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/clobetasone",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "clobetasone",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "clobetasone",
              "display": "Clobetasone"
            }
          ],
          "text": "Clobetasone"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "輕度濕疹、脂漏性皮炎、其他對類固醇有反應的皮膚疾患"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/clobetasone-primary-cutaneous-t-cell-lymphoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "clobetasone-primary-cutaneous-t-cell-lymphoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/clobetasone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "primary cutaneous T-cell lymphoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/clobetasone-sezary-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "clobetasone-sezary-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/clobetasone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Sezary syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9978
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/clobetasone-primary-cutaneous-b-cell-lymphoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "clobetasone-primary-cutaneous-b-cell-lymphoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/clobetasone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "primary cutaneous B-cell lymphoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/clobetasone-granulomatous-slack-skin-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "clobetasone-granulomatous-slack-skin-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/clobetasone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "granulomatous slack skin disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9974
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/clobetasone-crohn-s-colitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "clobetasone-crohn-s-colitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/clobetasone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Crohn's colitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9972
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/clobetasone-adrenocortical-insufficiency",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "clobetasone-adrenocortical-insufficiency",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/clobetasone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "adrenocortical insufficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9971
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/clobetasone-primary-cutaneous-t-cell-non-hodgkin-lymphoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "clobetasone-primary-cutaneous-t-cell-non-hodgkin-lymphoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/clobetasone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "primary cutaneous T-cell non-Hodgkin lymphoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/clobetasone-nephrotic-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "clobetasone-nephrotic-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/clobetasone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "nephrotic syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9969
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/clobetasone-cystic-teratoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "clobetasone-cystic-teratoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/clobetasone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cystic teratoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9965
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/clobetasone-spinal-cord-dermoid-cyst",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "clobetasone-spinal-cord-dermoid-cyst",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/clobetasone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "spinal cord dermoid cyst"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9965
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/homatropine_methylbromide",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "homatropine_methylbromide",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "homatropine_methylbromide",
              "display": "Homatropine methylbromide"
            }
          ],
          "text": "Homatropine methylbromide"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "副交感神經抑制劑"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/homatropine_methylbromide-gastroduodenitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "homatropine_methylbromide-gastroduodenitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/homatropine_methylbromide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gastroduodenitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9939
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/homatropine_methylbromide-cauda-equina-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "homatropine_methylbromide-cauda-equina-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/homatropine_methylbromide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cauda equina syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/alfacalcidol",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "alfacalcidol",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "alfacalcidol",
              "display": "Alfacalcidol"
            }
          ],
          "text": "Alfacalcidol"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "骨質疏鬆症、軟骨病、副甲狀腺低下症、佝僂病、維他命Ｄ缺乏症。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alfacalcidol-familial-isolated-hypoparathyroidism-due-to-impaire",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alfacalcidol-familial-isolated-hypoparathyroidism-due-to-impaire",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alfacalcidol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "familial isolated hypoparathyroidism due to impaired PTH secretion"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9961
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alfacalcidol-dahlberg-borer-newcomer-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alfacalcidol-dahlberg-borer-newcomer-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alfacalcidol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Dahlberg-Borer-Newcomer syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.996
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alfacalcidol-craniofacial-conodysplasia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alfacalcidol-craniofacial-conodysplasia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alfacalcidol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "craniofacial conodysplasia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alfacalcidol-acromesomelic-dysplasia-campailla-martinelli-type",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alfacalcidol-acromesomelic-dysplasia-campailla-martinelli-type",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alfacalcidol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acromesomelic dysplasia, Campailla Martinelli type"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9953
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alfacalcidol-renal-tubular-acidosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alfacalcidol-renal-tubular-acidosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alfacalcidol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "renal tubular acidosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9926999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/potassium_iodide",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "potassium_iodide",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "potassium_iodide",
              "display": "Potassium Iodide"
            }
          ],
          "text": "Potassium Iodide"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "外科殺菌敷傷用、皮膚殺菌消毒"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/potassium_iodide-nasal-cavity-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "potassium_iodide-nasal-cavity-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/potassium_iodide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "nasal cavity disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/potassium_iodide-acute-laryngopharyngitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "potassium_iodide-acute-laryngopharyngitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/potassium_iodide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acute laryngopharyngitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/naphazoline",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "naphazoline",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "naphazoline",
              "display": "Naphazoline"
            }
          ],
          "text": "Naphazoline"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "過敏性鼻炎、鼻塞"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/naphazoline-hypotrichosis-simplex-of-the-scalp",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "naphazoline-hypotrichosis-simplex-of-the-scalp",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/naphazoline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hypotrichosis simplex of the scalp"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9983
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/naphazoline-congenital-hypotrichosis-milia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "naphazoline-congenital-hypotrichosis-milia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/naphazoline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congenital hypotrichosis milia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9982
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/naphazoline-diffuse-alopecia-areata",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "naphazoline-diffuse-alopecia-areata",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/naphazoline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "diffuse alopecia areata"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9979
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/naphazoline-alopecia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "naphazoline-alopecia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/naphazoline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "alopecia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/naphazoline-primary-hereditary-glaucoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "naphazoline-primary-hereditary-glaucoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/naphazoline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "primary hereditary glaucoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9962000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/naphazoline-hypertrichosis-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "naphazoline-hypertrichosis-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/naphazoline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hypertrichosis (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.996
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/naphazoline-ambras-type-hypertrichosis-universalis-congenita",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "naphazoline-ambras-type-hypertrichosis-universalis-congenita",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/naphazoline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Ambras type hypertrichosis universalis congenita"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.996
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/naphazoline-open-angle-glaucoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "naphazoline-open-angle-glaucoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/naphazoline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "open-angle glaucoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9959
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/naphazoline-malformation-syndrome-with-odontal-and-or-periodonta",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "naphazoline-malformation-syndrome-with-odontal-and-or-periodonta",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/naphazoline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "malformation syndrome with odontal and/or periodontal component"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9956999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/naphazoline-syndrome-with-a-dandy-walker-malformation-as-major-f",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "naphazoline-syndrome-with-a-dandy-walker-malformation-as-major-f",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/naphazoline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "syndrome with a Dandy-Walker malformation as major feature"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9952
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/methocarbamol",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "methocarbamol",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "methocarbamol",
              "display": "Methocarbamol"
            }
          ],
          "text": "Methocarbamol"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "骨骼肌弛緩劑"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/methocarbamol-cauda-equina-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "methocarbamol-cauda-equina-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/methocarbamol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cauda equina syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/methocarbamol-irritable-bowel-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "methocarbamol-irritable-bowel-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/methocarbamol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "irritable bowel syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/methocarbamol-panuveitis-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "methocarbamol-panuveitis-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/methocarbamol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "panuveitis (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/methocarbamol-anaphylaxis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "methocarbamol-anaphylaxis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/methocarbamol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "anaphylaxis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/methocarbamol-iris-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "methocarbamol-iris-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/methocarbamol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "iris disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/methocarbamol-uveitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "methocarbamol-uveitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/methocarbamol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "uveitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/methocarbamol-ventricular-tachycardia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "methocarbamol-ventricular-tachycardia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/methocarbamol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "ventricular tachycardia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/methocarbamol-food-dependent-exercise-induced-anaphylaxis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "methocarbamol-food-dependent-exercise-induced-anaphylaxis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/methocarbamol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "food-dependent exercise-induced anaphylaxis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/methocarbamol-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "methocarbamol-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/methocarbamol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/methocarbamol-obsolete-bundle-branch-block",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "methocarbamol-obsolete-bundle-branch-block",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/methocarbamol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "obsolete bundle branch block"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/sacituzumab_govitecan",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "sacituzumab_govitecan",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "sacituzumab_govitecan",
              "display": "Sacituzumab govitecan"
            }
          ],
          "text": "Sacituzumab govitecan"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "1. 適用於治療先前已接受兩次以上全身性治療無效(其中一次需為治療晚期疾病)之無法切除的局部晚期或轉..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sacituzumab_govitecan-drug-induced-osteoporosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sacituzumab_govitecan-drug-induced-osteoporosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sacituzumab_govitecan"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "drug-induced osteoporosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9978
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sacituzumab_govitecan-severe-nonproliferative-diabetic-retinopat",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sacituzumab_govitecan-severe-nonproliferative-diabetic-retinopat",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sacituzumab_govitecan"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "severe nonproliferative diabetic retinopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9969
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sacituzumab_govitecan-diabetic-retinopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sacituzumab_govitecan-diabetic-retinopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sacituzumab_govitecan"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "diabetic retinopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.996
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sacituzumab_govitecan-diabetic-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sacituzumab_govitecan-diabetic-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sacituzumab_govitecan"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "diabetic cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9912000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/carbenoxolone",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "carbenoxolone",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "carbenoxolone",
              "display": "Carbenoxolone"
            }
          ],
          "text": "Carbenoxolone"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "十二指腸潰瘍"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/carbenoxolone-non-syndromic-esophageal-malformation",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "carbenoxolone-non-syndromic-esophageal-malformation",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/carbenoxolone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "non-syndromic esophageal malformation"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/carbenoxolone-vitamin-deficiency-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "carbenoxolone-vitamin-deficiency-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/carbenoxolone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "vitamin deficiency disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/carbenoxolone-biotin-metabolic-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "carbenoxolone-biotin-metabolic-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/carbenoxolone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "biotin metabolic disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/carbenoxolone-filariasis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "carbenoxolone-filariasis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/carbenoxolone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "filariasis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/carbenoxolone-bile-duct-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "carbenoxolone-bile-duct-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/carbenoxolone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "bile duct disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/carbenoxolone-bile-duct-neoplasm",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "carbenoxolone-bile-duct-neoplasm",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/carbenoxolone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "bile duct neoplasm"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9948
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/carbenoxolone-tinea-nigra",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "carbenoxolone-tinea-nigra",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/carbenoxolone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "tinea nigra"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9922
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/sulfamerazine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "sulfamerazine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "sulfamerazine",
              "display": "Sulfamerazine"
            }
          ],
          "text": "Sulfamerazine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "肺炎球菌、鏈球菌、葡萄球菌、腦膜炎菌感染症"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sulfamerazine-gout",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sulfamerazine-gout",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sulfamerazine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gout"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9934999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sulfamerazine-autosomal-dominant-familial-hematuria-retinal-arte",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sulfamerazine-autosomal-dominant-familial-hematuria-retinal-arte",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sulfamerazine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9919
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sulfamerazine-brain-small-vessel-disease-1-with-or-without-ocula",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sulfamerazine-brain-small-vessel-disease-1-with-or-without-ocula",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sulfamerazine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brain small vessel disease 1 with or without ocular anomalies"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9919
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sulfamerazine-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sulfamerazine-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sulfamerazine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9902
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/ropinirole",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "ropinirole",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "ropinirole",
              "display": "Ropinirole"
            }
          ],
          "text": "Ropinirole"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "治療自發性帕金森氏症(IDIOPATHIC PARKINSON'S DISEASE)治療原發性腳部躁..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ropinirole-attention-deficit-hyperactivity-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ropinirole-attention-deficit-hyperactivity-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ropinirole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "attention deficit-hyperactivity disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ropinirole-faciodigitogenital-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ropinirole-faciodigitogenital-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ropinirole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "faciodigitogenital syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ropinirole-polymicrogyria-perisylvian-with-cerebellar-hypoplasia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ropinirole-polymicrogyria-perisylvian-with-cerebellar-hypoplasia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ropinirole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ropinirole-retinal-dystrophy-with-or-without-extraocular-anomali",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ropinirole-retinal-dystrophy-with-or-without-extraocular-anomali",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ropinirole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "retinal dystrophy with or without extraocular anomalies"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ropinirole-schizophrenia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ropinirole-schizophrenia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ropinirole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "schizophrenia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ropinirole-myopia-x-linked",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ropinirole-myopia-x-linked",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ropinirole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "myopia X-linked"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ropinirole-congenital-disorder-of-glycosylation-with-defective-f",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ropinirole-congenital-disorder-of-glycosylation-with-defective-f",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ropinirole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congenital disorder of glycosylation with defective fucosylation"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ropinirole-atypical-glycine-encephalopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ropinirole-atypical-glycine-encephalopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ropinirole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "atypical glycine encephalopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ropinirole-myopia-26-x-linked-female-limited",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ropinirole-myopia-26-x-linked-female-limited",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ropinirole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "myopia 26, X-linked, female-limited"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ropinirole-charcot-marie-tooth-disease-demyelinating-type-1g",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ropinirole-charcot-marie-tooth-disease-demyelinating-type-1g",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ropinirole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Charcot-Marie-Tooth disease, demyelinating, type 1G"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/tolmetin",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "tolmetin",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "tolmetin",
              "display": "Tolmetin"
            }
          ],
          "text": "Tolmetin"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "風濕性關節炎（關節紅腫、關節痛、肌肉僵硬）之緩解"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tolmetin-acromesomelic-dysplasia-hunter-thompson-type",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tolmetin-acromesomelic-dysplasia-hunter-thompson-type",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tolmetin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acromesomelic dysplasia, Hunter-Thompson type"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tolmetin-brachyolmia-amelogenesis-imperfecta-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tolmetin-brachyolmia-amelogenesis-imperfecta-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tolmetin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brachyolmia-amelogenesis imperfecta syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tolmetin-myosclerosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tolmetin-myosclerosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tolmetin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "myosclerosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tolmetin-brachyolmia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tolmetin-brachyolmia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tolmetin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brachyolmia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tolmetin-pseudoachondroplasia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tolmetin-pseudoachondroplasia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tolmetin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pseudoachondroplasia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tolmetin-rheumatoid-nodulosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tolmetin-rheumatoid-nodulosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tolmetin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "rheumatoid nodulosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tolmetin-rheumatoid-factor-positive-polyarticular-juvenile-idiop",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tolmetin-rheumatoid-factor-positive-polyarticular-juvenile-idiop",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tolmetin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "rheumatoid factor-positive polyarticular juvenile idiopathic arthritis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9975
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tolmetin-spondyloarthropathy-susceptibility-to",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tolmetin-spondyloarthropathy-susceptibility-to",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tolmetin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "spondyloarthropathy, susceptibility to"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9975
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tolmetin-colobomatous-microphthalmia-rhizomelic-dysplasia-syndro",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tolmetin-colobomatous-microphthalmia-rhizomelic-dysplasia-syndro",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tolmetin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "colobomatous microphthalmia-rhizomelic dysplasia syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9972
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tolmetin-whim-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tolmetin-whim-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tolmetin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "WHIM syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9971
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/pralatrexate",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "pralatrexate",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "pralatrexate",
              "display": "Pralatrexate"
            }
          ],
          "text": "Pralatrexate"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "治療復發或頑固型周邊T細胞淋巴瘤(PTCL)。適應症依據為腫瘤反應率，目前沒有資料證實無惡化存活期或..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pralatrexate-pleural-adenomatoid-tumor",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pralatrexate-pleural-adenomatoid-tumor",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pralatrexate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pleural adenomatoid tumor"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pralatrexate-relapsing-remitting-multiple-sclerosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pralatrexate-relapsing-remitting-multiple-sclerosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pralatrexate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "relapsing-remitting multiple sclerosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pralatrexate-pleural-biphasic-mesothelioma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pralatrexate-pleural-biphasic-mesothelioma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pralatrexate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pleural biphasic mesothelioma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pralatrexate-pleural-epithelioid-mesothelioma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pralatrexate-pleural-epithelioid-mesothelioma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pralatrexate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pleural epithelioid mesothelioma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pralatrexate-lymphohistiocytoid-mesothelioma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pralatrexate-lymphohistiocytoid-mesothelioma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pralatrexate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "lymphohistiocytoid mesothelioma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pralatrexate-pericardium-cancer",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pralatrexate-pericardium-cancer",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pralatrexate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pericardium cancer"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pralatrexate-pleural-sarcomatoid-mesothelioma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pralatrexate-pleural-sarcomatoid-mesothelioma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pralatrexate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pleural sarcomatoid mesothelioma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pralatrexate-malignant-peritoneal-mesothelioma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pralatrexate-malignant-peritoneal-mesothelioma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pralatrexate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "malignant peritoneal mesothelioma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pralatrexate-well-differentiated-papillary-mesothelioma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pralatrexate-well-differentiated-papillary-mesothelioma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pralatrexate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "well differentiated papillary mesothelioma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pralatrexate-pleural-mesothelioma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pralatrexate-pleural-mesothelioma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pralatrexate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pleural mesothelioma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/human_immunoglobulin_g",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "human_immunoglobulin_g",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "human_immunoglobulin_g",
              "display": "Human immunoglobulin G"
            }
          ],
          "text": "Human immunoglobulin G"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "IgG的替代治療用藥，適應症包括：1.原發性免疫不全症（primary immune deficie..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/human_immunoglobulin_g-severe-nonproliferative-diabetic-retinopa",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "human_immunoglobulin_g-severe-nonproliferative-diabetic-retinopa",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/human_immunoglobulin_g"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "severe nonproliferative diabetic retinopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9975
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/human_immunoglobulin_g-diabetic-retinopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "human_immunoglobulin_g-diabetic-retinopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/human_immunoglobulin_g"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "diabetic retinopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9963
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/human_immunoglobulin_g-drug-induced-osteoporosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "human_immunoglobulin_g-drug-induced-osteoporosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/human_immunoglobulin_g"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "drug-induced osteoporosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9937
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/inclisiran",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "inclisiran",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "inclisiran",
              "display": "Inclisiran"
            }
          ],
          "text": "Inclisiran"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "原發性高血脂症(其中之家族性高膽固醇血症僅適用於異合子家族性高膽固醇血症(HeFH))：作為飲食及其..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/inclisiran-potassium-deficiency-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "inclisiran-potassium-deficiency-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/inclisiran"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "potassium deficiency disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/inclisiran-esophageal-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "inclisiran-esophageal-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/inclisiran"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "esophageal disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/inclisiran-atypical-coarctation-of-aorta",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "inclisiran-atypical-coarctation-of-aorta",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/inclisiran"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "atypical coarctation of aorta"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9986
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/inclisiran-migraine-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "inclisiran-migraine-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/inclisiran"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "migraine disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9983
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/inclisiran-non-syndromic-esophageal-malformation",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "inclisiran-non-syndromic-esophageal-malformation",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/inclisiran"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "non-syndromic esophageal malformation"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9983
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/inclisiran-migraine-with-brainstem-aura",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "inclisiran-migraine-with-brainstem-aura",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/inclisiran"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "migraine with brainstem aura"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9978
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/inclisiran-migraine-with-or-without-aura-susceptibility-to",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "inclisiran-migraine-with-or-without-aura-susceptibility-to",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/inclisiran"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "migraine with or without aura, susceptibility to"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9978
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/inclisiran-aortic-malformation",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "inclisiran-aortic-malformation",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/inclisiran"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "aortic malformation"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/inclisiran-esophageal-ulcer",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "inclisiran-esophageal-ulcer",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/inclisiran"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "esophageal ulcer"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9973000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/inclisiran-raynaud-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "inclisiran-raynaud-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/inclisiran"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Raynaud disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9973000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/interferon_beta-1b",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "interferon_beta-1b",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "interferon_beta-1b",
              "display": "Interferon beta-1b"
            }
          ],
          "text": "Interferon beta-1b"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "降低反覆發作型多發性硬化症的發作頻率及嚴重度。降低續發型多發性硬化症(secondary progr..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/interferon_beta-1b-hairy-cell-leukemia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "interferon_beta-1b-hairy-cell-leukemia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/interferon_beta-1b"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hairy cell leukemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9915999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/interferon_beta-1b-autoimmune-disease-of-central-nervous-system",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "interferon_beta-1b-autoimmune-disease-of-central-nervous-system",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/interferon_beta-1b"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "autoimmune disease of central nervous system"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9902
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/sulfamethazine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "sulfamethazine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "sulfamethazine",
              "display": "Sulfamethazine"
            }
          ],
          "text": "Sulfamethazine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "細菌性感染症"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sulfamethazine-gout",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sulfamethazine-gout",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sulfamethazine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gout"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sulfamethazine-brain-small-vessel-disease-1-with-or-without-ocul",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sulfamethazine-brain-small-vessel-disease-1-with-or-without-ocul",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sulfamethazine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brain small vessel disease 1 with or without ocular anomalies"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9983
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sulfamethazine-autosomal-dominant-familial-hematuria-retinal-art",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sulfamethazine-autosomal-dominant-familial-hematuria-retinal-art",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sulfamethazine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9983
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sulfamethazine-diabetic-nephropathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sulfamethazine-diabetic-nephropathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sulfamethazine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "diabetic nephropathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sulfamethazine-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sulfamethazine-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sulfamethazine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9943000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/sulfamethazine-bronchitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "sulfamethazine-bronchitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/sulfamethazine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "bronchitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9934000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/oxybutynin",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "oxybutynin",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "oxybutynin",
              "display": "Oxybutynin"
            }
          ],
          "text": "Oxybutynin"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "因膀胱神經之控制不適所伴隨排尿諸症之緩解。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/oxybutynin-restless-legs-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "oxybutynin-restless-legs-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/oxybutynin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "restless legs syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9974
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/oxybutynin-gastroduodenitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "oxybutynin-gastroduodenitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/oxybutynin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gastroduodenitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9962000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/oxybutynin-peptic-ulcer-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "oxybutynin-peptic-ulcer-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/oxybutynin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "peptic ulcer disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9931
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/cobicistat",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "cobicistat",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "cobicistat",
              "display": "Cobicistat"
            }
          ],
          "text": "Cobicistat"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "下列感染第一型人類免疫缺乏病毒(HIV-1)且不具已知與嵌入酶抑制劑類藥品、emtricitabin..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cobicistat-simian-immunodeficiency-virus-infection",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cobicistat-simian-immunodeficiency-virus-infection",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cobicistat"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "simian immunodeficiency virus infection"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cobicistat-feline-acquired-immunodeficiency-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cobicistat-feline-acquired-immunodeficiency-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cobicistat"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "feline acquired immunodeficiency syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cobicistat-neurodevelopmental-disorder-with-ataxic-gait-absent-s",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cobicistat-neurodevelopmental-disorder-with-ataxic-gait-absent-s",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cobicistat"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/omalizumab",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "omalizumab",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "omalizumab",
              "display": "Omalizumab"
            }
          ],
          "text": "Omalizumab"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "1.過敏性氣喘附加療法：為附加療法用於改善已接受高劑量吸入性類固醇製劑及長效乙二型作用劑(s2-  ..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/omalizumab-bronchitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "omalizumab-bronchitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/omalizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "bronchitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/omalizumab-atopic-eczema",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "omalizumab-atopic-eczema",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/omalizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "atopic eczema"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/omalizumab-obstructive-lung-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "omalizumab-obstructive-lung-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/omalizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "obstructive lung disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/omalizumab-dermatitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "omalizumab-dermatitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/omalizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "dermatitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/omalizumab-bronchial-neoplasm-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "omalizumab-bronchial-neoplasm-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/omalizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "bronchial neoplasm (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/omalizumab-acne-keloid",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "omalizumab-acne-keloid",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/omalizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acne keloid"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/omalizumab-acrodermatitis-chronica-atrophicans",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "omalizumab-acrodermatitis-chronica-atrophicans",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/omalizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acrodermatitis chronica atrophicans"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/omalizumab-hydroa-vacciniforme-familial",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "omalizumab-hydroa-vacciniforme-familial",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/omalizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hydroa vacciniforme, familial"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/omalizumab-neonatal-dermatomyositis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "omalizumab-neonatal-dermatomyositis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/omalizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "neonatal dermatomyositis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/omalizumab-secondary-interstitial-lung-disease-specific-to-child",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "omalizumab-secondary-interstitial-lung-disease-specific-to-child",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/omalizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "secondary interstitial lung disease specific to childhood associated with a connective tissue disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/nebivolol",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "nebivolol",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "nebivolol",
              "display": "Nebivolol"
            }
          ],
          "text": "Nebivolol"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "治療原發性高血壓。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nebivolol-malignant-renovascular-hypertension",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nebivolol-malignant-renovascular-hypertension",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nebivolol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "malignant renovascular hypertension"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9942
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nebivolol-malignant-hypertensive-renal-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nebivolol-malignant-hypertensive-renal-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nebivolol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "malignant hypertensive renal disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9942
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nebivolol-pulmonary-hypertension-owing-to-lung-disease-and-or-hy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nebivolol-pulmonary-hypertension-owing-to-lung-disease-and-or-hy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nebivolol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pulmonary hypertension owing to lung disease and/or hypoxia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9939
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nebivolol-pulmonary-hypertension-with-unclear-multifactorial-mec",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nebivolol-pulmonary-hypertension-with-unclear-multifactorial-mec",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nebivolol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pulmonary hypertension with unclear multifactorial mechanism"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9939
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nebivolol-braddock-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nebivolol-braddock-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nebivolol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Braddock syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9914000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/ouabain",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "ouabain",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "ouabain",
              "display": "Ouabain"
            }
          ],
          "text": "Ouabain"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "心臟衰竭、心房撲動、心房纖維顫動、陣發性上室性心博過速"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ouabain-prinzmetal-angina",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ouabain-prinzmetal-angina",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ouabain"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Prinzmetal angina"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9969
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ouabain-hemoglobinopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ouabain-hemoglobinopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ouabain"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hemoglobinopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9948
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ouabain-myocardial-infarction",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ouabain-myocardial-infarction",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ouabain"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "myocardial infarction"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9942
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ouabain-thrombotic-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ouabain-thrombotic-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ouabain"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "thrombotic disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9933
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ouabain-hyperthyroidism",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ouabain-hyperthyroidism",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ouabain"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hyperthyroidism"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9926
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ouabain-homozygous-familial-hypercholesterolemia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ouabain-homozygous-familial-hypercholesterolemia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ouabain"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "homozygous familial hypercholesterolemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9919
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ouabain-partial-deletion-of-the-short-arm-of-chromosome-16",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ouabain-partial-deletion-of-the-short-arm-of-chromosome-16",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ouabain"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "partial deletion of the short arm of chromosome 16"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9917
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ouabain-beta-thalassemia-with-other-manifestations",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ouabain-beta-thalassemia-with-other-manifestations",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ouabain"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "beta-thalassemia with other manifestations"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9917
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ouabain-brain-small-vessel-disease-1-with-or-without-ocular-anom",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ouabain-brain-small-vessel-disease-1-with-or-without-ocular-anom",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ouabain"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brain small vessel disease 1 with or without ocular anomalies"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9917
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ouabain-autosomal-dominant-familial-hematuria-retinal-arteriolar",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ouabain-autosomal-dominant-familial-hematuria-retinal-arteriolar",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ouabain"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9915
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/dehydrocholic_acid",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "dehydrocholic_acid",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "dehydrocholic_acid",
              "display": "Dehydrocholic acid"
            }
          ],
          "text": "Dehydrocholic acid"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "利膽劑"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dehydrocholic_acid-acute-urate-nephropathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dehydrocholic_acid-acute-urate-nephropathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dehydrocholic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acute urate nephropathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dehydrocholic_acid-nephrolithiasis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dehydrocholic_acid-nephrolithiasis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dehydrocholic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "nephrolithiasis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dehydrocholic_acid-bile-duct-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dehydrocholic_acid-bile-duct-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dehydrocholic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "bile duct disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dehydrocholic_acid-bile-duct-neoplasm",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dehydrocholic_acid-bile-duct-neoplasm",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dehydrocholic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "bile duct neoplasm"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dehydrocholic_acid-apical-periodontitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dehydrocholic_acid-apical-periodontitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dehydrocholic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "apical periodontitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dehydrocholic_acid-suppurative-periapical-periodontitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dehydrocholic_acid-suppurative-periapical-periodontitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dehydrocholic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "suppurative periapical periodontitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dehydrocholic_acid-periapical-granuloma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dehydrocholic_acid-periapical-granuloma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dehydrocholic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "periapical granuloma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dehydrocholic_acid-disorder-of-phenylalanine-metabolism",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dehydrocholic_acid-disorder-of-phenylalanine-metabolism",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dehydrocholic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "disorder of phenylalanine metabolism"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dehydrocholic_acid-urolithiasis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dehydrocholic_acid-urolithiasis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dehydrocholic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "urolithiasis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dehydrocholic_acid-disorder-of-tyrosine-metabolism",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dehydrocholic_acid-disorder-of-tyrosine-metabolism",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dehydrocholic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "disorder of tyrosine metabolism"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/aspirin",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "aspirin",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "aspirin",
              "display": "aspirin"
            }
          ],
          "text": "aspirin"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/avelumab",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "avelumab",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "avelumab",
              "display": "Avelumab"
            }
          ],
          "text": "Avelumab"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "適用於治療轉移性默克細胞癌 (Merkel Cell Carcinoma)之成人病人。\r\n併用 ax..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/avelumab-human-herpesvirus-8-related-tumor",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "avelumab-human-herpesvirus-8-related-tumor",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/avelumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "human herpesvirus 8-related tumor"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/avelumab-middle-ear-neuroendocrine-tumor",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "avelumab-middle-ear-neuroendocrine-tumor",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/avelumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "middle ear neuroendocrine tumor"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/avelumab-malignant-cutaneous-granular-cell-skin-tumor",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "avelumab-malignant-cutaneous-granular-cell-skin-tumor",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/avelumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "malignant cutaneous granular cell skin tumor"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/avelumab-ectomesenchymoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "avelumab-ectomesenchymoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/avelumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "ectomesenchymoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/avelumab-adenosine-deaminase-deficiency",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "avelumab-adenosine-deaminase-deficiency",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/avelumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "adenosine deaminase deficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/avelumab-reticular-dysgenesis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "avelumab-reticular-dysgenesis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/avelumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "reticular dysgenesis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/avelumab-immunoerythromyeloid-hypoplasia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "avelumab-immunoerythromyeloid-hypoplasia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/avelumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Immunoerythromyeloid hypoplasia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/avelumab-non-severe-combined-immunodeficiency",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "avelumab-non-severe-combined-immunodeficiency",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/avelumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "non-severe combined immunodeficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/avelumab-prostatic-urethra-urothelial-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "avelumab-prostatic-urethra-urothelial-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/avelumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "prostatic urethra urothelial carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/avelumab-kidney-pelvis-sarcomatoid-transitional-cell-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "avelumab-kidney-pelvis-sarcomatoid-transitional-cell-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/avelumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "kidney pelvis sarcomatoid transitional cell carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/urea",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "urea",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "urea",
              "display": "Urea"
            }
          ],
          "text": "Urea"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "創傷、手術創外傷、火傷"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/disopyramide",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "disopyramide",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "disopyramide",
              "display": "Disopyramide"
            }
          ],
          "text": "Disopyramide"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "抗心室性不整律劑"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/disopyramide-tourette-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "disopyramide-tourette-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/disopyramide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Tourette syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9986
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/disopyramide-attention-deficit-hyperactivity-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "disopyramide-attention-deficit-hyperactivity-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/disopyramide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "attention deficit-hyperactivity disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9982
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/disopyramide-trichotillomania",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "disopyramide-trichotillomania",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/disopyramide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "trichotillomania"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9981
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/disopyramide-attention-deficit-hyperactivity-disorder-inattentiv",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "disopyramide-attention-deficit-hyperactivity-disorder-inattentiv",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/disopyramide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "attention deficit hyperactivity disorder, inattentive type"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9974
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/disopyramide-faciodigitogenital-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "disopyramide-faciodigitogenital-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/disopyramide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "faciodigitogenital syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9965999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/disopyramide-specific-developmental-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "disopyramide-specific-developmental-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/disopyramide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "specific developmental disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/disopyramide-idiopathic-neonatal-atrial-flutter",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "disopyramide-idiopathic-neonatal-atrial-flutter",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/disopyramide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "idiopathic neonatal atrial flutter"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9942
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/disopyramide-chondromyxoid-fibroma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "disopyramide-chondromyxoid-fibroma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/disopyramide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "chondromyxoid fibroma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9941
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/disopyramide-multifocal-atrial-tachycardia-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "disopyramide-multifocal-atrial-tachycardia-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/disopyramide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "multifocal atrial tachycardia (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9921
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/disopyramide-trigeminal-nerve-neoplasm",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "disopyramide-trigeminal-nerve-neoplasm",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/disopyramide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "trigeminal nerve neoplasm"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9915999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/carboplatin",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "carboplatin",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "carboplatin",
              "display": "Carboplatin"
            }
          ],
          "text": "Carboplatin"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "一、應使用於下列HER2過度表現或HER2基因amplification之早期乳癌、轉移性乳癌病人：..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/carboplatin-female-breast-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "carboplatin-female-breast-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/carboplatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "female breast carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9986
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/carboplatin-rectum-mucinous-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "carboplatin-rectum-mucinous-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/carboplatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "rectum mucinous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9928
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/carboplatin-colon-mucinous-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "carboplatin-colon-mucinous-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/carboplatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "colon mucinous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9926
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/carboplatin-adult-germ-cell-tumor",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "carboplatin-adult-germ-cell-tumor",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/carboplatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "adult germ cell tumor"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9924
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/carboplatin-cervical-mucinous-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "carboplatin-cervical-mucinous-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/carboplatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cervical mucinous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9924
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/carboplatin-gallbladder-mucinous-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "carboplatin-gallbladder-mucinous-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/carboplatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gallbladder mucinous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9923000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/carboplatin-endometrial-mucinous-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "carboplatin-endometrial-mucinous-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/carboplatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "endometrial mucinous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/carboplatin-endometrial-mixed-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "carboplatin-endometrial-mixed-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/carboplatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "endometrial mixed adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/carboplatin-villoglandular-endometrial-endometrioid-adenocarcino",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "carboplatin-villoglandular-endometrial-endometrioid-adenocarcino",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/carboplatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "villoglandular endometrial endometrioid adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/carboplatin-extrahepatic-bile-duct-mucinous-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "carboplatin-extrahepatic-bile-duct-mucinous-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/carboplatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "extrahepatic bile duct mucinous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9918
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/gemcitabine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "gemcitabine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "gemcitabine",
              "display": "Gemcitabine"
            }
          ],
          "text": "Gemcitabine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "1. 與gemcitabine和oxaliplatin併用，適用於治療復發型(relapsed)或難..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/gemcitabine-female-breast-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "gemcitabine-female-breast-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/gemcitabine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "female breast carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/gemcitabine-rectum-mucinous-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "gemcitabine-rectum-mucinous-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/gemcitabine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "rectum mucinous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/gemcitabine-colon-mucinous-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "gemcitabine-colon-mucinous-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/gemcitabine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "colon mucinous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/gemcitabine-endometrial-mixed-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "gemcitabine-endometrial-mixed-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/gemcitabine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "endometrial mixed adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/gemcitabine-villoglandular-endometrial-endometrioid-adenocarcino",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "gemcitabine-villoglandular-endometrial-endometrioid-adenocarcino",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/gemcitabine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "villoglandular endometrial endometrioid adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/gemcitabine-endometrial-mucinous-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "gemcitabine-endometrial-mucinous-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/gemcitabine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "endometrial mucinous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9975
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/gemcitabine-cervical-mucinous-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "gemcitabine-cervical-mucinous-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/gemcitabine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cervical mucinous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9975
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/gemcitabine-gallbladder-mucinous-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "gemcitabine-gallbladder-mucinous-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/gemcitabine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gallbladder mucinous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9975
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/gemcitabine-rete-ovarii-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "gemcitabine-rete-ovarii-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/gemcitabine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "rete ovarii adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9973000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/gemcitabine-secretory-uterine-corpus-endometrioid-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "gemcitabine-secretory-uterine-corpus-endometrioid-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/gemcitabine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "secretory uterine corpus endometrioid adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9973000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/cyclizine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "cyclizine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "cyclizine",
              "display": "Cyclizine"
            }
          ],
          "text": "Cyclizine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "偏頭痛及因偏頭痛所引起之噁心、嘔吐、頭暈等症狀之緩解"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cyclizine-allergic-urticaria",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cyclizine-allergic-urticaria",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cyclizine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "allergic urticaria"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cyclizine-nasal-cavity-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cyclizine-nasal-cavity-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cyclizine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "nasal cavity disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cyclizine-acute-laryngopharyngitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cyclizine-acute-laryngopharyngitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cyclizine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acute laryngopharyngitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cyclizine-cold-urticaria",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cyclizine-cold-urticaria",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cyclizine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cold urticaria"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cyclizine-rosacea-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cyclizine-rosacea-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cyclizine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "rosacea conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9975
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cyclizine-headache-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cyclizine-headache-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cyclizine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "headache disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9948999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cyclizine-trigeminal-autonomic-cephalalgia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cyclizine-trigeminal-autonomic-cephalalgia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cyclizine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "trigeminal autonomic cephalalgia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9943000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cyclizine-rhinitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cyclizine-rhinitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cyclizine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "rhinitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9934999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cyclizine-recalcitrant-atopic-dermatitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cyclizine-recalcitrant-atopic-dermatitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cyclizine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "recalcitrant atopic dermatitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9928
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/ibuprofen",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "ibuprofen",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "ibuprofen",
              "display": "Ibuprofen"
            }
          ],
          "text": "Ibuprofen"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "關節炎、關節痛、神經炎、神經痛、手術後或外傷之消炎、鎮痛、解熱。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ibuprofen-acromesomelic-dysplasia-hunter-thompson-type",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ibuprofen-acromesomelic-dysplasia-hunter-thompson-type",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ibuprofen"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acromesomelic dysplasia, Hunter-Thompson type"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9974
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ibuprofen-brachyolmia-amelogenesis-imperfecta-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ibuprofen-brachyolmia-amelogenesis-imperfecta-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ibuprofen"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brachyolmia-amelogenesis imperfecta syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9971
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ibuprofen-myosclerosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ibuprofen-myosclerosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ibuprofen"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "myosclerosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9968
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ibuprofen-brachyolmia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ibuprofen-brachyolmia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ibuprofen"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brachyolmia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9967
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ibuprofen-brachydactyly-syndactyly-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ibuprofen-brachydactyly-syndactyly-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ibuprofen"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brachydactyly-syndactyly syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9965999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ibuprofen-pseudoachondroplasia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ibuprofen-pseudoachondroplasia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ibuprofen"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pseudoachondroplasia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9965999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ibuprofen-colobomatous-microphthalmia-rhizomelic-dysplasia-syndr",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ibuprofen-colobomatous-microphthalmia-rhizomelic-dysplasia-syndr",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ibuprofen"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "colobomatous microphthalmia-rhizomelic dysplasia syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.996
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/polyethylene_glycol_400",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "polyethylene_glycol_400",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "polyethylene_glycol_400",
              "display": "Polyethylene glycol 400"
            }
          ],
          "text": "Polyethylene glycol 400"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "暫時緩解因眼睛乾澀所引起灼熱感與刺激感。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/polyethylene_glycol_400-bronchitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "polyethylene_glycol_400-bronchitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/polyethylene_glycol_400"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "bronchitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9958
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/polyethylene_glycol_400-congenital-ichthyosiform-erythroderma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "polyethylene_glycol_400-congenital-ichthyosiform-erythroderma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/polyethylene_glycol_400"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congenital ichthyosiform erythroderma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/acetazolamide",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "acetazolamide",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "acetazolamide",
              "display": "Acetazolamide"
            }
          ],
          "text": "Acetazolamide"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "利尿劑"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/acetazolamide-exercise-induced-malignant-hyperthermia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "acetazolamide-exercise-induced-malignant-hyperthermia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/acetazolamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "exercise-induced malignant hyperthermia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/acetazolamide-hypertrophic-cardiomyopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "acetazolamide-hypertrophic-cardiomyopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/acetazolamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hypertrophic cardiomyopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/acetazolamide-congenital-myopathy-with-excess-of-thin-filaments",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "acetazolamide-congenital-myopathy-with-excess-of-thin-filaments",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/acetazolamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congenital myopathy with excess of thin filaments"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/acetazolamide-hypertrophic-cardiomyopathy-due-to-intensive-athle",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "acetazolamide-hypertrophic-cardiomyopathy-due-to-intensive-athle",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/acetazolamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hypertrophic cardiomyopathy due to intensive athletic training"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/acetazolamide-distal-myopathy-tateyama-type",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "acetazolamide-distal-myopathy-tateyama-type",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/acetazolamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "distal myopathy, Tateyama type"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/acetazolamide-cirrhotic-cardiomyopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "acetazolamide-cirrhotic-cardiomyopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/acetazolamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cirrhotic cardiomyopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/acetazolamide-cardiomyopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "acetazolamide-cardiomyopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/acetazolamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cardiomyopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9983
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/acetazolamide-intestinal-obstruction",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "acetazolamide-intestinal-obstruction",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/acetazolamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "intestinal obstruction"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9982
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/acetazolamide-glycogen-storage-disease-due-to-acid-maltase-defic",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "acetazolamide-glycogen-storage-disease-due-to-acid-maltase-defic",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/acetazolamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "glycogen storage disease due to acid maltase deficiency, late-onset"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/acetazolamide-unclassified-intestinal-pseudoobstruction",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "acetazolamide-unclassified-intestinal-pseudoobstruction",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/acetazolamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "unclassified intestinal pseudoobstruction"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9979
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/dl-alpha-tocopherol",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "dl-alpha-tocopherol",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "dl-alpha-tocopherol",
              "display": "DL-alpha-Tocopherol"
            }
          ],
          "text": "DL-alpha-Tocopherol"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "維他命Ｅ缺乏症"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dl-alpha-tocopherol-immature-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dl-alpha-tocopherol-immature-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dl-alpha-tocopherol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "immature cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dl-alpha-tocopherol-mature-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dl-alpha-tocopherol-mature-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dl-alpha-tocopherol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "mature cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dl-alpha-tocopherol-tetanic-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dl-alpha-tocopherol-tetanic-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dl-alpha-tocopherol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "tetanic cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dl-alpha-tocopherol-craniostenosis-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dl-alpha-tocopherol-craniostenosis-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dl-alpha-tocopherol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "craniostenosis cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dl-alpha-tocopherol-diabetes-mellitus-type-2-associated-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dl-alpha-tocopherol-diabetes-mellitus-type-2-associated-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dl-alpha-tocopherol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "diabetes mellitus type 2 associated cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dl-alpha-tocopherol-diabetic-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dl-alpha-tocopherol-diabetic-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dl-alpha-tocopherol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "diabetic cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dl-alpha-tocopherol-nuclear-senile-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dl-alpha-tocopherol-nuclear-senile-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dl-alpha-tocopherol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "nuclear senile cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dl-alpha-tocopherol-cortical-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dl-alpha-tocopherol-cortical-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dl-alpha-tocopherol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cortical cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dl-alpha-tocopherol-senile-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dl-alpha-tocopherol-senile-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dl-alpha-tocopherol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "senile cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dl-alpha-tocopherol-antithrombin-deficiency-type-2",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dl-alpha-tocopherol-antithrombin-deficiency-type-2",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dl-alpha-tocopherol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "antithrombin deficiency type 2"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/xylitol",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "xylitol",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "xylitol",
              "display": "Xylitol"
            }
          ],
          "text": "Xylitol"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "糖尿病時代謝異常之補液"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/xylitol-meningococcal-infection",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "xylitol-meningococcal-infection",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/xylitol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "meningococcal infection"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9965999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/nystatin",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "nystatin",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "nystatin",
              "display": "Nystatin"
            }
          ],
          "text": "Nystatin"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "念珠菌引起之感染症"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nystatin-vulvovaginitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nystatin-vulvovaginitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nystatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "vulvovaginitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nystatin-disease-of-orbital-region",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nystatin-disease-of-orbital-region",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nystatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "disease of orbital region"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nystatin-disease-of-orbital-part-of-eye-adnexa",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nystatin-disease-of-orbital-part-of-eye-adnexa",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nystatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "disease of orbital part of eye adnexa"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nystatin-cystic-teratoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nystatin-cystic-teratoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nystatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cystic teratoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nystatin-spinal-cord-dermoid-cyst",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nystatin-spinal-cord-dermoid-cyst",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nystatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "spinal cord dermoid cyst"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nystatin-postmenopausal-atrophic-vaginitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nystatin-postmenopausal-atrophic-vaginitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nystatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "postmenopausal atrophic vaginitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nystatin-biotin-metabolic-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nystatin-biotin-metabolic-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nystatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "biotin metabolic disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nystatin-vulvitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nystatin-vulvitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nystatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "vulvitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9983
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nystatin-commissural-lip-fistula",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nystatin-commissural-lip-fistula",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nystatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "commissural lip fistula"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9983
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nystatin-osteoradionecrosis-of-the-mandible",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nystatin-osteoradionecrosis-of-the-mandible",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nystatin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "osteoradionecrosis of the mandible"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9983
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/isoleucine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "isoleucine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "isoleucine",
              "display": "Isoleucine"
            }
          ],
          "text": "Isoleucine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "營養劑。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/isoleucine-gastroparesis-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "isoleucine-gastroparesis-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/isoleucine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gastroparesis (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9932
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/bevacizumab",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "bevacizumab",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "bevacizumab",
              "display": "Bevacizumab"
            }
          ],
          "text": "Bevacizumab"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "轉移性大腸直腸癌(mCRC)\r\n與含有5-fluorouracil為基礎的化學療法合併使用，可以作為..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/bevacizumab-epiglottis-neoplasm",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "bevacizumab-epiglottis-neoplasm",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/bevacizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "epiglottis neoplasm"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/bevacizumab-benign-neoplasm-of-tongue",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "bevacizumab-benign-neoplasm-of-tongue",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/bevacizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "benign neoplasm of tongue"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/bevacizumab-tumor-of-testis-and-paratestis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "bevacizumab-tumor-of-testis-and-paratestis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/bevacizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "tumor of testis and paratestis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/bevacizumab-benign-neoplasm-of-hypopharynx",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "bevacizumab-benign-neoplasm-of-hypopharynx",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/bevacizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "benign neoplasm of hypopharynx"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/bevacizumab-benign-neoplasm-of-floor-of-mouth",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "bevacizumab-benign-neoplasm-of-floor-of-mouth",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/bevacizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "benign neoplasm of floor of mouth"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/bevacizumab-cervical-neuroblastoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "bevacizumab-cervical-neuroblastoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/bevacizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cervical neuroblastoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/bevacizumab-cystic-neoplasm",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "bevacizumab-cystic-neoplasm",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/bevacizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cystic neoplasm"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/bevacizumab-nasal-cavity-inverting-papilloma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "bevacizumab-nasal-cavity-inverting-papilloma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/bevacizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "nasal cavity inverting papilloma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/bevacizumab-mesenchymoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "bevacizumab-mesenchymoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/bevacizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "mesenchymoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/bevacizumab-schwannoma-of-jugular-foramen",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "bevacizumab-schwannoma-of-jugular-foramen",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/bevacizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "schwannoma of jugular foramen"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/mannitol",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "mannitol",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "mannitol",
              "display": "Mannitol"
            }
          ],
          "text": "Mannitol"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "腦神經外科手術中、腦容積增大、腦壓亢進、腦腫瘍等之治療與預防"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/mannitol-nephrogenic-syndrome-of-inappropriate-antidiuresis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "mannitol-nephrogenic-syndrome-of-inappropriate-antidiuresis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/mannitol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "nephrogenic syndrome of inappropriate antidiuresis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/mannitol-acute-pulmonary-heart-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "mannitol-acute-pulmonary-heart-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/mannitol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acute pulmonary heart disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/mannitol-exercise-induced-malignant-hyperthermia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "mannitol-exercise-induced-malignant-hyperthermia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/mannitol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "exercise-induced malignant hyperthermia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9986
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/mannitol-malignant-hyperthermia-susceptibility-to",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "mannitol-malignant-hyperthermia-susceptibility-to",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/mannitol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "malignant hyperthermia, susceptibility to"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/mannitol-familial-periodic-paralysis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "mannitol-familial-periodic-paralysis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/mannitol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "familial periodic paralysis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9975
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/mannitol-hypokalemic-periodic-paralysis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "mannitol-hypokalemic-periodic-paralysis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/mannitol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hypokalemic periodic paralysis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9972
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/mannitol-congenital-multicore-myopathy-with-external-ophthalmopl",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "mannitol-congenital-multicore-myopathy-with-external-ophthalmopl",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/mannitol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congenital multicore myopathy with external ophthalmoplegia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9972
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/mannitol-moderate-multiminicore-disease-with-hand-involvement",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "mannitol-moderate-multiminicore-disease-with-hand-involvement",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/mannitol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "moderate multiminicore disease with hand involvement"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9971
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/mannitol-nephrogenic-diabetes-insipidus",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "mannitol-nephrogenic-diabetes-insipidus",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/mannitol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "nephrogenic diabetes insipidus"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/mannitol-king-denborough-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "mannitol-king-denborough-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/mannitol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "King-Denborough syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9969
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/tetrabenazine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "tetrabenazine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "tetrabenazine",
              "display": "Tetrabenazine"
            }
          ],
          "text": "Tetrabenazine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "治療亨汀頓舞蹈症之舞蹈症狀。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tetrabenazine-polycystic-kidney-disease-3-with-or-without-polycy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tetrabenazine-polycystic-kidney-disease-3-with-or-without-polycy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tetrabenazine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "polycystic kidney disease 3 with or without polycystic liver disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tetrabenazine-renal-hepatic-pancreatic-dysplasia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tetrabenazine-renal-hepatic-pancreatic-dysplasia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tetrabenazine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "renal-hepatic-pancreatic dysplasia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tetrabenazine-joubert-syndrome-with-renal-defect",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tetrabenazine-joubert-syndrome-with-renal-defect",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tetrabenazine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Joubert syndrome with renal defect"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tetrabenazine-karyomegalic-interstitial-nephritis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tetrabenazine-karyomegalic-interstitial-nephritis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tetrabenazine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "karyomegalic interstitial nephritis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tetrabenazine-thoracic-malformation",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tetrabenazine-thoracic-malformation",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tetrabenazine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "thoracic malformation"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tetrabenazine-polymicrogyria-perisylvian-with-cerebellar-hypopla",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tetrabenazine-polymicrogyria-perisylvian-with-cerebellar-hypopla",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tetrabenazine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tetrabenazine-acute-intermittent-porphyria",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tetrabenazine-acute-intermittent-porphyria",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tetrabenazine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acute intermittent porphyria"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9983
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tetrabenazine-adult-familial-nephronophthisis-spastic-quadripare",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tetrabenazine-adult-familial-nephronophthisis-spastic-quadripare",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tetrabenazine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "adult familial nephronophthisis-spastic quadriparesia syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9983
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tetrabenazine-atypical-glycine-encephalopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tetrabenazine-atypical-glycine-encephalopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tetrabenazine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "atypical glycine encephalopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9983
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tetrabenazine-congenital-disorder-of-glycosylation-with-defectiv",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tetrabenazine-congenital-disorder-of-glycosylation-with-defectiv",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tetrabenazine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congenital disorder of glycosylation with defective fucosylation"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9982
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/levamisole",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "levamisole",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "levamisole",
              "display": "levamisole"
            }
          ],
          "text": "levamisole"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/levamisole-drug-induced-osteoporosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "levamisole-drug-induced-osteoporosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/levamisole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "drug-induced osteoporosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/levamisole-benign-neoplasm-of-tongue",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "levamisole-benign-neoplasm-of-tongue",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/levamisole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "benign neoplasm of tongue"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/levamisole-cervical-neuroblastoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "levamisole-cervical-neuroblastoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/levamisole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cervical neuroblastoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/xylometazoline",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "xylometazoline",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "xylometazoline",
              "display": "Xylometazoline"
            }
          ],
          "text": "Xylometazoline"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "一般感冒、鼻塞、流鼻水、打噴嚏、過敏性鼻炎及由過敏引起之鼻充血。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/xylometazoline-nasal-cavity-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "xylometazoline-nasal-cavity-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/xylometazoline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "nasal cavity disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/xylometazoline-acute-laryngopharyngitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "xylometazoline-acute-laryngopharyngitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/xylometazoline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acute laryngopharyngitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/allopurinol",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "allopurinol",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "allopurinol",
              "display": "Allopurinol"
            }
          ],
          "text": "Allopurinol"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "痛風症、痛風性關節炎、尿酸結石、癌症、或經化學治療產生之高尿酸血症。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/allopurinol-hepatic-porphyria",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "allopurinol-hepatic-porphyria",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/allopurinol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hepatic porphyria"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/allopurinol-hepatoportal-sclerosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "allopurinol-hepatoportal-sclerosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/allopurinol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hepatoportal sclerosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/allopurinol-primitive-portal-vein-thrombosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "allopurinol-primitive-portal-vein-thrombosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/allopurinol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "primitive portal vein thrombosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/allopurinol-idiopathic-copper-associated-cirrhosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "allopurinol-idiopathic-copper-associated-cirrhosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/allopurinol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "idiopathic copper-associated cirrhosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/allopurinol-early-onset-familial-noncirrhotic-portal-hypertensio",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "allopurinol-early-onset-familial-noncirrhotic-portal-hypertensio",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/allopurinol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "early-onset familial noncirrhotic portal hypertension"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/allopurinol-hepatopulmonary-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "allopurinol-hepatopulmonary-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/allopurinol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hepatopulmonary syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/allopurinol-disorder-of-phenylalanine-metabolism",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "allopurinol-disorder-of-phenylalanine-metabolism",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/allopurinol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "disorder of phenylalanine metabolism"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/allopurinol-immune-mediated-necrotizing-myopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "allopurinol-immune-mediated-necrotizing-myopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/allopurinol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "immune-mediated necrotizing myopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9986
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/allopurinol-antisynthetase-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "allopurinol-antisynthetase-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/allopurinol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "antisynthetase syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/allopurinol-inflammatory-myopathy-with-abundant-macrophages",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "allopurinol-inflammatory-myopathy-with-abundant-macrophages",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/allopurinol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "inflammatory myopathy with abundant macrophages"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/tofacitinib",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "tofacitinib",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "tofacitinib",
              "display": "Tofacitinib"
            }
          ],
          "text": "Tofacitinib"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "１、類風濕性關節炎：適用於治療患有中至重度活動性類風濕性關節炎(Rheumatoid Arthrit..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/nefopam",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "nefopam",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "nefopam",
              "display": "Nefopam"
            }
          ],
          "text": "Nefopam"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "鎮痛"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nefopam-tetanic-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nefopam-tetanic-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nefopam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "tetanic cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nefopam-immature-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nefopam-immature-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nefopam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "immature cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nefopam-diabetes-mellitus-type-2-associated-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nefopam-diabetes-mellitus-type-2-associated-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nefopam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "diabetes mellitus type 2 associated cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nefopam-mature-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nefopam-mature-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nefopam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "mature cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nefopam-craniostenosis-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nefopam-craniostenosis-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nefopam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "craniostenosis cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nefopam-nuclear-senile-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nefopam-nuclear-senile-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nefopam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "nuclear senile cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nefopam-cortical-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nefopam-cortical-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nefopam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cortical cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nefopam-senile-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nefopam-senile-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nefopam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "senile cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nefopam-diabetic-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nefopam-diabetic-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nefopam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "diabetic cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/nefopam-lumbar-spinal-stenosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "nefopam-lumbar-spinal-stenosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/nefopam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "lumbar spinal stenosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/caplacizumab",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "caplacizumab",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "caplacizumab",
              "display": "Caplacizumab"
            }
          ],
          "text": "Caplacizumab"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "適用於合併血漿置換術及免疫抑制劑，治療患有後天性血栓性血小板低下紫班症(acquired throm..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/caplacizumab-primary-release-disorder-of-platelets",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "caplacizumab-primary-release-disorder-of-platelets",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/caplacizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "primary release disorder of platelets"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/caplacizumab-pseudo-von-willebrand-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "caplacizumab-pseudo-von-willebrand-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/caplacizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pseudo-von Willebrand disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/caplacizumab-glanzmann-thrombasthenia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "caplacizumab-glanzmann-thrombasthenia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/caplacizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Glanzmann thrombasthenia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/caplacizumab-scott-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "caplacizumab-scott-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/caplacizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Scott syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/caplacizumab-thrombotic-thrombocytopenic-purpura",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "caplacizumab-thrombotic-thrombocytopenic-purpura",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/caplacizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "thrombotic thrombocytopenic purpura"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/caplacizumab-bleeding-diathesis-due-to-a-collagen-receptor-defec",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "caplacizumab-bleeding-diathesis-due-to-a-collagen-receptor-defec",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/caplacizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "bleeding diathesis due to a collagen receptor defect"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/caplacizumab-hemorrhagic-disorder-due-to-a-constitutional-thromb",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "caplacizumab-hemorrhagic-disorder-due-to-a-constitutional-thromb",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/caplacizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hemorrhagic disorder due to a constitutional thrombocytopenia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/caplacizumab-fetal-and-neonatal-alloimmune-thrombocytopenia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "caplacizumab-fetal-and-neonatal-alloimmune-thrombocytopenia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/caplacizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "fetal and neonatal alloimmune thrombocytopenia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/caplacizumab-hemophilia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "caplacizumab-hemophilia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/caplacizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hemophilia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/caplacizumab-platelet-type-bleeding-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "caplacizumab-platelet-type-bleeding-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/caplacizumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "platelet-type bleeding disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/raloxifene",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "raloxifene",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "raloxifene",
              "display": "Raloxifene"
            }
          ],
          "text": "Raloxifene"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "預防及治療停經後婦女骨質疏鬆症。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/raloxifene-duodenal-ulcer-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "raloxifene-duodenal-ulcer-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/raloxifene"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "duodenal ulcer (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9972
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/raloxifene-hypoalphalipoproteinemia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "raloxifene-hypoalphalipoproteinemia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/raloxifene"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hypoalphalipoproteinemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9965
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/raloxifene-duodenal-obstruction",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "raloxifene-duodenal-obstruction",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/raloxifene"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "duodenal obstruction"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9964
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/raloxifene-duodenogastric-reflux",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "raloxifene-duodenogastric-reflux",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/raloxifene"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "duodenogastric reflux"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9959
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/teriparatide",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "teriparatide",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "teriparatide",
              "display": "Teriparatide"
            }
          ],
          "text": "Teriparatide"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "副甲狀腺激素補充劑。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/teriparatide-duodenal-ulcer-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "teriparatide-duodenal-ulcer-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/teriparatide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "duodenal ulcer (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9986
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/teriparatide-non-syndromic-esophageal-malformation",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "teriparatide-non-syndromic-esophageal-malformation",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/teriparatide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "non-syndromic esophageal malformation"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/teriparatide-duodenal-obstruction",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "teriparatide-duodenal-obstruction",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/teriparatide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "duodenal obstruction"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9978
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/teriparatide-duodenogastric-reflux",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "teriparatide-duodenogastric-reflux",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/teriparatide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "duodenogastric reflux"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9978
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/teriparatide-esophageal-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "teriparatide-esophageal-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/teriparatide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "esophageal disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9974
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/teriparatide-worth-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "teriparatide-worth-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/teriparatide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Worth syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9969
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/teriparatide-autosomal-dominant-neovascular-inflammatory-vitreor",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "teriparatide-autosomal-dominant-neovascular-inflammatory-vitreor",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/teriparatide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "autosomal dominant neovascular inflammatory vitreoretinopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9965999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/teriparatide-pregnancy-associated-osteoporosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "teriparatide-pregnancy-associated-osteoporosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/teriparatide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pregnancy associated osteoporosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/teriparatide-succinyl-coa-3-ketoacid-coa-transferase-deficiency",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "teriparatide-succinyl-coa-3-ketoacid-coa-transferase-deficiency",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/teriparatide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "succinyl-CoA:3-ketoacid CoA transferase deficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9947
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/teriparatide-amenorrhea-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "teriparatide-amenorrhea-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/teriparatide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "amenorrhea (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9904000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/oxytetracycline",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "oxytetracycline",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "oxytetracycline",
              "display": "Oxytetracycline"
            }
          ],
          "text": "Oxytetracycline"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "革蘭氏陽性菌和陰性菌、立克次氏體及大型濾過性病毒引起之感染症"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/oxytetracycline-chronic-rhinosinusitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "oxytetracycline-chronic-rhinosinusitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/oxytetracycline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "chronic rhinosinusitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9961
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/oxytetracycline-chronic-ethmoidal-sinusitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "oxytetracycline-chronic-ethmoidal-sinusitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/oxytetracycline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "chronic ethmoidal sinusitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9961
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/oxytetracycline-paranasal-sinus-neoplasm-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "oxytetracycline-paranasal-sinus-neoplasm-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/oxytetracycline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "paranasal sinus neoplasm (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9958
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/oxytetracycline-punctate-epithelial-keratoconjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "oxytetracycline-punctate-epithelial-keratoconjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/oxytetracycline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "punctate epithelial keratoconjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9952
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/oxytetracycline-postinfectious-vasculitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "oxytetracycline-postinfectious-vasculitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/oxytetracycline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "postinfectious vasculitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9937
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/oxytetracycline-post-bacterial-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "oxytetracycline-post-bacterial-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/oxytetracycline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "post-bacterial disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9934999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/oxytetracycline-post-infectious-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "oxytetracycline-post-infectious-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/oxytetracycline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "post-infectious syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9933
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/oxytetracycline-infective-urethral-stricture",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "oxytetracycline-infective-urethral-stricture",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/oxytetracycline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "infective urethral stricture"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9928
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/oxytetracycline-chagas-cardiomyopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "oxytetracycline-chagas-cardiomyopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/oxytetracycline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Chagas cardiomyopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9926999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/oxytetracycline-otitis-externa",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "oxytetracycline-otitis-externa",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/oxytetracycline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "otitis externa"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9926999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/bempedoic_acid",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "bempedoic_acid",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "bempedoic_acid",
              "display": "Bempedoic acid"
            }
          ],
          "text": "Bempedoic acid"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "１、適用於患有異合子家族性或非家族性之原發性高膽固醇血症、或混合型血脂異常的成人病人，作為飲食的輔助..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/bempedoic_acid-hyperthyroidism",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "bempedoic_acid-hyperthyroidism",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/bempedoic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hyperthyroidism"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9961
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/bempedoic_acid-resistance-to-thyroid-hormone-due-to-a-mutation-i",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "bempedoic_acid-resistance-to-thyroid-hormone-due-to-a-mutation-i",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/bempedoic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9958
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/bempedoic_acid-malignant-catarrh",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "bempedoic_acid-malignant-catarrh",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/bempedoic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "malignant catarrh"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9958
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/bempedoic_acid-infectious-bovine-rhinotracheitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "bempedoic_acid-infectious-bovine-rhinotracheitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/bempedoic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "infectious bovine rhinotracheitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9958
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/bempedoic_acid-cytomegalovirus-infection",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "bempedoic_acid-cytomegalovirus-infection",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/bempedoic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cytomegalovirus infection"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9953
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/bempedoic_acid-homozygous-familial-hypercholesterolemia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "bempedoic_acid-homozygous-familial-hypercholesterolemia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/bempedoic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "homozygous familial hypercholesterolemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9948
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/bempedoic_acid-hyperthyroxinemia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "bempedoic_acid-hyperthyroxinemia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/bempedoic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hyperthyroxinemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9934000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/bempedoic_acid-drug-induced-osteoporosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "bempedoic_acid-drug-induced-osteoporosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/bempedoic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "drug-induced osteoporosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9921
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/bempedoic_acid-multiple-endocrine-neoplasia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "bempedoic_acid-multiple-endocrine-neoplasia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/bempedoic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "multiple endocrine neoplasia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9918
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/bempedoic_acid-pregnancy-associated-osteoporosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "bempedoic_acid-pregnancy-associated-osteoporosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/bempedoic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pregnancy associated osteoporosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9917
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/fenoterol",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "fenoterol",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "fenoterol",
              "display": "Fenoterol"
            }
          ],
          "text": "Fenoterol"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "下列支氣管痙攣疾患之治療與預防：支氣管氣喘、阻塞性支氣管炎、肺氣腫和伴有支氣管痙攣之肺支氣管障害"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fenoterol-multiple-system-atrophy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fenoterol-multiple-system-atrophy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fenoterol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "multiple system atrophy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fenoterol-postural-orthostatic-tachycardia-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fenoterol-postural-orthostatic-tachycardia-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fenoterol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "postural orthostatic tachycardia syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9961
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fenoterol-variably-protease-sensitive-prionopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fenoterol-variably-protease-sensitive-prionopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fenoterol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "variably protease-sensitive prionopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fenoterol-open-angle-glaucoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fenoterol-open-angle-glaucoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fenoterol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "open-angle glaucoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9943000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fenoterol-raynaud-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fenoterol-raynaud-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fenoterol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Raynaud disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9941
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fenoterol-primary-hereditary-glaucoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fenoterol-primary-hereditary-glaucoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fenoterol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "primary hereditary glaucoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9937
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fenoterol-sinoatrial-block",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fenoterol-sinoatrial-block",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fenoterol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "sinoatrial block"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9934999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fenoterol-sinoatrial-node-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fenoterol-sinoatrial-node-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fenoterol"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "sinoatrial node disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9925
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/ramucirumab",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "ramucirumab",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "ramucirumab",
              "display": "Ramucirumab"
            }
          ],
          "text": "Ramucirumab"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "1.胃癌：\r\n(1)Ramucirumab併用paclitaxel適用於治療正接受或接受過fluor..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ramucirumab-uterine-ligament-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ramucirumab-uterine-ligament-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ramucirumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "uterine ligament adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ramucirumab-endocervical-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ramucirumab-endocervical-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ramucirumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "endocervical carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ramucirumab-adenoid-cystic-carcinoma-of-the-cervix-uteri",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ramucirumab-adenoid-cystic-carcinoma-of-the-cervix-uteri",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ramucirumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "adenoid cystic carcinoma of the cervix uteri"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ramucirumab-uterine-ligament-serous-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ramucirumab-uterine-ligament-serous-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ramucirumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "uterine ligament serous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ramucirumab-signet-ring-cell-variant-cervical-mucinous-adenocarc",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ramucirumab-signet-ring-cell-variant-cervical-mucinous-adenocarc",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ramucirumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "signet ring cell variant cervical mucinous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ramucirumab-cervical-adenosquamous-carcinoma-glassy-cell-variant",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ramucirumab-cervical-adenosquamous-carcinoma-glassy-cell-variant",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ramucirumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cervical adenosquamous carcinoma, glassy cell variant"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ramucirumab-uterine-ligament-endometrioid-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ramucirumab-uterine-ligament-endometrioid-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ramucirumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "uterine ligament endometrioid adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ramucirumab-uterine-ligament-clear-cell-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ramucirumab-uterine-ligament-clear-cell-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ramucirumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "uterine ligament clear cell adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ramucirumab-uterine-ligament-mucinous-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ramucirumab-uterine-ligament-mucinous-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ramucirumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "uterine ligament mucinous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ramucirumab-intestinal-variant-cervical-mucinous-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ramucirumab-intestinal-variant-cervical-mucinous-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ramucirumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "intestinal variant cervical mucinous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/polysorbate_80",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "polysorbate_80",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "polysorbate_80",
              "display": "Polysorbate 80"
            }
          ],
          "text": "Polysorbate 80"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "用於18歲(含)以上的成人主動免疫接種，以預防H5N1病毒株所引起的流感。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/polysorbate_80-congenital-ichthyosiform-erythroderma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "polysorbate_80-congenital-ichthyosiform-erythroderma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/polysorbate_80"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congenital ichthyosiform erythroderma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9943000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/verteporfin",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "verteporfin",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "verteporfin",
              "display": "Verteporfin"
            }
          ],
          "text": "Verteporfin"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "因年齡相關性黃斑部退化病變引起之主要典型或潛隱性視網膜下中央凹脈絡膜血管新生，病理性近視(PM)或疑..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/verteporfin-mitochondrial-oxidative-phosphorylation-disorder-due",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "verteporfin-mitochondrial-oxidative-phosphorylation-disorder-due",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/verteporfin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9948999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/tiaprofenic_acid",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "tiaprofenic_acid",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "tiaprofenic_acid",
              "display": "Tiaprofenic acid"
            }
          ],
          "text": "Tiaprofenic acid"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "消炎鎮痛"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tiaprofenic_acid-brachydactyly-syndactyly-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tiaprofenic_acid-brachydactyly-syndactyly-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tiaprofenic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brachydactyly-syndactyly syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tiaprofenic_acid-colobomatous-microphthalmia-rhizomelic-dysplasi",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tiaprofenic_acid-colobomatous-microphthalmia-rhizomelic-dysplasi",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tiaprofenic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "colobomatous microphthalmia-rhizomelic dysplasia syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tiaprofenic_acid-brachyolmia-amelogenesis-imperfecta-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tiaprofenic_acid-brachyolmia-amelogenesis-imperfecta-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tiaprofenic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brachyolmia-amelogenesis imperfecta syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tiaprofenic_acid-acromesomelic-dysplasia-hunter-thompson-type",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tiaprofenic_acid-acromesomelic-dysplasia-hunter-thompson-type",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tiaprofenic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acromesomelic dysplasia, Hunter-Thompson type"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tiaprofenic_acid-myosclerosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tiaprofenic_acid-myosclerosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tiaprofenic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "myosclerosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tiaprofenic_acid-spondyloarthropathy-susceptibility-to",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tiaprofenic_acid-spondyloarthropathy-susceptibility-to",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tiaprofenic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "spondyloarthropathy, susceptibility to"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tiaprofenic_acid-brachyolmia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tiaprofenic_acid-brachyolmia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tiaprofenic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brachyolmia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tiaprofenic_acid-factor-5-excess-with-spontaneous-thrombosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tiaprofenic_acid-factor-5-excess-with-spontaneous-thrombosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tiaprofenic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "factor 5 excess with spontaneous thrombosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tiaprofenic_acid-heparin-cofactor-2-deficiency",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tiaprofenic_acid-heparin-cofactor-2-deficiency",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tiaprofenic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "heparin cofactor 2 deficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tiaprofenic_acid-pseudoachondroplasia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tiaprofenic_acid-pseudoachondroplasia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tiaprofenic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pseudoachondroplasia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/clomipramine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "clomipramine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "clomipramine",
              "display": "Clomipramine"
            }
          ],
          "text": "Clomipramine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "鬱病、抑鬱狀態"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/clomipramine-anxiety-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "clomipramine-anxiety-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/clomipramine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "anxiety disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/clomipramine-benign-paroxysmal-torticollis-of-infancy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "clomipramine-benign-paroxysmal-torticollis-of-infancy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/clomipramine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "benign paroxysmal torticollis of infancy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/clomipramine-schizotypal-personality-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "clomipramine-schizotypal-personality-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/clomipramine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "schizotypal personality disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/clomipramine-histrionic-personality-disorder-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "clomipramine-histrionic-personality-disorder-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/clomipramine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "histrionic personality disorder (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/clomipramine-paranoid-personality-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "clomipramine-paranoid-personality-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/clomipramine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "paranoid personality disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/clomipramine-schizoid-personality-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "clomipramine-schizoid-personality-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/clomipramine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "schizoid personality disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/clomipramine-agoraphobia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "clomipramine-agoraphobia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/clomipramine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "agoraphobia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/clomipramine-major-depressive-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "clomipramine-major-depressive-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/clomipramine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "major depressive disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/clomipramine-endogenous-depression",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "clomipramine-endogenous-depression",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/clomipramine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "endogenous depression"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9971
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/clomipramine-attention-deficit-hyperactivity-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "clomipramine-attention-deficit-hyperactivity-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/clomipramine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "attention deficit-hyperactivity disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9958
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/cefmetazole",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "cefmetazole",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "cefmetazole",
              "display": "Cefmetazole"
            }
          ],
          "text": "Cefmetazole"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "葡萄球菌、鏈球菌、肺炎雙球菌、腦膜炎球菌及其他具有感受性細菌引起之感染。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cefmetazole-hyperamylasemia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cefmetazole-hyperamylasemia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cefmetazole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hyperamylasemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cefmetazole-polyclonal-hyperviscosity-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cefmetazole-polyclonal-hyperviscosity-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cefmetazole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "polyclonal hyperviscosity syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cefmetazole-congenital-analbuminemia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cefmetazole-congenital-analbuminemia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cefmetazole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congenital analbuminemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9945999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cefmetazole-blood-group-incompatibility",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cefmetazole-blood-group-incompatibility",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cefmetazole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "blood group incompatibility"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9923000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cefmetazole-gonococcal-urethritis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cefmetazole-gonococcal-urethritis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cefmetazole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gonococcal urethritis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9915
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cefmetazole-ureaplasma-urethritis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cefmetazole-ureaplasma-urethritis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cefmetazole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Ureaplasma urethritis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9915
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cefmetazole-premalignant-hematological-system-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cefmetazole-premalignant-hematological-system-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cefmetazole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "premalignant hematological system disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9912000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cefmetazole-monoclonal-gammopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cefmetazole-monoclonal-gammopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cefmetazole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "monoclonal gammopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9908
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/cefmetazole-hematological-disease-associated-with-an-acquired-pe",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "cefmetazole-hematological-disease-associated-with-an-acquired-pe",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/cefmetazole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hematological disease associated with an acquired peripheral neuropathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9902
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/lidocaine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "lidocaine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "lidocaine",
              "display": "Lidocaine"
            }
          ],
          "text": "Lidocaine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "葡萄球菌、鏈鎖球菌、肺炎菌、髓膜炎菌、淋菌引起之感染症"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/lidocaine-punctate-epithelial-keratoconjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "lidocaine-punctate-epithelial-keratoconjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/lidocaine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "punctate epithelial keratoconjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/lidocaine-papillary-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "lidocaine-papillary-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/lidocaine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "papillary conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/lidocaine-rosacea-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "lidocaine-rosacea-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/lidocaine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "rosacea conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/lidocaine-exposure-keratitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "lidocaine-exposure-keratitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/lidocaine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "exposure keratitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/lidocaine-atopic-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "lidocaine-atopic-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/lidocaine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "atopic conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9986
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/lidocaine-conjunctival-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "lidocaine-conjunctival-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/lidocaine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "conjunctival disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/lidocaine-nephrotic-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "lidocaine-nephrotic-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/lidocaine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "nephrotic syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9983
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/lidocaine-non-human-animal-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "lidocaine-non-human-animal-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/lidocaine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "non-human animal disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9982
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/lidocaine-tinea-corporis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "lidocaine-tinea-corporis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/lidocaine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "tinea corporis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9982
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/lidocaine-sporadic-idiopathic-steroid-resistant-nephrotic-syndro",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "lidocaine-sporadic-idiopathic-steroid-resistant-nephrotic-syndro",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/lidocaine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "sporadic idiopathic steroid-resistant nephrotic syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9979
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/benazepril",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "benazepril",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "benazepril",
              "display": "Benazepril"
            }
          ],
          "text": "Benazepril"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "治療高血壓，此複方藥品不適合用於起始治療"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/benazepril-malignant-renovascular-hypertension",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "benazepril-malignant-renovascular-hypertension",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/benazepril"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "malignant renovascular hypertension"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9965
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/benazepril-malignant-hypertensive-renal-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "benazepril-malignant-hypertensive-renal-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/benazepril"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "malignant hypertensive renal disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9965
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/benazepril-pulmonary-hypertension-with-unclear-multifactorial-me",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "benazepril-pulmonary-hypertension-with-unclear-multifactorial-me",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/benazepril"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pulmonary hypertension with unclear multifactorial mechanism"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.996
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/benazepril-pulmonary-hypertension-owing-to-lung-disease-and-or-h",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "benazepril-pulmonary-hypertension-owing-to-lung-disease-and-or-h",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/benazepril"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pulmonary hypertension owing to lung disease and/or hypoxia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.996
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/benazepril-braddock-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "benazepril-braddock-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/benazepril"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Braddock syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9944
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/griseofulvin",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "griseofulvin",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "griseofulvin",
              "display": "Griseofulvin"
            }
          ],
          "text": "Griseofulvin"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "抗黴菌病"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/griseofulvin-myiasis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "griseofulvin-myiasis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/griseofulvin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "myiasis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9941
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/griseofulvin-furuncular-myiasis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "griseofulvin-furuncular-myiasis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/griseofulvin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "furuncular myiasis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9934000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/griseofulvin-wound-myiasis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "griseofulvin-wound-myiasis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/griseofulvin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "wound myiasis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9934000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/griseofulvin-creeping-myiasis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "griseofulvin-creeping-myiasis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/griseofulvin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "creeping myiasis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9934000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/griseofulvin-echinococcus-granulosus-infectious-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "griseofulvin-echinococcus-granulosus-infectious-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/griseofulvin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "echinococcus granulosus infectious disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9932
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/pipemidic_acid",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "pipemidic_acid",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "pipemidic_acid",
              "display": "Pipemidic acid"
            }
          ],
          "text": "Pipemidic acid"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "腎盂腎炎、腎盂炎、膀胱炎、尿道炎、前列腺炎、細菌性痢疾、腸炎、中耳炎、副鼻腔炎"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pipemidic_acid-heart-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pipemidic_acid-heart-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pipemidic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "heart disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pipemidic_acid-laubry-pezzi-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pipemidic_acid-laubry-pezzi-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pipemidic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Laubry-Pezzi syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pipemidic_acid-pierre-robin-syndrome-associated-with-a-chromosom",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pipemidic_acid-pierre-robin-syndrome-associated-with-a-chromosom",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pipemidic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Pierre Robin syndrome associated with a chromosomal anomaly"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pipemidic_acid-genetic-syndromic-pierre-robin-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pipemidic_acid-genetic-syndromic-pierre-robin-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pipemidic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "genetic syndromic Pierre Robin syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pipemidic_acid-partial-deletion-of-the-long-arm-of-chromosome-7",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pipemidic_acid-partial-deletion-of-the-long-arm-of-chromosome-7",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pipemidic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "partial deletion of the long arm of chromosome 7"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pipemidic_acid-orofacial-clefting-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pipemidic_acid-orofacial-clefting-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pipemidic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "orofacial clefting syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pipemidic_acid-pulmonary-valve-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pipemidic_acid-pulmonary-valve-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pipemidic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pulmonary valve disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pipemidic_acid-disorder-of-fucoglycosan-synthesis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pipemidic_acid-disorder-of-fucoglycosan-synthesis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pipemidic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "disorder of fucoglycosan synthesis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pipemidic_acid-mitral-valve-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pipemidic_acid-mitral-valve-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pipemidic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "mitral valve disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pipemidic_acid-jeune-syndrome-situs-inversus",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pipemidic_acid-jeune-syndrome-situs-inversus",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pipemidic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Jeune syndrome situs inversus"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/ipratropium",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "ipratropium",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "ipratropium",
              "display": "Ipratropium"
            }
          ],
          "text": "Ipratropium"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "慢性阻塞性支氣管炎、支氣管氣喘　＊＊ＤＪＵＳＴ　ＰＨ　ＴＯ　３．４＝０．０００７４ＭＬ"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ipratropium-obstructive-lung-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ipratropium-obstructive-lung-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ipratropium"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "obstructive lung disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ipratropium-nasal-cavity-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ipratropium-nasal-cavity-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ipratropium"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "nasal cavity disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9986
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ipratropium-pharyngitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ipratropium-pharyngitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ipratropium"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pharyngitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ipratropium-acute-laryngopharyngitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ipratropium-acute-laryngopharyngitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ipratropium"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acute laryngopharyngitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ipratropium-respiratory-malformation",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ipratropium-respiratory-malformation",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ipratropium"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "respiratory malformation"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ipratropium-papillary-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ipratropium-papillary-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ipratropium"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "papillary conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9975
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ipratropium-rienhoff-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ipratropium-rienhoff-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ipratropium"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Rienhoff syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9969
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ipratropium-tracheal-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ipratropium-tracheal-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ipratropium"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "tracheal disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9965999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ipratropium-anaphylaxis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ipratropium-anaphylaxis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ipratropium"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "anaphylaxis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9937999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/ipratropium-food-dependent-exercise-induced-anaphylaxis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "ipratropium-food-dependent-exercise-induced-anaphylaxis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/ipratropium"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "food-dependent exercise-induced anaphylaxis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9936
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/dorzolamide",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "dorzolamide",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "dorzolamide",
              "display": "Dorzolamide"
            }
          ],
          "text": "Dorzolamide"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "高眼壓症，廣角性青光眼。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dorzolamide-primary-hereditary-glaucoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dorzolamide-primary-hereditary-glaucoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dorzolamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "primary hereditary glaucoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dorzolamide-hypotrichosis-simplex-of-the-scalp",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dorzolamide-hypotrichosis-simplex-of-the-scalp",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dorzolamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hypotrichosis simplex of the scalp"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dorzolamide-congenital-hypotrichosis-milia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dorzolamide-congenital-hypotrichosis-milia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dorzolamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congenital hypotrichosis milia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dorzolamide-alopecia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dorzolamide-alopecia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dorzolamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "alopecia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dorzolamide-diffuse-alopecia-areata",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dorzolamide-diffuse-alopecia-areata",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dorzolamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "diffuse alopecia areata"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dorzolamide-glaucoma-1-open-angle",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dorzolamide-glaucoma-1-open-angle",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dorzolamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "glaucoma 1, open angle"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9975
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dorzolamide-open-angle-glaucoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dorzolamide-open-angle-glaucoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dorzolamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "open angle glaucoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dorzolamide-congestive-heart-failure",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dorzolamide-congestive-heart-failure",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dorzolamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congestive heart failure"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9961
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dorzolamide-acute-pulmonary-heart-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dorzolamide-acute-pulmonary-heart-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dorzolamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acute pulmonary heart disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9953
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/dorzolamide-respiratory-failure",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "dorzolamide-respiratory-failure",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/dorzolamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "respiratory failure"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9926999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/vismodegib",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "vismodegib",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "vismodegib",
              "display": "Vismodegib"
            }
          ],
          "text": "Vismodegib"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "治療轉移性基底細胞癌，或不適合接受手術或放射線治療之局部晚期(Locally Advanced)基底..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vismodegib-medulloblastoma-with-extensive-nodularity",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vismodegib-medulloblastoma-with-extensive-nodularity",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vismodegib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "medulloblastoma with extensive nodularity"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vismodegib-xeroderma-pigmentosum",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vismodegib-xeroderma-pigmentosum",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vismodegib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "xeroderma pigmentosum"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vismodegib-annular-epidermolytic-ichthyosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vismodegib-annular-epidermolytic-ichthyosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vismodegib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "annular epidermolytic ichthyosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vismodegib-epidermolysis-bullosa-simplex-with-mottled-pigmentati",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vismodegib-epidermolysis-bullosa-simplex-with-mottled-pigmentati",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vismodegib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "epidermolysis bullosa simplex with mottled pigmentation"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9986
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vismodegib-prostate-cancer-brain-cancer-susceptibility",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vismodegib-prostate-cancer-brain-cancer-susceptibility",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vismodegib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "prostate cancer/brain cancer susceptibility"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vismodegib-brenner-tumor",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vismodegib-brenner-tumor",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vismodegib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Brenner tumor"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9983
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vismodegib-cutaneous-adenocystic-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vismodegib-cutaneous-adenocystic-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vismodegib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cutaneous adenocystic carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9983
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vismodegib-prostate-leiomyoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vismodegib-prostate-leiomyoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vismodegib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "prostate leiomyoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9983
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vismodegib-skin-cancer",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vismodegib-skin-cancer",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vismodegib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "skin cancer"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9982
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/vismodegib-benign-neoplasm-of-sweat-gland",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "vismodegib-benign-neoplasm-of-sweat-gland",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/vismodegib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "benign neoplasm of sweat gland"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9982
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/rotigotine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "rotigotine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "rotigotine",
              "display": "Rotigotine"
            }
          ],
          "text": "Rotigotine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "原發性帕金森氏症。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/rotigotine-attention-deficit-hyperactivity-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "rotigotine-attention-deficit-hyperactivity-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/rotigotine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "attention deficit-hyperactivity disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/rotigotine-schizophrenia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "rotigotine-schizophrenia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/rotigotine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "schizophrenia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/rotigotine-polymicrogyria-perisylvian-with-cerebellar-hypoplasia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "rotigotine-polymicrogyria-perisylvian-with-cerebellar-hypoplasia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/rotigotine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/rotigotine-faciodigitogenital-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "rotigotine-faciodigitogenital-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/rotigotine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "faciodigitogenital syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/rotigotine-congenital-disorder-of-glycosylation-with-defective-f",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "rotigotine-congenital-disorder-of-glycosylation-with-defective-f",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/rotigotine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congenital disorder of glycosylation with defective fucosylation"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/rotigotine-retinal-dystrophy-with-or-without-extraocular-anomali",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "rotigotine-retinal-dystrophy-with-or-without-extraocular-anomali",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/rotigotine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "retinal dystrophy with or without extraocular anomalies"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/rotigotine-myopia-x-linked",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "rotigotine-myopia-x-linked",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/rotigotine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "myopia X-linked"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/rotigotine-atypical-glycine-encephalopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "rotigotine-atypical-glycine-encephalopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/rotigotine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "atypical glycine encephalopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/rotigotine-charcot-marie-tooth-disease-demyelinating-type-1g",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "rotigotine-charcot-marie-tooth-disease-demyelinating-type-1g",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/rotigotine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Charcot-Marie-Tooth disease, demyelinating, type 1G"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/rotigotine-myopia-26-x-linked-female-limited",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "rotigotine-myopia-26-x-linked-female-limited",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/rotigotine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "myopia 26, X-linked, female-limited"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/treprostinil",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "treprostinil",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "treprostinil",
              "display": "Treprostinil"
            }
          ],
          "text": "Treprostinil"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "抗凝血劑。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/treprostinil-pulmonary-arteriovenous-malformation-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "treprostinil-pulmonary-arteriovenous-malformation-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/treprostinil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pulmonary arteriovenous malformation (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/treprostinil-pulmonary-arterial-hypertension-associated-with-con",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "treprostinil-pulmonary-arterial-hypertension-associated-with-con",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/treprostinil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pulmonary arterial hypertension associated with congenital heart disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.996
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/treprostinil-pulmonary-arterial-hypertension-associated-with-hiv",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "treprostinil-pulmonary-arterial-hypertension-associated-with-hiv",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/treprostinil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pulmonary arterial hypertension associated with HIV infection"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/treprostinil-pulmonary-arterial-hypertension-associated-with-chr",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "treprostinil-pulmonary-arterial-hypertension-associated-with-chr",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/treprostinil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pulmonary arterial hypertension associated with chronic hemolytic anemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/treprostinil-pulmonary-arterial-hypertension-associated-with-con",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "treprostinil-pulmonary-arterial-hypertension-associated-with-con",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/treprostinil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pulmonary arterial hypertension associated with connective tissue disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/treprostinil-pulmonary-arterial-hypertension-associated-with-sch",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "treprostinil-pulmonary-arterial-hypertension-associated-with-sch",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/treprostinil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pulmonary arterial hypertension associated with schistosomiasis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/treprostinil-hypotrichosis-simplex-of-the-scalp",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "treprostinil-hypotrichosis-simplex-of-the-scalp",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/treprostinil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hypotrichosis simplex of the scalp"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9948
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/treprostinil-congenital-hypotrichosis-milia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "treprostinil-congenital-hypotrichosis-milia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/treprostinil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congenital hypotrichosis milia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.993
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/treprostinil-malformation-syndrome-with-odontal-and-or-periodont",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "treprostinil-malformation-syndrome-with-odontal-and-or-periodont",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/treprostinil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "malformation syndrome with odontal and/or periodontal component"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9921
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/treprostinil-ambras-type-hypertrichosis-universalis-congenita",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "treprostinil-ambras-type-hypertrichosis-universalis-congenita",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/treprostinil"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Ambras type hypertrichosis universalis congenita"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9917
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/polymyxin_b",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "polymyxin_b",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "polymyxin_b",
              "display": "Polymyxin B"
            }
          ],
          "text": "Polymyxin B"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "傷口感染、皮膚創傷、膿瘍、燒傷、初期膿皮膚病二期感染皮膚痛。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/polymyxin_b-bronchitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "polymyxin_b-bronchitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/polymyxin_b"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "bronchitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/polymyxin_b-laryngotracheitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "polymyxin_b-laryngotracheitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/polymyxin_b"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "laryngotracheitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9962000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/polymyxin_b-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "polymyxin_b-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/polymyxin_b"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9906
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/atracurium_besylate",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "atracurium_besylate",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "atracurium_besylate",
              "display": "Atracurium besylate"
            }
          ],
          "text": "Atracurium besylate"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "本藥乃一高選擇性及競爭性的非去極化神經肌肉阻斷劑。可作為手術全身麻醉或加護病房鎮靜的輔助劑、以鬆弛骨..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/atracurium_besylate-preeclampsia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "atracurium_besylate-preeclampsia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/atracurium_besylate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "preeclampsia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/atracurium_besylate-cauda-equina-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "atracurium_besylate-cauda-equina-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/atracurium_besylate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cauda equina syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/atracurium_besylate-blepharospasm",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "atracurium_besylate-blepharospasm",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/atracurium_besylate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "blepharospasm"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/atracurium_besylate-migraine-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "atracurium_besylate-migraine-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/atracurium_besylate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "migraine disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/atracurium_besylate-obsolete-neurogenic-bladder-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "atracurium_besylate-obsolete-neurogenic-bladder-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/atracurium_besylate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "obsolete neurogenic bladder (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9991
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/atracurium_besylate-thrombotic-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "atracurium_besylate-thrombotic-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/atracurium_besylate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "thrombotic disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9989
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/atracurium_besylate-migraine-with-brainstem-aura",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "atracurium_besylate-migraine-with-brainstem-aura",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/atracurium_besylate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "migraine with brainstem aura"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/atracurium_besylate-severe-pre-eclampsia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "atracurium_besylate-severe-pre-eclampsia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/atracurium_besylate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "severe pre-eclampsia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9986
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/atracurium_besylate-mild-pre-eclampsia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "atracurium_besylate-mild-pre-eclampsia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/atracurium_besylate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "mild pre-eclampsia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9986
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/atracurium_besylate-irritable-bowel-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "atracurium_besylate-irritable-bowel-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/atracurium_besylate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "irritable bowel syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/etanercept",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "etanercept",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "etanercept",
              "display": "Etanercept"
            }
          ],
          "text": "Etanercept"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "適用於對疾病緩解型抗風濕性藥物(即DMARDs，例如methotrexate) 無適當療效之成人活動..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/etanercept-rheumatoid-vasculitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "etanercept-rheumatoid-vasculitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/etanercept"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "rheumatoid vasculitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9971
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/etanercept-hypermobility-of-coccyx",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "etanercept-hypermobility-of-coccyx",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/etanercept"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hypermobility of coccyx"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9963
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/etanercept-inflammatory-spondylopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "etanercept-inflammatory-spondylopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/etanercept"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "inflammatory spondylopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9956999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/etanercept-kummell-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "etanercept-kummell-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/etanercept"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Kummell disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/etanercept-polyarticular-juvenile-rheumatoid-arthritis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "etanercept-polyarticular-juvenile-rheumatoid-arthritis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/etanercept"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "polyarticular juvenile rheumatoid arthritis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/etanercept-vertebral-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "etanercept-vertebral-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/etanercept"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "vertebral disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9915999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/prednisone",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "prednisone",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "prednisone",
              "display": "Prednisone"
            }
          ],
          "text": "Prednisone"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "風溼性關節炎"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisone-alopecia-areata",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisone-alopecia-areata",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "alopecia areata"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisone-alopecia-mucinosa",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisone-alopecia-mucinosa",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "alopecia mucinosa"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisone-telogen-effluvium",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisone-telogen-effluvium",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "telogen effluvium"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisone-quinquaud-s-folliculitis-decalvans",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisone-quinquaud-s-folliculitis-decalvans",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Quinquaud's folliculitis decalvans"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisone-alopecia-antibody-deficiency",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisone-alopecia-antibody-deficiency",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "alopecia antibody deficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisone-hereditary-hypotrichosis-with-recurrent-skin-vesicles",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisone-hereditary-hypotrichosis-with-recurrent-skin-vesicles",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hereditary hypotrichosis with recurrent skin vesicles"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisone-alopecia-intellectual-disability-hypergonadotropic-hy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisone-alopecia-intellectual-disability-hypergonadotropic-hy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisone-atrichia-with-papular-lesions",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisone-atrichia-with-papular-lesions",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "atrichia with papular lesions"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisone-tenosynovitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisone-tenosynovitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "tenosynovitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisone-prolapse-of-lacrimal-gland",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisone-prolapse-of-lacrimal-gland",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisone"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "prolapse of lacrimal gland"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9965999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/anastrozole",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "anastrozole",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "anastrozole",
              "display": "Anastrozole"
            }
          ],
          "text": "Anastrozole"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "抗腫瘤原料藥。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/anastrozole-female-breast-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "anastrozole-female-breast-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/anastrozole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "female breast carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9968
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/anastrozole-neuroblastoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "anastrozole-neuroblastoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/anastrozole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "neuroblastoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9953
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/anastrozole-vertebral-anomalies-and-variable-endocrine-and-t-cel",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "anastrozole-vertebral-anomalies-and-variable-endocrine-and-t-cel",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/anastrozole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "vertebral anomalies and variable endocrine and T-cell dysfunction"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9942
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/anastrozole-ganglioneuroblastoma-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "anastrozole-ganglioneuroblastoma-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/anastrozole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "ganglioneuroblastoma (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9941
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/anastrozole-retroperitoneal-neoplasm",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "anastrozole-retroperitoneal-neoplasm",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/anastrozole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "retroperitoneal neoplasm"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9933
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/anastrozole-monocytic-leukemia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "anastrozole-monocytic-leukemia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/anastrozole"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "monocytic leukemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9915999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/fenoprofen",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "fenoprofen",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "fenoprofen",
              "display": "Fenoprofen"
            }
          ],
          "text": "Fenoprofen"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "風濕性關節炎、骨關節炎、關節強硬性脊椎炎、急性痛風、非關節風濕病、外傷、手術後傷口、女陰切開術後或子..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fenoprofen-acromesomelic-dysplasia-hunter-thompson-type",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fenoprofen-acromesomelic-dysplasia-hunter-thompson-type",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fenoprofen"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acromesomelic dysplasia, Hunter-Thompson type"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fenoprofen-brachyolmia-amelogenesis-imperfecta-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fenoprofen-brachyolmia-amelogenesis-imperfecta-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fenoprofen"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brachyolmia-amelogenesis imperfecta syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fenoprofen-myosclerosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fenoprofen-myosclerosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fenoprofen"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "myosclerosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fenoprofen-brachyolmia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fenoprofen-brachyolmia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fenoprofen"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brachyolmia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fenoprofen-brachydactyly-syndactyly-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fenoprofen-brachydactyly-syndactyly-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fenoprofen"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brachydactyly-syndactyly syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fenoprofen-colobomatous-microphthalmia-rhizomelic-dysplasia-synd",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fenoprofen-colobomatous-microphthalmia-rhizomelic-dysplasia-synd",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fenoprofen"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "colobomatous microphthalmia-rhizomelic dysplasia syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fenoprofen-pseudoachondroplasia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fenoprofen-pseudoachondroplasia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fenoprofen"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pseudoachondroplasia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fenoprofen-spondyloarthropathy-susceptibility-to",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fenoprofen-spondyloarthropathy-susceptibility-to",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fenoprofen"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "spondyloarthropathy, susceptibility to"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fenoprofen-whim-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fenoprofen-whim-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fenoprofen"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "WHIM syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/fenoprofen-ankylosing-spondylitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "fenoprofen-ankylosing-spondylitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/fenoprofen"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "ankylosing spondylitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/pemetrexed",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "pemetrexed",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "pemetrexed",
              "display": "Pemetrexed"
            }
          ],
          "text": "Pemetrexed"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "1.黑色素細胞瘤： 治療無法切除或轉移性黑色素瘤病人。 作為輔助性療法治療患有第IIB或IIC期黑色..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pemetrexed-malignant-peritoneal-mesothelioma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pemetrexed-malignant-peritoneal-mesothelioma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pemetrexed"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "malignant peritoneal mesothelioma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pemetrexed-pleural-adenomatoid-tumor",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pemetrexed-pleural-adenomatoid-tumor",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pemetrexed"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pleural adenomatoid tumor"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pemetrexed-pleural-mesothelioma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pemetrexed-pleural-mesothelioma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pemetrexed"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pleural mesothelioma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pemetrexed-pleural-epithelioid-mesothelioma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pemetrexed-pleural-epithelioid-mesothelioma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pemetrexed"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pleural epithelioid mesothelioma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pemetrexed-pleural-sarcomatoid-mesothelioma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pemetrexed-pleural-sarcomatoid-mesothelioma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pemetrexed"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pleural sarcomatoid mesothelioma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pemetrexed-pleural-biphasic-mesothelioma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pemetrexed-pleural-biphasic-mesothelioma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pemetrexed"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pleural biphasic mesothelioma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pemetrexed-pericardium-cancer",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pemetrexed-pericardium-cancer",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pemetrexed"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pericardium cancer"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pemetrexed-well-differentiated-papillary-mesothelioma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pemetrexed-well-differentiated-papillary-mesothelioma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pemetrexed"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "well differentiated papillary mesothelioma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pemetrexed-lymphohistiocytoid-mesothelioma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pemetrexed-lymphohistiocytoid-mesothelioma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pemetrexed"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "lymphohistiocytoid mesothelioma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/pemetrexed-iminoglycinuria",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "pemetrexed-iminoglycinuria",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/pemetrexed"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "iminoglycinuria"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/salicylamide",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "salicylamide",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "salicylamide",
              "display": "Salicylamide"
            }
          ],
          "text": "Salicylamide"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "解熱鎮痛劑"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/salicylamide-pharyngitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "salicylamide-pharyngitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/salicylamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pharyngitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/salicylamide-nasal-cavity-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "salicylamide-nasal-cavity-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/salicylamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "nasal cavity disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/salicylamide-acute-laryngopharyngitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "salicylamide-acute-laryngopharyngitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/salicylamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acute laryngopharyngitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/salicylamide-trigeminal-autonomic-cephalalgia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "salicylamide-trigeminal-autonomic-cephalalgia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/salicylamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "trigeminal autonomic cephalalgia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9994
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/salicylamide-common-cold",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "salicylamide-common-cold",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/salicylamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "common cold"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/salicylamide-allergic-urticaria",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "salicylamide-allergic-urticaria",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/salicylamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "allergic urticaria"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9965
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/salicylamide-lung-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "salicylamide-lung-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/salicylamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "lung disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9964
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/salicylamide-massive-neonatal-aspiration-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "salicylamide-massive-neonatal-aspiration-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/salicylamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "massive neonatal aspiration syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9958
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/salicylamide-respiratory-syncytial-virus-bronchiolitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "salicylamide-respiratory-syncytial-virus-bronchiolitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/salicylamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "respiratory syncytial virus bronchiolitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9956
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/salicylamide-hantavirus-infectious-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "salicylamide-hantavirus-infectious-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/salicylamide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hantavirus infectious disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9953
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/brodalumab",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "brodalumab",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "brodalumab",
              "display": "Brodalumab"
            }
          ],
          "text": "Brodalumab"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "１、 斑塊性乾癬：治療適合接受全身性治療的中至重度斑塊性乾癬成人病人。\n２、膿疱性乾癬：治療適合接受..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/brodalumab-strongyloidiasis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "brodalumab-strongyloidiasis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/brodalumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "strongyloidiasis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/brodalumab-eye-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "brodalumab-eye-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/brodalumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "eye disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9982
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/brodalumab-vitamin-deficiency-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "brodalumab-vitamin-deficiency-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/brodalumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "vitamin deficiency disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/brodalumab-von-hippel-anomaly",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "brodalumab-von-hippel-anomaly",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/brodalumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "von Hippel anomaly"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/brodalumab-recurrent-idiopathic-neuroretinitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "brodalumab-recurrent-idiopathic-neuroretinitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/brodalumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "recurrent idiopathic neuroretinitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/brodalumab-optic-perineuritis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "brodalumab-optic-perineuritis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/brodalumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "optic perineuritis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/brodalumab-chronic-relapsing-inflammatory-optic-neuropathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "brodalumab-chronic-relapsing-inflammatory-optic-neuropathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/brodalumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "chronic relapsing inflammatory optic neuropathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/brodalumab-isolated-optic-neuritis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "brodalumab-isolated-optic-neuritis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/brodalumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "isolated optic neuritis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/brodalumab-nodular-episcleritis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "brodalumab-nodular-episcleritis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/brodalumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "nodular episcleritis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/brodalumab-episcleritis-periodica-fugax",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "brodalumab-episcleritis-periodica-fugax",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/brodalumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "episcleritis periodica fugax"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9976
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/simoctocog_alfa",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "simoctocog_alfa",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "simoctocog_alfa",
              "display": "Simoctocog alfa"
            }
          ],
          "text": "Simoctocog alfa"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "治療與預防A型血友病(先天性第八凝血因子缺乏)病人的出血。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/simoctocog_alfa-pseudo-von-willebrand-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "simoctocog_alfa-pseudo-von-willebrand-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/simoctocog_alfa"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pseudo-von Willebrand disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/simoctocog_alfa-primary-release-disorder-of-platelets",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "simoctocog_alfa-primary-release-disorder-of-platelets",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/simoctocog_alfa"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "primary release disorder of platelets"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/simoctocog_alfa-glanzmann-thrombasthenia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "simoctocog_alfa-glanzmann-thrombasthenia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/simoctocog_alfa"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Glanzmann thrombasthenia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/simoctocog_alfa-scott-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "simoctocog_alfa-scott-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/simoctocog_alfa"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Scott syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/simoctocog_alfa-acquired-coagulation-factor-deficiency",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "simoctocog_alfa-acquired-coagulation-factor-deficiency",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/simoctocog_alfa"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acquired coagulation factor deficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/simoctocog_alfa-bleeding-diathesis-due-to-a-collagen-receptor-de",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "simoctocog_alfa-bleeding-diathesis-due-to-a-collagen-receptor-de",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/simoctocog_alfa"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "bleeding diathesis due to a collagen receptor defect"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/simoctocog_alfa-hemorrhagic-disorder-due-to-a-constitutional-thr",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "simoctocog_alfa-hemorrhagic-disorder-due-to-a-constitutional-thr",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/simoctocog_alfa"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hemorrhagic disorder due to a constitutional thrombocytopenia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/simoctocog_alfa-fetal-and-neonatal-alloimmune-thrombocytopenia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "simoctocog_alfa-fetal-and-neonatal-alloimmune-thrombocytopenia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/simoctocog_alfa"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "fetal and neonatal alloimmune thrombocytopenia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/simoctocog_alfa-hemophilia-a-with-vascular-abnormality",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "simoctocog_alfa-hemophilia-a-with-vascular-abnormality",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/simoctocog_alfa"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hemophilia A with vascular abnormality"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9978
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/simoctocog_alfa-thrombotic-thrombocytopenic-purpura",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "simoctocog_alfa-thrombotic-thrombocytopenic-purpura",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/simoctocog_alfa"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "thrombotic thrombocytopenic purpura"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9972
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/hydroxyurea",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "hydroxyurea",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "hydroxyurea",
              "display": "Hydroxyurea"
            }
          ],
          "text": "Hydroxyurea"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "1.\t適用於治療中度風險或高風險之骨髓纖維化，包括原發性骨髓纖維化、真性紅血球增多症後骨髓纖維化、或..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroxyurea-female-breast-carcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroxyurea-female-breast-carcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroxyurea"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "female breast carcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroxyurea-sickle-cell-hemoglobin-e-disease-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroxyurea-sickle-cell-hemoglobin-e-disease-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroxyurea"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "sickle cell-hemoglobin E disease syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9967
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroxyurea-sickle-cell-hemoglobin-c-disease-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroxyurea-sickle-cell-hemoglobin-c-disease-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroxyurea"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "sickle cell-hemoglobin c disease syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9967
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroxyurea-hereditary-persistence-of-fetal-hemoglobin-sickle-ce",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroxyurea-hereditary-persistence-of-fetal-hemoglobin-sickle-ce",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroxyurea"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "hereditary persistence of fetal hemoglobin-sickle cell disease syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9967
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroxyurea-sickle-cell-hemoglobin-d-disease-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroxyurea-sickle-cell-hemoglobin-d-disease-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroxyurea"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "sickle cell-hemoglobin d disease syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9967
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroxyurea-sickle-cell-beta-thalassemia-disease-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroxyurea-sickle-cell-beta-thalassemia-disease-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroxyurea"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "sickle cell-beta-thalassemia disease syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9967
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroxyurea-cervical-adenosarcoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroxyurea-cervical-adenosarcoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroxyurea"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cervical adenosarcoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9940000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroxyurea-colon-mucinous-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroxyurea-colon-mucinous-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroxyurea"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "colon mucinous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9932
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroxyurea-rectum-mucinous-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroxyurea-rectum-mucinous-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroxyurea"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "rectum mucinous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9931
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/hydroxyurea-gallbladder-mucinous-adenocarcinoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "hydroxyurea-gallbladder-mucinous-adenocarcinoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/hydroxyurea"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gallbladder mucinous adenocarcinoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9928
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/tizanidine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "tizanidine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "tizanidine",
              "display": "Tizanidine"
            }
          ],
          "text": "Tizanidine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "神經疾患所引起的痙攣症狀、疼痛性肌肉痙攣。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tizanidine-migraine-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tizanidine-migraine-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tizanidine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "migraine disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9979
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tizanidine-migraine-with-brainstem-aura",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tizanidine-migraine-with-brainstem-aura",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tizanidine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "migraine with brainstem aura"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9971
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tizanidine-migraine-with-or-without-aura-susceptibility-to",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tizanidine-migraine-with-or-without-aura-susceptibility-to",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tizanidine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "migraine with or without aura, susceptibility to"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tizanidine-atrophoderma-vermiculata",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tizanidine-atrophoderma-vermiculata",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tizanidine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "atrophoderma vermiculata"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9931
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tizanidine-tourette-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tizanidine-tourette-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tizanidine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Tourette syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9917
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/tizanidine-ulerythema-ophryogenesis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "tizanidine-ulerythema-ophryogenesis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/tizanidine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "ulerythema ophryogenesis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9913
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/silicon_dioxide",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "silicon_dioxide",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "silicon_dioxide",
              "display": "Silicon dioxide"
            }
          ],
          "text": "Silicon dioxide"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "下列各種疾患的袪痰：急慢性支氣管炎、支氣管擴張症、支氣管喘喉頭炎、感冒慢性副鼻腔炎之排膿"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/silicon_dioxide-active-peptic-ulcer-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "silicon_dioxide-active-peptic-ulcer-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/silicon_dioxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "active peptic ulcer disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9993000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/silicon_dioxide-gastrojejunal-ulcer",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "silicon_dioxide-gastrojejunal-ulcer",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/silicon_dioxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gastrojejunal ulcer"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/silicon_dioxide-peptic-ulcer-perforation",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "silicon_dioxide-peptic-ulcer-perforation",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/silicon_dioxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "peptic ulcer perforation"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9992
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/silicon_dioxide-gastric-ulcer-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "silicon_dioxide-gastric-ulcer-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/silicon_dioxide"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gastric ulcer (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9983
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/threonine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "threonine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "threonine",
              "display": "Threonine"
            }
          ],
          "text": "Threonine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "營養補給"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/threonine-gastroparesis-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "threonine-gastroparesis-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/threonine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "gastroparesis (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9932
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/alirocumab",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "alirocumab",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "alirocumab",
              "display": "Alirocumab"
            }
          ],
          "text": "Alirocumab"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "1. 預防心血管事件：對於已確診心血管疾病的成年病人，Praluent可用於降低心肌梗塞、中風以及需..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alirocumab-ichthyosis-x-linked-without-steroid-sulfatase-deficie",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alirocumab-ichthyosis-x-linked-without-steroid-sulfatase-deficie",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alirocumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "ichthyosis, X-linked, without steroid sulfatase deficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9943000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alirocumab-disorder-of-other-vitamins-and-cofactors-metabolism-a",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alirocumab-disorder-of-other-vitamins-and-cofactors-metabolism-a",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alirocumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "disorder of other vitamins and cofactors metabolism and transport"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9941
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alirocumab-xanthomatosis-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alirocumab-xanthomatosis-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alirocumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "xanthomatosis (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9937
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alirocumab-46-xy-disorder-of-sexual-development-due-to-dihydrote",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alirocumab-46-xy-disorder-of-sexual-development-due-to-dihydrote",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alirocumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "46,XY disorder of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9937
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alirocumab-cholesterol-catabolic-process-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alirocumab-cholesterol-catabolic-process-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alirocumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cholesterol catabolic process disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9936
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alirocumab-46-xy-disorder-of-sex-development-due-to-a-cholestero",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alirocumab-46-xy-disorder-of-sex-development-due-to-a-cholestero",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alirocumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "46,XY disorder of sex development due to a cholesterol synthesis defect"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9934999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alirocumab-dappled-diaphyseal-dysplasia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alirocumab-dappled-diaphyseal-dysplasia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alirocumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "dappled diaphyseal dysplasia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.993
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alirocumab-neutral-lipid-storage-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alirocumab-neutral-lipid-storage-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alirocumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "neutral lipid storage disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9929000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alirocumab-3-hydroxyacyl-coa-dehydrogenase-deficiency",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alirocumab-3-hydroxyacyl-coa-dehydrogenase-deficiency",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alirocumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "3-hydroxyacyl-CoA dehydrogenase deficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9929000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/alirocumab-spastic-paraplegia-optic-atrophy-neuropathy-and-spast",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "alirocumab-spastic-paraplegia-optic-atrophy-neuropathy-and-spast",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/alirocumab"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "spastic paraplegia-optic atrophy-neuropathy and spastic paraplegia-optic atrophy-neuropathy-related disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9926
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/aluminum_chloride",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "aluminum_chloride",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "aluminum_chloride",
              "display": "Aluminum chloride"
            }
          ],
          "text": "Aluminum chloride"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "抗多汗。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_chloride-seborrheic-keratosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_chloride-seborrheic-keratosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_chloride"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "seborrheic keratosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9968
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_chloride-congenital-prothrombin-deficiency",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_chloride-congenital-prothrombin-deficiency",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_chloride"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "congenital prothrombin deficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9965999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_chloride-seborrheic-dermatitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_chloride-seborrheic-dermatitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_chloride"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "seborrheic dermatitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9963
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_chloride-acne-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_chloride-acne-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_chloride"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acne (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9943000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_chloride-vulvar-inverted-follicular-keratosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_chloride-vulvar-inverted-follicular-keratosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_chloride"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "vulvar inverted follicular keratosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9937999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_chloride-skin-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_chloride-skin-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_chloride"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "skin disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9934999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_chloride-dry-eye-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_chloride-dry-eye-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_chloride"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "dry eye syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9931
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_chloride-eye-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_chloride-eye-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_chloride"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "eye disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9929000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_chloride-von-hippel-anomaly",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_chloride-von-hippel-anomaly",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_chloride"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "von Hippel anomaly"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9918
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/aluminum_chloride-chronic-relapsing-inflammatory-optic-neuropath",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "aluminum_chloride-chronic-relapsing-inflammatory-optic-neuropath",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/aluminum_chloride"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "chronic relapsing inflammatory optic neuropathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9915999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/salicylic_acid",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "salicylic_acid",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "salicylic_acid",
              "display": "Salicylic acid"
            }
          ],
          "text": "Salicylic acid"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "解熱鎮痛劑"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/salicylic_acid-papillary-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "salicylic_acid-papillary-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/salicylic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "papillary conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/salicylic_acid-colobomatous-microphthalmia-rhizomelic-dysplasia-",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "salicylic_acid-colobomatous-microphthalmia-rhizomelic-dysplasia-",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/salicylic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "colobomatous microphthalmia-rhizomelic dysplasia syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9978
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/salicylic_acid-brachydactyly-syndactyly-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "salicylic_acid-brachydactyly-syndactyly-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/salicylic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brachydactyly-syndactyly syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9973000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/salicylic_acid-brachyolmia-amelogenesis-imperfecta-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "salicylic_acid-brachyolmia-amelogenesis-imperfecta-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/salicylic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brachyolmia-amelogenesis imperfecta syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9954999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/salicylic_acid-rosacea-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "salicylic_acid-rosacea-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/salicylic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "rosacea conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9953
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/salicylic_acid-acromesomelic-dysplasia-hunter-thompson-type",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "salicylic_acid-acromesomelic-dysplasia-hunter-thompson-type",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/salicylic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acromesomelic dysplasia, Hunter-Thompson type"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9952
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/salicylic_acid-pseudoachondroplasia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "salicylic_acid-pseudoachondroplasia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/salicylic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pseudoachondroplasia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9951000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/salicylic_acid-myosclerosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "salicylic_acid-myosclerosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/salicylic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "myosclerosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9948999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/salicylic_acid-brachyolmia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "salicylic_acid-brachyolmia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/salicylic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brachyolmia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9944
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/salicylic_acid-spondyloarthropathy-susceptibility-to",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "salicylic_acid-spondyloarthropathy-susceptibility-to",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/salicylic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "spondyloarthropathy, susceptibility to"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9934000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/emedastine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "emedastine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "emedastine",
              "display": "Emedastine"
            }
          ],
          "text": "Emedastine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "過敏性結膜炎症狀及徵候的暫時性緩解。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/emedastine-allergic-urticaria",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "emedastine-allergic-urticaria",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/emedastine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "allergic urticaria"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9995999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/emedastine-cold-urticaria",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "emedastine-cold-urticaria",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/emedastine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cold urticaria"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9982
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/prednisolone_acetate",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "prednisolone_acetate",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "prednisolone_acetate",
              "display": "Prednisolone acetate"
            }
          ],
          "text": "Prednisolone acetate"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "眼瞼炎、結膜炎、角膜炎、鞏膜炎、虹彩毛樣體炎等過敏性疾患"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisolone_acetate-parasitic-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisolone_acetate-parasitic-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisolone_acetate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "parasitic conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9974
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisolone_acetate-chronic-follicular-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisolone_acetate-chronic-follicular-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisolone_acetate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "chronic follicular conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9974
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisolone_acetate-serous-conjunctivitis-except-viral",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisolone_acetate-serous-conjunctivitis-except-viral",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisolone_acetate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "serous conjunctivitis except viral"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9974
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisolone_acetate-conjunctival-folliculosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisolone_acetate-conjunctival-folliculosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisolone_acetate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "conjunctival folliculosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9974
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisolone_acetate-papillary-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisolone_acetate-papillary-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisolone_acetate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "papillary conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L2"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9972
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisolone_acetate-angelucci-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisolone_acetate-angelucci-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisolone_acetate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Angelucci syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9972
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisolone_acetate-pseudomembranous-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisolone_acetate-pseudomembranous-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisolone_acetate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pseudomembranous conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9971
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisolone_acetate-acute-hemorrhagic-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisolone_acetate-acute-hemorrhagic-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisolone_acetate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acute hemorrhagic conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisolone_acetate-vernal-conjunctivitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisolone_acetate-vernal-conjunctivitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisolone_acetate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "vernal conjunctivitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9958
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/prednisolone_acetate-postinfectious-vasculitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "prednisolone_acetate-postinfectious-vasculitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/prednisolone_acetate"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "postinfectious vasculitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9944
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/icatibant",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "icatibant",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "icatibant",
              "display": "Icatibant"
            }
          ],
          "text": "Icatibant"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "適用於體內C1酯酶抑制劑不足的成人、青少年及2歲以上兒童，在其遺傳性血管性水腫 (hereditar..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/icatibant-c1-inhibitor-deficiency",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "icatibant-c1-inhibitor-deficiency",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/icatibant"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "C1 inhibitor deficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/icatibant-serpinopathy-with-toxic-serpin-polymerization",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "icatibant-serpinopathy-with-toxic-serpin-polymerization",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/icatibant"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "serpinopathy with toxic serpin polymerization"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9998999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/icatibant-pseudo-von-willebrand-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "icatibant-pseudo-von-willebrand-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/icatibant"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pseudo-von Willebrand disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9921
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/icatibant-primary-release-disorder-of-platelets",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "icatibant-primary-release-disorder-of-platelets",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/icatibant"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "primary release disorder of platelets"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9914000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/icatibant-immune-mediated-necrotizing-myopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "icatibant-immune-mediated-necrotizing-myopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/icatibant"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "immune-mediated necrotizing myopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9906
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/icatibant-antisynthetase-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "icatibant-antisynthetase-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/icatibant"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "antisynthetase syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9902
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/icatibant-glanzmann-thrombasthenia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "icatibant-glanzmann-thrombasthenia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/icatibant"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Glanzmann thrombasthenia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.99
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/methionine",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "methionine",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "methionine",
              "display": "Methionine"
            }
          ],
          "text": "Methionine"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "胃、十二指腸潰瘍"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/methionine-acne-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "methionine-acne-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/methionine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acne (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/methionine-severe-nonproliferative-diabetic-retinopathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "methionine-severe-nonproliferative-diabetic-retinopathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/methionine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "severe nonproliferative diabetic retinopathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/methionine-immature-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "methionine-immature-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/methionine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "immature cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/methionine-craniostenosis-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "methionine-craniostenosis-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/methionine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "craniostenosis cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/methionine-mature-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "methionine-mature-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/methionine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "mature cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/methionine-diabetes-mellitus-type-2-associated-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "methionine-diabetes-mellitus-type-2-associated-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/methionine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "diabetes mellitus type 2 associated cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/methionine-tetanic-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "methionine-tetanic-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/methionine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "tetanic cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/methionine-cortical-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "methionine-cortical-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/methionine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "cortical cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/methionine-nuclear-senile-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "methionine-nuclear-senile-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/methionine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "nuclear senile cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/methionine-diabetic-cataract",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "methionine-diabetic-cataract",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/methionine"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "diabetic cataract"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 1.0
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/lornoxicam",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "lornoxicam",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "lornoxicam",
              "display": "Lornoxicam"
            }
          ],
          "text": "Lornoxicam"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "(1)輕度至中度急性疼痛之短期止痛。(2)退化性關節炎之症狀及徵象緩解。"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/lornoxicam-rheumatoid-arthritis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "lornoxicam-rheumatoid-arthritis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/lornoxicam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "rheumatoid arthritis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9990000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/lornoxicam-migraine-with-or-without-aura-susceptibility-to",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "lornoxicam-migraine-with-or-without-aura-susceptibility-to",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/lornoxicam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "migraine with or without aura, susceptibility to"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/lornoxicam-migraine-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "lornoxicam-migraine-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/lornoxicam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "migraine disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/lornoxicam-migraine-with-brainstem-aura",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "lornoxicam-migraine-with-brainstem-aura",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/lornoxicam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "migraine with brainstem aura"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/lornoxicam-brachydactyly-syndactyly-syndrome",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "lornoxicam-brachydactyly-syndactyly-syndrome",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/lornoxicam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brachydactyly-syndactyly syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9982
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/lornoxicam-colobomatous-microphthalmia-rhizomelic-dysplasia-synd",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "lornoxicam-colobomatous-microphthalmia-rhizomelic-dysplasia-synd",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/lornoxicam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "colobomatous microphthalmia-rhizomelic dysplasia syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9981
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/lornoxicam-headache-disorder",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "lornoxicam-headache-disorder",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/lornoxicam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "headache disorder"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.998
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/lornoxicam-trigeminal-autonomic-cephalalgia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "lornoxicam-trigeminal-autonomic-cephalalgia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/lornoxicam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "trigeminal autonomic cephalalgia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9975
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/lornoxicam-tendinitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "lornoxicam-tendinitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/lornoxicam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "tendinitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9972
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/lornoxicam-idiopathic-granulomatous-myositis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "lornoxicam-idiopathic-granulomatous-myositis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/lornoxicam"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "idiopathic granulomatous myositis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.997
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/theophylline",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "theophylline",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "theophylline",
              "display": "Theophylline"
            }
          ],
          "text": "Theophylline"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "平滑肌鬆弛藥"
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/theophylline-thrombotic-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "theophylline-thrombotic-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/theophylline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "thrombotic disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9962000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/theophylline-nasal-cavity-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "theophylline-nasal-cavity-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/theophylline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "nasal cavity disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9953
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/theophylline-laryngotracheitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "theophylline-laryngotracheitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/theophylline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "laryngotracheitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9951000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/theophylline-tracheal-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "theophylline-tracheal-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/theophylline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "tracheal disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9948999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/theophylline-obstructive-lung-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "theophylline-obstructive-lung-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/theophylline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "obstructive lung disease"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L1"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9948
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/theophylline-pharyngitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "theophylline-pharyngitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/theophylline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "pharyngitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9945999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/theophylline-acute-laryngopharyngitis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "theophylline-acute-laryngopharyngitis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/theophylline"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "acute laryngopharyngitis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9934999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/warfarin",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "warfarin",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "warfarin",
              "display": "warfarin"
            }
          ],
          "text": "warfarin"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/warfarin-heparin-cofactor-2-deficiency",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "warfarin-heparin-cofactor-2-deficiency",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/warfarin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "heparin cofactor 2 deficiency"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9987
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/warfarin-factor-5-excess-with-spontaneous-thrombosis",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "warfarin-factor-5-excess-with-spontaneous-thrombosis",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/warfarin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "factor 5 excess with spontaneous thrombosis"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/warfarin-antithrombin-deficiency-type-2",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "warfarin-antithrombin-deficiency-type-2",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/warfarin"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "antithrombin deficiency type 2"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9984000000000001
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/deoxycholic_acid",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "deoxycholic_acid",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "deoxycholic_acid",
              "display": "Deoxycholic acid"
            }
          ],
          "text": "Deoxycholic acid"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "膽固醇系膽結石之溶解、原發性膽道肝硬化〈primary biliary cirrhosis, PBC..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/deoxycholic_acid-autosomal-dominant-familial-hematuria-retinal-a",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "deoxycholic_acid-autosomal-dominant-familial-hematuria-retinal-a",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/deoxycholic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9948999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/deoxycholic_acid-brain-small-vessel-disease-1-with-or-without-oc",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "deoxycholic_acid-brain-small-vessel-disease-1-with-or-without-oc",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/deoxycholic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "brain small vessel disease 1 with or without ocular anomalies"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9948999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/deoxycholic_acid-diabetic-nephropathy",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "deoxycholic_acid-diabetic-nephropathy",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/deoxycholic_acid"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "diabetic nephropathy"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9932
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/MedicationKnowledge/zanubrutinib",
      "resource": {
        "resourceType": "MedicationKnowledge",
        "id": "zanubrutinib",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/MedicationKnowledge"
          ]
        },
        "status": "active",
        "code": {
          "coding": [
            {
              "system": "https://twtxgnn.yao.care/drugs",
              "code": "zanubrutinib",
              "display": "Zanubrutinib"
            }
          ],
          "text": "Zanubrutinib"
        },
        "intendedJurisdiction": [
          {
            "coding": [
              {
                "system": "urn:iso:std:iso:3166",
                "code": "TW",
                "display": "Taiwan"
              }
            ]
          }
        ],
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          }
        ],
        "indicationGuideline": [
          {
            "indication": [
              {
                "reference": {
                  "display": "1. 適用於先前曾接受至少一種治療的被套細胞淋巴瘤(Mantle Cell Lymphoma, MC..."
                }
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/zanubrutinib-myeloid-leukemia",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "zanubrutinib-myeloid-leukemia",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/zanubrutinib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "myeloid leukemia"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L3"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9965
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/zanubrutinib-vertebral-anomalies-and-variable-endocrine-and-t-ce",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "zanubrutinib-vertebral-anomalies-and-variable-endocrine-and-t-ce",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/zanubrutinib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "vertebral anomalies and variable endocrine and T-cell dysfunction"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9937999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/zanubrutinib-ganglioneuroblastoma-disease",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "zanubrutinib-ganglioneuroblastoma-disease",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/zanubrutinib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "ganglioneuroblastoma (disease)"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9936
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/zanubrutinib-retroperitoneal-neoplasm",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "zanubrutinib-retroperitoneal-neoplasm",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/zanubrutinib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "retroperitoneal neoplasm"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.993
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/zanubrutinib-ewing-sarcoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "zanubrutinib-ewing-sarcoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/zanubrutinib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "Ewing sarcoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L5"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9926999999999999
          }
        ]
      }
    },
    {
      "fullUrl": "https://twtxgnn.yao.care/fhir/ClinicalUseDefinition/zanubrutinib-neuroblastoma",
      "resource": {
        "resourceType": "ClinicalUseDefinition",
        "id": "zanubrutinib-neuroblastoma",
        "meta": {
          "profile": [
            "http://hl7.org/fhir/StructureDefinition/ClinicalUseDefinition"
          ]
        },
        "type": "indication",
        "status": {
          "coding": [
            {
              "system": "http://hl7.org/fhir/publication-status",
              "code": "draft",
              "display": "Draft"
            }
          ]
        },
        "subject": [
          {
            "reference": "MedicationKnowledge/zanubrutinib"
          }
        ],
        "indication": {
          "diseaseSymptomProcedure": {
            "concept": {
              "text": "neuroblastoma"
            }
          }
        },
        "extension": [
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/prediction-status",
            "valueCode": "predicted"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/evidence-level",
            "valueCode": "L4"
          },
          {
            "url": "https://twtxgnn.yao.care/fhir/StructureDefinition/txgnn-score",
            "valueDecimal": 0.9921
          }
        ]
      }
    }
  ]
}